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ABSTRACT
Introduction. Despite a substantial prevalence of subthreshold AttentionDeficit/Hyperactivity Disorder (ADHD) and research indicating that many youth with
this disorder have impaired functioning and negative outcomes, few studies have
considered patterns of symptom and functioning change for youth with probable ADHD,
subthreshold ADHD and youth without ADHD transitioning from childhood to
adolescence. Additionally, we are not aware of any studies examining predictors of
impairment severity among youth with subthreshold ADHD, and few studies have
examined predictors of treatment utilization and patterns of symptom and functioning
change based on medication status for youth with subthreshold ADHD compared to
youth with ADHD. Methods. This study utilized data from the South Carolina Project to
Learn about ADHD in Youth (SCPLAY). After a two-phase screening, a sample of
children at high and low risk (frequency-matched on gender) of ADHD and
parents/caregivers were invited for interviews. The Jacobson & Traux reliable change
index (RCI) and chi-square tests were used to examine patterns of (ADHD) symptom and
functional impairment change and logistic regression methods were used to identify
predictors of impairment severity and medication use. Results. At baseline interview,
children were identified who met symptom criteria for subthreshold ADHD (N=84),
probable ADHD (186), and probable non-ADHD (n=211) and patterns of change in
symptoms and functioning were examined at follow-up (starting three years later)
(n=292). Subthreshold ADHD symptoms were seen in as many as 17% (N = 84) of the
v

youth studied at baseline. Youth (both non-ADHD and subthreshold ADHD at baseline)
who achieved probable ADHD status at follow-up are more likely to show impaired
functioning than individuals achieving subthreshold ADHD or non-ADHD status. Thirty
three percent of youth who were subthreshold at baseline remained in that category at
follow-up and 12%-21% showed significant decline in at least one domain of
functioning. Youth who were subthreshold ADHD at baseline who were subthreshold at
follow-up and taking medication (year prior to follow-up) declined in four of the five
domains of functioning and youth who were subthreshold ADHD at baseline and
probable ADHD at follow-up (and medicated the year prior to follow-up) declined in
three out of five domains of functioning. Change in functioning, both improved
functioning and worsened functioning, often occurred when there was no reliable or
significant change in symptoms. In multivariable analyses, severe impairment was
significantly predicted by psychiatric comorbidity among probable ADHD cases, being
male among subthreshold ADHD, and primary parent psychiatric history and medication
use among individuals without ADHD at follow-up. Use of ADHD medication the year
prior to follow-up was significantly predicted by parent perceived burden in the
subthreshold ADHD model and female gender in the probable ADHD model.
Conclusions. The findings show the importance of examining both symptom and
functioning constructs in the consideration of their unique contributions to ADHD and
subthreshold ADHD diagnoses and of acknowledging the need to examine nuanced
changes in diagnostic status during development. These findings may be relevant to
efforts to intervene earlier in childhood and to help identify high-risk individuals who
may be good candidates for targeted interventions.
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Chapter 1
INTRODUCTION
BACKGROUND
Attention-Deficit/Hyperactivity Disorder (ADHD) is a highly prevalent,
persistent, heterogeneous, costly, and impairing disorder. In 2006, 7% (1.5 million) of
American children aged 3-17 had ADHD (Bloom & Cohen, 2007). Using a strict
diagnostic case definition, a recent longitudinal community-based study in South
Carolina (SCPLAY) reported an 8.7% ADHD prevalence rate among children 5-13 years
of age (M. L. Wolraich et al., 2012). Rates of parent-reported ADHD diagnosis increased
3% annually from 1997 to 2006 (Pastor & Reuben, 2008), and by 2007, parents reported
nearly one in ten American school-aged children had received a diagnosis (CDC, 2010).
While diagnostic retention (maintaining full ADHD diagnostic status over time)
rates vary, both clinical and community-based studies show that a considerable
proportion of childhood ADHD cases persist into adolescence (Bussing, Mason, Bell,
Porter, & Garvan, 2010; Polanczyk & Jensen, 2008). Symptom trajectory studies, those
that determine the number of ADHD symptoms exhibited across recurring assessments,
show a decrease in ADHD symptoms with increasing age; however, there is clear
evidence of variable symptom persistence for many (Holbrook, 2012; Willoughby, 2003).
The 1980’s marked the turning point when researchers began to refute the assumption
that ADHD remitted by adolescence (Willoughby, 2003). Since that time, the perception
1

of ADHD has changed from characterization as a childhood disorder to that of a lifespan
disorder (McGough & Barkley, 2004).
ADHD is heterogeneous in terms of symptom and functional impairment
expression and course. ADHD is characterized by hyperactive-impulsive and/or
inattentive symptoms (present before age 7) that continue over time and cause associated
social, academic, and/or occupational impairment in functioning in at least two settings
(e.g., home and school) (American Psychiatric Association, 2000). ADHD expression
reflects a dynamic interplay of individual characteristics and the circumstances of each
child (Johnston & Mash, 2001). The clinical complexity of ADHD is also marked by
frequent co-morbid disorders such as Oppositional Defiant Disorder (ODD), Depression,
and Conduct Disorder (CD) (Steinhausen, 2009).
The public health cost of ADHD is high both in fiscal and human terms. In the
US, the annual societal cost of ADHD in childhood and adolescence is approximately
$42.5 billion; an estimated yearly cost (health care, education, parental work loss, and
juvenile justice cost data from 13 studies in 2005) of $14,576 for individuals with ADHD
(W. E. Pelham, Foster, & Robb, 2007). In terms of the human toll, children with ADHD
have marked impairments which impact many aspects of the individual’s life (Health,
1998 Nov 16-18). Children with ADHD can experience adverse educational, vocational,
economic and social-emotional outcomes which, in turn, have a profound impact on
affected youth’s development, their families, schools, and society (Health, 1998 Nov 1618). Functional impairments, not symptom count or symptom severity drives these large
fiscal and societal costs (Goldstein & Naglieri, 2009).
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The developmental course of ADHD functioning from childhood to middle
adolescence has been described by one researcher as “a bumpy road for many”
(Mannuzza & Klein, 2000). Those who encounter prolonged underachievement and
failure, associated with ADHD, may fare more poorly throughout life (Young &
Gudjonsson, 2008) and childhood impairment is the best predictor of short- and longterm outcomes for children and adolescents (Fabiano & Pelham, 2009). As a result of the
significant ADHD-associated impairment experienced by youth, frequent utilization of
health services, and the large personal, economic, and societal impact, ADHD is
recognized as a major public health concern (W. E. Pelham, et al., 2007; Scahill et al.,
1999).
STATEMENT OF THE PROBLEM
Symptoms: Only Part of the ADHD Developmental Course Picture
Diagnostic retention and symptom trajectory studies, while valuable in helping to
shape our understanding of the persistence of ADHD and ADHD symptomatology, only
provide part of the ADHD developmental course picture. ADHD is a chronic condition
for many, and although symptoms tend to decline over time, this does not necessarily
mean that normalized functioning follows (Willoughby, 2003). Distress is caused more
by impairment than symptoms, and impairment is the main reason for treatment referrals.
(J. S. Owens, Johannes, & Karpenko, 2009). Impairment in daily function, rather than the
number of symptoms, determines one’s quality of life (Goldstein & Naglieri, 2009) and
allows for an understanding of service needs (Gordon et al., 2006). Measures of
impairment are as important as measures of symptoms in determining diagnosis (Lahey et
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al., 2004); and, measuring functional impairment is even more important in treatment
planning than measuring symptoms (Lahey, et al., 2004).
Functional Impairment: An Understudied Area
With regard to ADHD, much less research attention has been devoted to the study
of impairment than the study of symptoms (Fabiano & Pelham, 2009). Relatively few
studies have examined adolescents compared to children (Seidman, 2006), and more
prospective studies of children transitioning to adolescence are needed (Willoughby,
2003). The functional forms that developmental changes take are unclear, and potential
heterogeneity in patterns of change is an understudied area (Willoughby, 2003).
Assessing ADHD function is a weighty undertaking for clinicians and researchers
from both legislative and insurance standpoints because assessment results have
implications for youth obtaining treatment access (Canino, Costello, & Angold, 1999).
Many federal and state agencies and insurance company policies include the presence of
impairment as a requirement for service provision approval for ADHD (Canino, et al.,
1999). Decisions about the presence or absence or degree of impairment can affect
treatment, referrals, estimates of geographical service area needs, income support awards,
and eligibility of school services which in turn impacts youths' lives (Canino, et al.,
1999). Policies for assessment of impairment require that ADHD be evaluated using the
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR; a guidebook used
by professionals to make psychiatric diagnoses) criteria (American Psychiatric
Association, 2000), but do not contain recommendations or guidance on measuring
impairment (Canino, et al., 1999). The DSM-IV-TR, too, offers little guidance on how to
measure impairment (Gordon, et al., 2006).
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Youth with Subclinical ADHD: Need for Further Research
Research indicates that a sizable number of youth, not meeting symptom criteria
for a diagnosis of ADHD, experience significant functional impairment that may require
intervention (Angold, Costello, Farmer, Burns, & Erkanli, 1999; Steinhausen, 2009). This
subclinical group may have just as much impairment as youth who meet ADHD
diagnostic criteria (Goldstein & Naglieri, 2009).Researchers considering subclinical
ADHD have employed various terminologies (e.g., functional persistence, subsyndromal,
subthreshold, symptomatic persistence, ADHD Not Otherwise Specified (NOS), ADHD
residual type, and ADHD in partial remission). The term subclinical is used broadly in
this study to include any of these diminished forms of ADHD. Definitions of subclinical
ADHD often differ on the number of inclusionary symptoms, inclusion or exclusion and
degree of impairment, and inclusion or exclusion of other ADHD diagnostic criteria.
Chapter 1 provides a more in depth discussion of the nosological inconsistencies in the
ADHD literature. This study uses subthreshold ADHD, a term proposed by the American
Academy of Pediatrics in 1997, defined as three to five ADHD-HI or ADHD-IA
symptoms (using the DSM-IV diagnostic criteria (S. Faraone et al., 2006). When
referring to other studies or papers in which the authors use a different term for a
subthreshold form of ADHD that term will be used.
To date, there have been relatively few prospective longitudinal studies following
subthreshold cohorts of youth. We are not aware of any studies examining predictors of
impairment severity (e.g. socio-economic status, comorbidity, severity of symptoms, etc.)
among youth with subthreshold ADHD and few studies have examined predictors of
treatment utilization for youth with subthreshold ADHD compared to youth with ADHD
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(Bauermeister et al., 2003; Leslie et al., 2005). This is an area in need of study because
subthreshold ADHD (as with full ADHD diagnosis) is not a short-lasting problem and
may not be outgrown.
Youth who do not meet symptom count criteria, but demonstrate sufficiently
impairing symptoms, are a group who may be denied services based on current policies
(Canino, et al., 1999). For example, though children with subthreshold ADHD (meeting
fewer than the required symptoms for a diagnosis) are more likely to have poor
outcomes, they generally do not qualify for school or treatment services (Bussing, 2010).
Children and adolescents who fail to achieve full diagnosis or full remission but continue
to struggle with functional burden are a group in need of research and clinical attention
(Karpenko, Owens, Evangelista, & Dodds, 2009).
Symptom and Functional Impairment Trajectories: Patterns of Change
Recently in the ADHD literature, two studies have emerged focusing on the
poorly understood connection between reliable change in symptoms relative to
functioning (E. B. Owens, Hinshaw, Lee, & Lahey, 2009; Rosenblatt & Rosenblatt,
2002). “Reliable change” (RC) is a statistical approach to measuring an individual’s
change in performance on a standardized outcome measure (e.g.,. symptomatology or
impairment) (Jacobson & Truax, 1991).
Clinically significant (CS) change involves calculating the Reliable Change Index
(RCI) to determine if “the magnitude of change for a given client is statistically reliable”
(Jacobson & Truax, 1991) and evaluating if scores move from a clinical to a normative
distribution (Karpenko, et al., 2009). CS is often defined as return to normal functioning,
or when the level of functioning at the follow-up time point is closer to the mean of an
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individual (assesses change at the individual level) without ADHD than an individual
with ADHD (Jacobson & Truax, 1991).
Studies using CS change (Karpenko, et al., 2009) and RCI (Karpenko, et al.,
2009; E. B. Owens, et al., 2009; Rosenblatt & Rosenblatt, 2002) methodology confirm
that change in functioning, both improved functioning and worsened functioning, often
occurs when there is no reliable or significant change in symptoms. CS change may be
overly conservative compared to the RCI method alone for certain disorders, especially
ones in which a complete return to normal functioning is not expected (e.g. schizophrenia
and ADHD) because, while declines in symptoms and improvement in functioning may
occur, normative scores may only be achievable for a small number of individuals (J. S.
Owens, et al., 2009). Even if someone does not return to the normal range of functioning,
there is value in calculating the magnitude and direction of the impairment change (J. S.
Owens, et al., 2009). Of the various methods proposed to measure reliable change,
Jacobson and Traux’s method is recommended to enhance uniformity across studies (J. S.
Owens, et al., 2009).
Better understanding of the discordance between symptom and impairment
change (i.e., change in either, but not both, symptoms or impairment) would help in the
treatment decision making process (e.g., to continue or discontinue treatment/intervention
or to focus on specific domains of functioning) (J. S. Owens, et al., 2009). There is a need
for research in this area (Karpenko, et al., 2009) and to date, no studies have considered
patterns of change between symptoms and functional impairment comparing children in
the community with subthreshold ADHD to children with and without ADHD using
longitudinal naturalistic data. A consideration of the complex processes through which
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functional impairment trajectories unfold in relation to symptoms is the main focus of
this study.
PURPOSE OF THE STUDY
Study Overview
Project to Learn about ADHD in Youth (PLAY) is a joint collaboration
research project with the University of South Carolina and the University of Oklahoma
Health Sciences Center, funded by Centers for Disease Control and Prevention’s
(CDC) National Center on Birth Defects and Developmental Disabilities (NCBDDD).
PLAY is one of the largest community-based, epidemiologic investigations of ADHD in
the United States. This study will utilize data from the South Carolina site (South
Carolina Project to Learn about ADHD in Youth (SCPLAY)).
Study Goals
This study will examine the relationship between change in symptoms and
reliable change in functioning in children and adolescents with ADHD, subthreshold
ADHD, and children without ADHD who participated in the South Carolina Project to
Learn about ADHD (SCPLAY). Subthreshold ADHD is defined here as youth identified
as having three-to-five symptoms from either the inattentive or hyperactive/impulsive
ADHD subtype symptom lists (using the DSM-IV-TR). This study will enrich the literature

in several ways. First, while many studies have examined symptom trajectories, this
study is one of only a small handful of ADHD studies that examines the relation between
change in symptoms and domains of functioning (Gathje, Lewandowski, & Gordon,
2008; Karpenko, et al., 2009; Kazdin, 1999; J. S. Owens, et al., 2009; Rosenblatt &
Rosenblatt, 2002). Second, this study will use the Diagnostic Interview Schedule for
Children Version 4 (DISC-IV) (Shaffer, Fisher, Lucas, Dulcan, & Schwab-Stone, 2000)
8

to longitudinally assess patterns of change in symptoms among youth with ADHD, subclinical ADHD, and without ADHD. The DISC-IV is a highly structured, computer-based
diagnostic interview used to assess psychiatric symptoms of children and adolescents.
Third, the present study will incorporate parent/caregiver reports of functioning across
multiple domains (social, classroom, home, leisure activity, and intrapersonal), using the
Strengths & Difficulties Questionnaire (SDQ) (Goodman, 1999), to examine patterns of
change between symptoms and functioning using individual-level analysis. The SDQ
measure was selected because it allows for a consideration of functional impairment in
youth with subthreshold ADHD and control children, whereas, the DISC-IV only
assesses functioning in youth who meet symptom and other diagnostic criteria for
ADHD. Fourth, this study is novel in that it is the first to evaluate the association between
changes in symptoms and functioning based on treatment status (medicated/ not
medicated) considering youth with probable ADHD, youth with subthreshold ADHD,
and youth without ADHD in a community sample using the RCI methodology. Fifth,
predictors associated with more severe forms of ADHD functional impairment will be
explored to see if they are similar for youth with ADHD and youth with subthreshold
ADHD. Finally, predictive factors associated with subthreshold ADHD medication use
remain poorly understood; this study will identify child and family-related factors (e.g.
impairment severity and parent reported burden) that predict medication use among youth
with ADHD and youth with subthreshold ADHD.
RESEARCH QUESTIONS
Research Question 1: How do youth with subthreshold ADHD, youth with ADHD
and youth without ADHD change from baseline to follow-up with regard to patterns
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of change in symptoms and domains (both specific and aggregate) of functioning?
The 5 domains of functioning include social (friendships), school (classroom
learning), home (home life), intrapersonal (self), and free time (leisure activities).
Research Question 2: Are the risk factors that are associated with more severe
forms of ADHD functional impairment similar for youth with ADHD, youth with
subthreshold ADHD and youth without ADHD?
Research Question 3: How do youth with subthreshold ADHD, and youth with
ADHD change from baseline to follow-up with regard to patterns of change in
symptoms and functioning (both specific domains and aggregate) based on treatment
status? The 5 specific domains of functioning include social (friendships), school
(classroom learning), home (home life), intrapersonal (self), and free time (leisure
activities).
Research Question 4: Are the risk factors that are associated with ADHD
medication use similar for youth with subthreshold ADHD compared to youth with
ADHD?
PUBLIC HEALTH SIGNIFICANCE OF THE STUDY
Eight major goals addressing the public health mission of promoting mental
health and treatment of mental disorders in children were outlined at the Office of the
Surgeon General’s conference on Children's Mental Health: Developing a National
Action Agenda on September 18 – 19, 2000 in Washington, DC (U.S. Public Health
Service, 2000). In seeking to understand patterns of change between symptoms and
functional impairment trajectories of youth and exploring predictors of impairment and
service use, this research addresses four of the eight major public health goals outlined in
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the action agenda: 1. Promote social, emotional, and behavioral well-being as an integral
part of a child's healthy development; 2. Support research in developmental
psychopathology to help clarify diagnoses, 3. Increase provider understanding of
children's mental healthcare needs; and, 4. Increase research on diagnosis, prevention,
treatment, and service delivery issues to address disparities in access to mental healthcare
services, especially among different racial, ethnic, gender, and socioeconomic groups
(U.S. Public Health Service, 2000).
A better understanding of ADHD and subthreshold ADHD impairment and
symptom persistence and medication use has major clinical, scientific, and public health
relevance. Clinically, it may help in the design of targeted treatment strategies and
improvement in patient outcome. Evaluating patterns of change between symptoms and
impairment provides direct comparisons between individuals for a better understanding
of individual needs. Clinically, pinpointing areas of individual need is important so that
this information can be communicated clearly and meaningfully to caregivers and
individuals with ADHD and diminished forms of ADHD. Improved understanding of the
heterogeneity in the developmental characteristics that differentiate individuals with
ADHD versus subthreshold ADHD related to symptom and functional impairment
change would help clinicians who advise caregivers on matters related to prognosis,
treatment, and course.
This research can help identify individuals with a higher likelihood of
experiencing severe impairment and service utilization. It can also identify patterns that
have important implications for conceptualizing treatment in research and practice.
Additionally, this research will add to the existing understanding of ADHD and
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subthreshold diagnoses and explore RCI methodology that can be useful in interpreting
community longitudinal data. From a public health perspective, this knowledge can help
focus scarce societal resources toward youth at higher risk for persistent impairment. This
will allow us to better target early intervention and secondary prevention initiatives, with
the goal in mind of improving functioning of children and adolescents with subthreshold
ADHD and ADHD.
CHAPTER PREVIEW
A review of the scientific literature relating to child and adolescent ADHD and
subclinical ADHD developmental trajectories, predictors of impairment and service use
is presented in Chapter 2. Chapter 3 describes study methodology including overall
research purpose, study aims, questions, and hypotheses, participant screening and
recruitment, study design, measurement, data collection and analysis. Two manuscripts
are presented in Chapter 4 and include key study results. Chapter 5 provides a summary
of research results and discusses study implications and recommendations for future
research.
TERMINOLOGY AND KEY CONCEPTS
Adolescents: Minors ages 13 through 17 years
Attention-Deficit/Hyperactivity Disorder (ADHD): The term ADHD is used here to
refer to that subgroup of the population previously identified as attention deficit disorder
(ADD) with hyperactivity and without hyperactivity (DSM-III) (American Psychiatric
Association, 1980), ADHD (subtypes were discarded) (DSM-III-R) (American
Psychiatric Association, 1987), ADHD-combined type and hyperactive-impulsive type
(DSM-IV) (American Psychiatric Association, 1994) or, more recently predominantly
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inattentive type (ADHD-I), predominantly hyperactive/impulsive type (ADHD-HI), and
combined type (ADHD-C) (American Psychiatric Association, 2000).
Burden: “Effect the patient has upon the family, or the impact that living with the
patient has on the family's daily routines and, possibly, health. Studies have found that
caregivers experience relatively high levels of both objective burden (e.g., providing
transportation, assisting the patient with daily tasks) and subjective burden (e.g., reduced
caregiver well-being, worry)” (Angold et al., 1998).
Caregiver: Individual/s, over age 18, responsible for the direct care, safety, and
supervision for the participant in this study.
Children: Children ages 6 through 12 years
Diagnostic Retention Studies: A strategy for investigating the developmental course of
ADHD involving “identifying youth that met diagnostic criteria for ADHD (or its
historical precedents) at one point in time and determining what proportion of these youth
continued to meet diagnostic criteria at subsequent assessments” (Willoughby, 2003).
Ecologic Level Data: “Information limited to characteristics of aggregates (groups) of
individuals” (Greenland, 2001).
Group Level Analyses (statistically significant): “Most studies use inferential
statistical analyses to make conclusions about an average child/adolescent based on the
differences between group means” (Karpenko, 2009).
Impairment: In the ADHD literature, impairment is conceptualized as the “negative
impact of the symptom on the child’s functioning” (Fabiano & Pelham, 2009), the
“consequences in reality that ensue from symptom expressions” (Goldstein & Naglieri,
2009) and “An objectively measured assessment of a deviation from the mean for a broad
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range of functional domains” (Danckaerts, 2010). Functional impairments are defined
as “specific deficits in multiple domains of functioning developing subsequent to
ADHD” (Winter, 2005). In this study impairment and functional impairment are used
interchangeably.
Individual Level Data: “Individual level data denote information about individuals,
either contributed by the individuals themselves in surveys etc., or collected from
registers” (Hårfagres, 2012).
Individual Level Analysis [clinically significant (CS)]: “Change in treatment that is
meaningful and noticeable to the individual client or to significant people in the client’s
life” (Karpenko, et al., 2009).
Medicated Group: Participants who were taking ADHD medication (stimulant/nonstimulant)
Mental Health: “A state of successful performance of mental function, resulting in
productive activities, fulfilling relationships with other people, and the ability to adapt to
change and to cope with challenges. Mental health is essential to personal well-being,
family and interpersonal relationships, and the ability to contribute to community or
society” (Healthy People 2020, 2012).
Parent: Parent or legal guardian (biological mother in most cases)
Preschoolers: Children ages 3 through 5 years
Quality of Life (QOL): “Describes an individual’s subjective perception of their
position in life as evidenced by their physical, psychological, and social functioning”
(Danckaerts et al., 2010).
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Symptoms: “Any subjective evidence of disease or of a patient's condition, i.e., such
evidence as perceived by the patient; a change in a patient's condition indicative of some
bodily or mental state” (Symptom. (n.d.), 2007). The focus of this study is on objective
symptoms - “ones that are evident to the observer” (e.g. parent or teacher) (Symptom.
(n.d.), 2007). One definition of symptoms provided by a well known ADHD researcher is
“the physical, cognitive or behavioral expressions of an individual that may signal the
presence of a disorder” (Barkley, 2010).
Symptom Trajectory Studies: A strategy for investigating the developmental course of
ADHD by “determining the number of ADHD symptoms that individuals exhibit across
repeated assessments” (Willoughby, 2003).
Trajectory: “The presentation of changes in functional status over time in terms of
development” (Halfon & Hochstein, 2002).
Youth: Children and adolescents
DSM Diagnostic Classifications
ADHD In Full Remission: “There are no longer any symptoms or signs of the disorder,
but it is still clinically relevant to note the disorder” (American Psychiatric Association,
2000).
ADHD In Partial Remission: “For individuals (especially adolescents and adults) who
currently have symptoms that no longer meet full criteria…If clinically significant
symptoms remain but criteria are no longer met for any of the subtypes, the appropriate
diagnosis is ADHD, In Partial Remission” (American Psychiatric Association, 2000).
ADHD Not Otherwise Specified (NOS): “When an individual’s symptoms do not
currently meet full criteria for the disorder and it is unclear whether criteria for the
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disorder have previously been met, ADHD NOS should be diagnosed. Examples include
1. Individuals whose symptoms and impairment meet the criteria for ADHD,
Predominantly Inattentive Type but whose age at onset is 7 years or after; 2. Individuals
with clinically significant impairment who present with inattention and whose symptom
pattern does not meet the full criteria for the disorder but have a behavioral pattern
marked by sluggishness, daydreaming, and hypoactivity” (American Psychiatric
Association, 2000).
ADHD Residual Type: “DSM-III and DSM-IV (but not DSM-III-R) versions include an
ADHD ‘residual type’ that could be assigned to an individual who previously had ADHD
and currently have significant impairment but do not meet the full symptom count
criteria” (Biederman, Mick, & Faraone, 2000).
Non-DSM Diagnostic Classifications
Functional Persistence: Subjects who were functionally impaired with a Global
Assessment of Functioning (GAF) score less than or equal to 60 (Biederman, 2011).
Note: definitions vary from study to study. GAF considers psychological, social, and
occupational functioning on a hypothetical continuum (0-100) of mental health-illness.
(DSM-IV-TR, p. 34.)
Remission: “A loss of diagnostic status based on standardized measures of ADHD,
minimal or no symptoms, and optimal functioning when individuals are being treated
with or without medication” (Steele, Jensen, & Quinn, 2006).
Subclinical: Subclinical is often used more similarly to the term subsyndromal in the
ADHD literature to mean exhibiting symptoms that are not severe enough for diagnosis.
Little consensus for a definition exists and disparate definitions are used. For example,
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one study created a subclinical ADHD outcome variable including 4 or 5 endorsed
symptoms (Bussing, et al., 2010) while another study considered subclinical ADHD to be
<6 symptoms (Fuemmeler, Østbye, Yang, McClernon, & Kollins, 2010). In this study,
subclinical ADHD is used broadly to mean any diminished form of ADHD that does not
meet full ADHD diagnostic criteria.
Subsyndromal: “Characterized by or exhibiting symptoms that are not severe enough
for diagnosis as a clinically recognized syndrome” (Subsyndromal, 2012). This term is
used less frequently in the ADHD literature than the term subclinical or subthreshold.
Subthreshold: “Subthreshold conditions are defined as slightly below the threshold for
diagnosis” (Malmberg, Edbom, Wargelius, & Larsson, 2011). As proposed by the AAP
in 1997, subthreshold is three to five ADHD-HI or ADHD-IA symptoms (using the
DSM-IV diagnostic criteria) (S. Faraone et al., 2006). Some have included “without
substantial functional impairment” in the definition (Scahill, et al., 1999). “Subthreshold
ADHD seems to be a milder form of the disorder, or perhaps a heterogeneous group of
true ADHD cases and false positives” (S. V. Faraone et al., 2007). Note: this definition is
not in the DSM and no clear definition exists in the literature. This study uses the AAP’s
definition of subthreshold ADHD.
Symptomatic persistence: Subjects meeting subclinical DSM criteria (more than half of
the symptoms required for a full diagnosis) (Biederman, 2011). Note: definitions vary
from study to study.
Syndromatic persistence: Subjects meeting full DSM criteria for ADHD (Biederman,
2011).
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Chapter 2
LITERATURE REVIEW
INTRODUCTION
This review is intended to be an in-depth overview and discussion of the
importance of symptoms and associated impairment for a better understanding of the
developmental course of child and adolescent Attention-Deficit/Hyperactivity Disorder
(ADHD). It begins with an inquiry into a longstanding theoretical debate on the
authenticity of the disorder and current diagnostic perceptions. General background is
provided regarding etiology, conceptualization and use of diagnostic criteria, the study of
developmental trajectories, and efforts to bring together ideas on impairment from a
variety of research, clinical, and measurement perspectives. Information related to
ADHD treatment practices, predictors of impairment and treatment use is also provided.
An analysis of research following individuals with subclinical forms of ADHD over time
will offer the reader an understanding of what is known about functional impairment
associated with insufficient symptoms to receive a diagnosis of ADHD, the main focus of
this research. Analyzing ADHD developmental trajectory studies (that include a
subclinical group) helped pinpoint gaps in the literature and formulate research questions
that are explored in manuscripts I and II (see Chapter 4).
This review is a systematic examination in that it: 1) makes a concerted effort to
identify and methodically draw together the findings of the studies that are judged to be
of acceptable quality for inclusion in the analysis; 2) categorizes studies in order to
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narrow and elucidate what has and has not been explored to date, and 3) provides an upto date summary of the research investigating issues surrounding subclinical ADHD and
impairment trajectories.
Publications reviewed here were found by internet-based literature searches in
PubMed, EBSCOhost, PsycLit, and Google Scholar. In addition, literature references of
relevant papers, books, or other sources were explored. The focus of the review is mainly
on papers published within the last 20 years, emphasizing recent findings. However,
earlier work is referenced that highlights relevant historical or theoretical points.
ADHD: BACKGROUND, DIAGNOSTIC CONCEPTUALIZATION, & DEVELOPMENTAL
PERSPECTIVE
Debate: Does ADHD exist?
Attention-deficit/hyperactivity disorder (ADHD) is considered by some to be an
“unsatisfactory umbrella term applied to children with widely differing temperaments and
functional problems, but sharing certain core features” (Halasz & Vance, 2002). That
sentiment reflects a longstanding theoretical debate over whether ADHD is a real
disorder or a social catch-all construct with a poorly identified biological threshold
(Amaral, 2007). In a letter to the editor, Amaral argues that “it is in defining such a
diagnostic threshold that lies the social construction, as the boundaries of normality in a
given region are set by psychiatrists (by choosing and applying diagnostic criteria) and
society (by recognizing symptoms as deserving of medical care)” (Amaral, 2007). In
reply, Polanczyk and Rohde maintain that while diagnostic criteria for mental disorders
are based on theoretical concepts, the validity of ADHD is supported by empirical
evidence (Polanczyk & Rohde, 2007a).
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Evidence Suggests ADHD is Underdiagnosed
There is a common public perception and media portrayal that ADHD is
overdiagnosed (Sciutto & Eisenberg, 2007). A review of prevalence studies shows there
is not sufficient evidence to suggest that ADHD is systematically over-diagnosed (Sciutto
& Eisenberg, 2007). While that may occur in some cases, there is stronger evidence that
ADHD is often under-diagnosed (Adler, Spencer, Stein, & Newcorn, 2008), and
consequently, under-treated (Cuffe, Moore, & McKeown, 2009; Vierhile, Robb, & RyanKrause, 2009). For example, one study, using 2001-2004 National Health and Nutrition
Examination Survey (NHANES) data, found among the children who met ADHD DSMIV criteria at the time of the survey, only 47.9% had a previous diagnosis and only 32.0%
had been treated with ADHD medications over the past year (Froehlich et al., 2007).
Using data from the National Health Interview Survey, Cuffe et al. (2009) found that
although children with a probable diagnosis of ADHD saw a mental health provider or
general doctor significantly more often than children without ADHD, 40% of children
with ADHD saw neither health professional in the last year and only 48% of males and
41% of females were reported to have taken medication for ADHD in the last 3 months.
ADHD Etiology
ADHD is a disorder of multifactorial (e.g., neurological and genetic) etiology
(Nigg, 2006). Differences in functional trajectories are shaped by the dynamic and
continuous interplay between biology and environmental factors (e.g., individual, family,
and social experiences) over a lifetime (Halfon & Hochstein, 2002). A brief overview of
neuro-biological factors (including genetics) of ADHD followed by a discussion of
psychosocial and environmental factors in the expression of ADHD is provided below.
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ADHD is the most heritable of all psychiatric conditions (Stephen P. Hinshaw &
Blachman, 2005). ADHD clusters in families (Rowland, Lesesne, & Abramowitz, 2002)
and twin and adoption research indicates that genetic factors contribute to the etiology
and continuity of ADHD symptoms (Thapar, Langley, Owen, & O'Donovan, 2007). Due
to the heterogeneity of ADHD it is thought that a strong genetic component exerts
influence over the expression of ADHD symptoms (Swanson et al., 2001). It seems likely
that genetic vulnerability is caused, not by one or two genes, but by the small
contributions of many genes (Steinhausen, 2009).
There are differences in brain structure and functioning in children with and
without ADHD. Structurally, overall brain volume is lower and specific brain areas (e.g.
the pre-frontal cortex, part of the frontal lobe involved in weighing alternatives and
inhibiting responses or impulses) appear to be smaller in children with ADHD compared
to children without ADHD (Castellanos et al., 2002; Krueger & South, 2009). Regarding
functioning, recently published findings provide evidence for multiple and persistent
neural processing deficits in ADHD (Doehnert, Brandeis, Imhof, Drechsler, &
Steinhausen, 2010). Such findings do not support the developmental lag theory (where
attention problems in ADHD become smaller and disappear as the brain matures) (Shaw
et al., 2007) and instead suggest a persistent developmental lag that is not outgrown
(Steinhausen, 2009).
While clarity regarding etiology of ADHD is emerging, data is lacking to support
the use of diagnostic tests or biomarkers to diagnosis ADHD (McGough & Barkley,
2004). Until such tests and biomarkers are established, ADHD will remain what Halasz
calls a “nosological conundrum” and McGough a “clinical diagnosis” (McGough &
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Barkley, 2004). The Diagnostic and Statistical Manual of Mental Disorders (4th editionText Revision (DSM-IV-TR)) (American Psychiatric Association, 2000) is a classification
system utilizing evidence-based criteria, is designed to establish a reliable and valid
diagnosis, (Rohde, 2008) and offers a temporary solution for diagnoses until the causes of
ADHD are better understood (Lollar, 2008). Some argue that, because ADHD is
classified as a neurobiological condition, functional impairment should be assessed and
considered an outcome but not included in the diagnostic criteria (Lollar, 2008; Stein,
2007). However, until the DSM is able to classify ADHD on the basis of etiology, the
DSM is limited to using symptoms and functioning to distinguish between wellness and
illness (McIntyre, Fallu, & Konarski, 2006).
Differences in Clinical Expression
While uncovering physiological and biological underpinnings of ADHD
symptoms is of utmost importance, psychosocial and environmental variables deserve
greater consideration in research (Wolf & Wasserstein, 2001). It is these critical variables
that interact with biological vulnerability to shape symptom expression (BrassettHarknett & Butler, 2007), impairment (Biederman et al., 1995), and comorbidity (S.
Hinshaw, 1999). Gene expression, for example, is considered dynamic in nature, not
static; that is, reacting to and interacting with environmental experiences (Kendler, 1995)
and significant associations of genes thought to be linked to ADHD account for less than
5% of explained behavioral differences (Steinhausen, 2009).
There is ample research evidence demonstrating environmental influences on
ADHD expression. One intervention study demonstrated improvements in children’s
ADHD symptoms, when parents were coached in parenting skills (Sonuga-Barke, Daley,
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Thompson, Laver-Bradbury, & Weeks, 2001). Findings from gene/environment studies
provide evidence suggesting environmental factors such as family adversity moderates
the impact of genotype on the expression of ADHD symptoms (Laucht et al., 2007).
Environmental factors are often critical in promoting or diminishing the risk to a child’s
academic and social functioning and eventual outcome (Halasz & Vance, 2002).
Clinical expression of ADHD is also influenced by associations with comorbidity,
gender effects, and the impact of the disorder on psychosocial functioning (also known as
impairment) (Steinhausen, 2009). A brief discussion of comorbidity and gender effects is
provided here. Later, an analysis of the literature pertaining to patterns of change between
symptom change and functional impairment among youth with ADHD, youth with
subclinical ADHD and youth without ADHD is provided (the main focus of this literature
review).
ADHD Comorbidity
ADHD is often correlated with and exists alongside other psychiatric conditions
at greater than chance levels, especially in adolescents (Biederman et al., 2006; Gordon,
et al., 2006). The probability of having oppositional-defiant disorder (ODD), conduct
disorder (CD), anxiety, antisocial, obsessive-compulsive disorder, post-traumatic stress
disorder, mood disorder, cognitive performance and learning disorders, tic disorder, or
substance use disorder is significantly enhanced in the presence of ADHD (Biederman, et
al., 2006; Gordon, et al., 2006). Approximately 50% of children with ADHD develop
either ODD or CD.(Pliszka, 1998). Conduct Disorder (CD) is characterized by a pattern
of aggression toward others and or serious violations of rules, laws, and social norms and
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ODD is a pattern of behaving negatively and defiantly toward adults or others (American
Psychiatric Association, 1994).
Youth with ADHD tend to experience more functional impairment if comorbid
disorders are present (Biederman et al., 1996). In a recent review, it was noted that
children with both conduct problems and ADHD show a worse course than children with
either disorder alone (Waschbusch et al., 2002). Youth with ADHD and comorbid ODD
or CD tend to have more severe social impairment than children with ADHD alone
(Nijmeijer et al., 2008).
ADHD & Gender
Gender may affect vulnerability to ADHD, as boys are diagnosed with ADHD 2.4
times more often than girls (Polanczyk & Jensen, 2008). There are fewer females than
males with ADHD represented in epidemiological and clinical samples (Steinhausen,
2009), and research involving community samples of females of varying ages is an area
in need of further research (Rohde, 2008). Girls, especially those with inattention
problems are more likely to be under-referred, and less likely to be diagnosed and treated
than boys (Stephen P. Hinshaw & Blachman, 2005; Staller & Faraone, 2006).
Evidence suggests that girls with ADHD, similar to boys with ADHD, exhibit
high levels of social, cognitive, academic, and personal impairment, across multiple
domains (Stephen P. Hinshaw & Blachman, 2005; Staller & Faraone, 2006). Results from
a meta-analysis of clinic referred and non-referred children found no gender differences
in social and peer and academic performance (Gaub & Carlson, 1997). More research is
needed to better understand symptom and impairment trajectories of girls with ADHD
(S.P. Hinshaw, Owens, Sami, & Fargeon, 2006).
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Among the three ADHD subtypes, girls are most likely to present with inattentive
type, compared to boys (Staller & Faraone, 2006), and children often do not present
clinical levels of impairment for inattention until middle school or later (Barkley &
Biederman, 1997). For girls, problems may be pronounced by the time they are referred,
and levels of impairment may increase through adolescence (Stephen P. Hinshaw &
Blachman, 2005). This is concerning, because if impairment is not detected until late
elementary or middle school, they may not receive a diagnosis because of the age seven
onset diagnostic requirement (diagnostic criteria discussed below) (Stephen P. Hinshaw
& Blachman, 2005).
Current Diagnostic Criteria
A diagnosis of ADHD is often made using guidelines outlined in the DSM-IV-TR
which specifies five diagnostic criteria (criteria A-E) for ADHD (American Psychiatric
Association, 2000). Criterion A categorizes symptom presentation into inattention and
hyperactivity/impulsivity dimensions, from which three ADHD ‘types’ or ‘subtypes’ are
derived. The first dimension includes nine symptoms of inattention and makes up the
ADHD Predominantly Inattentive Type (ADHD-I). It includes behaviors such as “often
fails to give close attention to details,” “often loses things,” and “often forgetful in daily
activities” (American Psychiatric Association, 2000). The second dimension contains six
symptoms of hyperactivity (e.g., “often “on the go”” and “often talks excessively”) and
three symptoms of impulsivity (e.g., “often has difficulty awaiting turn” and “often
interrupts”) (American Psychiatric Association, 2000). This dimension makes up the
ADHD Predominantly Hyperactive-Impulsive Type (ADHD-HI). The ADHD Combined
Type (ADHD-C), includes all 9 ADHD-HI and all 9 ADHD-I symptoms (18 in total).
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ADHD diagnosis requires endorsement of six (or more) of the nine symptoms for
ADHD-I and ADHD-HI diagnosis and 12 (or more) for ADHD-C diagnosis. Diagnostic
criteria requires that symptoms have persisted for at least 6 months that are maladaptive
compared to individuals of similar developmental stage (American Psychiatric
Association, 2000).
Criterion B-E states the following: “B: Some hyperactive-impulsive or inattentive
symptoms that caused impairment were present before age 7; C: Some impairment from
the symptoms is present in 2 or more settings (e.g., at school [or work] and at home); D:
There must be clear evidence of clinically significant impairment in social, academic, or
occupational functioning;” and E: Symptoms are not better accounted for by another
mental disorder (American Psychiatric Association, 2000).
Categorical vs. Dimensional ADHD Model
Identifying an individual as having or not having ADHD is an oversimplification
of a dimensionally complex disorder. The DSM-IV adopts a categorical (“by kind”)
rather than a dimensional (“by degree”) model of ADHD with subtypes being considered
qualitatively distinct symptom domains (Sonuga-Barke, 1998; Wilson, 1993). In the
general population, hyperactive, inattentive and impulsive behaviors are continuously
distributed with no clear distinction between behavior that is normal or abnormal
(Buitelaar & Rothenberger, 2004). Epidemiological evidence supports the dimensional
view of ADHD, with symptoms and impairments lying at the upper end (Shaw et al.,
2011). However, for practical clinical decision making and research considerations,
categorical distinctions are often used (Rohde, 2008). This is similar to the identification
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of hypertension where blood pressure is thought to be a dimensional construct, yet use of
a clinical cut-off point is standard practice (Rohde, 2008).
Subtype Information
The purpose of subtypes is to clarify the heterogeneous nature of ADHD to aid
clinical and research practice (Lahey & Willcutt, 2010). Recent studies challenge current
subtype classifications (Rohde, 2008). Longitudinal evidence suggests high levels of
subtype diagnostic instability, temporal instability, and an inability to distinguish
subtypes on the basis of treatment response and separable factors for inattention and
hyperactivity/impulsivity and functional impairment (Lahey, Pelham, Loney, Lee, &
Willcutt, 2005; Riley et al., 2008; Todd et al., 2008; Valo & Tannock, 2010). Several
researchers have recently called for the need to replace the categorical subtypes with a
focus on dimensional case identification of ADHD using severity or counts of symptoms
and resultant impairment (Lahey & Willcutt, 2010; Lubke, Hudziak, Derks, van
Bijsterveldt, & Boomsma, 2009; Rowland et al., 2008; Valo & Tannock, 2010).
Information related to subtype instability is discussed in greater detail in the symptom
trajectory studies section.
Evolution of Diagnostic Criteria
Since the first publication in 1952, the DSM went from listing 106 to 182, to 265
to 292, and to 297 diagnostic categories with each successive edition (DSM-I to DSM-II,
DSM-III to DSM-III-R, to DSM-IV, respectively) (Wikipedia contributors, 2012).
Diagnostic conceptualization of ADHD has changed substantially over time when it was
first included in the DSM-II as ‘hyperkinetic reaction of childhood’ (American
Psychiatric Association, 1968). DSM-III was the first version to include inattention as a
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diagnostic component for what was then called attention deficit disorder (ADD)
(Biederman, Petty, Evans, Small, & Faraone, 2010).
In the 80’s and 90’s, large epidemiological studies such as the National
Comorbidity Survey (NCS) demonstrated that DSM diagnostic criteria at the time (DSMIII-R) did not differentiate well between people with and without impairment who met
symptom count criteria (less severe disorder from more severe disorder) (Regier, 2003).
This finding affirmed the need to reconsider and revise diagnostic criteria for mental
disorders and the assessment of clinical significance (Regier, 2003). While increasing the
number of symptoms required for an ADHD diagnosis was suggested by some, the DSMIV (published in 1994), required “clinically significant” impairment in addition to the
required number of symptoms (Regier, 2003).
DSM-III and DSM-IV (but not DSM-III-R) versions include an ADHD "residual
type" that could be assigned to an individual who previously had ADHD and currently
have significant impairment but do not meet the full symptom count criteria (Biederman,
et al., 2010). These subclinical categories are important because considering only fullsyndrome ADHD may overlook an important group of children and be an
oversimplification of a more nuanced problem (Barnow, Schuckit, Smith, & Freyberger,
2006). To be clinically important, any reduced definition of ADHD should be associated
with impairment (Mick, Faraone, & Biederman, 2004).
Other DSM reduced ADHD definitions include ADHD in Partial Remission
(ADHD-IPR) and ADHD Not Otherwise Specified (ADHD-NOS). ADHD-IPR (similar
to ADHD ‘residual type’) is assigned when symptoms no longer meet full criteria for any
of the subtypes but some symptoms or signs of ADHD remain (American Psychiatric
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Association, 2000). ADHD-NOS, is defined in the DSM-IV as “prominent symptoms of
inattention or hyperactivity-impulsivity that do not meet criteria for ADHD” (American
Psychiatric Association, 2000). Examples included for the use of ADHD-NOS include
the following: 1. For individuals meeting symptom and impairment criteria but not
meeting the age of onset criteria and, 2. For individuals who present with clinically
significant impairment but do not meet symptom count criteria (American Psychiatric
Association, 2000).
According to the vague descriptions provided in the DSM, it is not clear how to
determine if a child meets criteria for these reduced ADHD definitions (Leslie, 2002).
For example, “the number of symptoms required for 'prominence' or the degree of
impairment necessary” are not provided (Bauermeister et al., 2011). Nor is it clear from
the literature if there is a distinct difference between terms such as ADHD-NOS and
ADHD-IPR; or if they can be used interchangeably.
This review provides a consideration of timely topics as the research and clinical
community awaits the publication of the fifth edition of the DSM in 2013. Discussions
such as how to treat and define subsyndromal ADHD continue as the new DSM edition is
prepared (Bauermeister, et al., 2011). Despite decades of research and scientific strides
that have improved our understanding of ADHD, Barkley writes of the new manual,
“Much work remains to be done as we seek to identify more rigorous diagnostic criteria
for ADHD that amend the already considerable and useful work that has gone into prior
DSMs” (Barkley, 2007).
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Inconsistencies in Adoption and Use of DSM Diagnostic Criteria
Conceptually, measurement of ADHD in children and adolescents is
straightforward. Based on the DSM-IV diagnostic criteria, measurement requires a
certain number of symptoms, the presence of impairment, age and duration criteria, and
assessment from multiple perspectives and in multiple contexts. Methodologically,
however, diagnosing ADHD is challenging and ambiguous (Stein, 2007). Measurement
variability, subjective interpretations, and controversy regarding measurement approach
abound in the literature. Understanding current diagnostic measurement obstacles is
important both for illuminating the challenges that clinicians and researchers face given
the diagnostic limitations of the DSM-IV and to cover salient measurement topics related
to this study.
Variation in the use of DSM-IV diagnostic criteria exists across practitioners,
research and geographic areas and may result in missed or inappropriate diagnosis
(Magyary & Brandt, 2002). After finding wide variations in clinical treatment of ADHD
in 1998, an expert panel on the diagnosis and treatment of ADHD concluded that there
was a real need for improved ADHD assessment and follow-up (Health, 1998 Nov 1618). Evidence based practice guidelines (based on DSM-IV criteria) for diagnosis and
treatment of ADHD were published by both The American Academy of Child and
Adolescent Psychiatry (AACAP; 1997) and the American Academy of Pediatrics (AAP;
2000) (Dulcan, 1997; Homer et al.). Years after the National Institute of Health (NIH)
expert panel call for improvements, literature on ADHD measurement is far from
standardized (Rushton, Fant, & Clark, 2004) and comprehensive assessments are often
not provided to children (Rosenblatt & Rosenblatt, 2002; Stein, 2007).
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Equally disconcerting is the fact that since 1980, when guidelines requiring the
consideration of impairment were adopted and the Global Assessment of Functioning
(GAF) (an impairment measure) included in the DSM-III, symptom criteria alone are still
used to diagnose ADHD by some researchers and clinicians (Gathje, et al., 2008).
Impairment instruments are not routinely used in research and clinical practice (Gordon,
et al., 2006), in spite of the DSM-IV diagnostic requirement that “there must be clear
evidence of clinically significant impairment in social, academic, or occupational
functioning” (American Psychiatric Association, 1994). The lack of adherence to
diagnostic standards has treatment implications. One community study documented that,
while 72% of children received stimulant medication during a four year period, parents
did not report any impairing ADHD symptoms for the majority of those children
(Angold, Erkanli, Egger, & Costello, 2000).
The reason for inconsistencies in the adoption and use of DSM diagnostic criteria
related to impairment is likely due to several reasons. Barkley pinpointed one reason
when he wrote, “for many years, we have erroneously assumed that higher scores on our
tests and absence or reduction in symptoms equated with less impairment and better
quality of life” (Goldstein & Naglieri, 2009). Other reasons could be a belief that there is
no difference between symptoms and impairment (Mannuzza et al., 2011) or a lack of
clarity on identifying and measuring impairment (Gathje, et al., 2008).
Examples of inconsistencies in the adoption, use, and understanding of DSM
diagnostic criteria abound in the literature. As recently as the late 90’s, researchers wrote,
“Indeed, when the symptoms of ADHD remit, the functioning of the child normalizes”
(Biederman, Mick, & Faraone, 1998) and “impairment can be captured through careful
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measurement of symptom severity” (Scahill, et al., 1999). Disparate definitions for all of
the subsyndromal ADHD categories are widespread in the literature. ADHD-IPR in one
study was defined as “reserved for adults who met the criteria for ADHD in childhood
and continue to have significant symptoms and impairment that fell below the threshold
for the full diagnosis” (McGough & Barkley, 2004) whereas another study defined
ADHD-IPR as “continuing impairment, but failure to meet full diagnostic criteria based
on ADHD symptoms” (Sciberras, Roos, & Efron, 2009).
SUBCLINICAL ADHD
Some researchers concerned with studying subclinical ADHD syndromes have
relied on the DSM-based classifications of ADHD (those described above), while others
have adopted the APA definition of subthreshold ADHD. Subthreshold ADHD is a
category proposed by the AAP in 1997 that, like the DSM definitions, provides an
alternative to narrowly dichotomizing ADHD (Scahill, et al., 1999). This “subclinical
syndrome” is typically defined as having a “chronic history” of three-to-five ADHD-HI
or ADHD-IA symptoms (using the DSM-IV diagnostic criteria) (S. Faraone, Kunwar,
Adamson, & Biederman, 2009). Researchers considering subthreshold ADHD have
employed various definitions, differing on the number of inclusionary symptoms,
inclusion or exclusion and degree of impairment. For example, some have included
“without substantial functional impairment” in the definition (Rogers, Hwang, Toplak,
Weiss, & Tannock, 2011; Scahill, et al., 1999).
Subthreshold ADHD is more prevalent than ADHD (Lewinsohn, Shankman, Gau,
& Klein) with up to 22% of youth exhibiting subclinical inattentive and hyperactive
subthreshold symptoms (Scahill et al., 1999), yet there are very few follow-up studies on
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the longitudinal course of subthreshold ADHD. Subthreshold ADHD is a risk factor for
developing ADHD (Shankman et al., 2009) and expressed from the same set of genes as
ADHD (Levy, Hay, McStephen, Wood, & Waldman, 1997). Further, youth with
subclinical ADHD may have less (Galéra, Melchior, Chastang, Bouvard, & Fombonne,
2009) or just as much impairment as youth who meet ADHD diagnostic criteria
(Bagwell, Molina, Pelham Jr, & Hoza, 2001) and were as likely to develop later
psychopathology as children meeting symptom count but not impairment (Angold, et al.,
1999; Shankman, et al., 2009).
While some have raised questions about the validity of subthreshold ADHD (S.
Faraone, et al., 2006), clinical research evidence shows this milder form of ADHD
(Mason, Walker, Wine, Knoper, & Tercyak, 2007) to be a “clinically meaningful” and
“valid” target population (Costello & Shugart, 1992; Scahill, et al., 1999) and deserving
further research attention (S. V. Faraone et al., 2006). Identifying children with
subthreshold levels of ADHD allows for examination of psychosocial correlates and
comparisons with children who meet full ADHD criteria and with children who do not
have ADHD. From a public health standpoint, subthreshold ADHD may have similar risk
factors as ADHD and be a useful designation for targeted interventions and for
preventing “further functional decline” (Scahill, et al., 1999).
METHODS AND MEASUREMENT
Diagnostic Retention Studies
Since the early 70’s, the temporal stability of ADHD has been extensively
explored through both epidemiological community samples and clinic-referred samples
in the United States (S. V. Faraone, Biederman, & Mick, 2006; Mannuzza, Klein, &
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Moulton, 2003; Willoughby, 2003). The first longitudinal studies of ADHD persistence
were clinic-based, diagnostic retention studies, identifying youth meeting diagnostic
criteria for ADHD at one point in time and seeing what proportion still met criteria at a
later point in time (Willoughby, 2003). The results of these studies have since been called
into question, as critics often attribute the wide variance in reported prevalence over time
to differences in early study methodology (S. V. Faraone, J. Biederman, & E. Mick,
2006; Polanczyk & Rohde, 2007b). While diagnostic continuity of ADHD has been
studied using different diagnostic criteria and assessment procedures, ADHD is
considered to be a persistent disorder (Bauermeister, et al., 2011).
One study, comparing different diagnostic approaches found that childhood
ADHD persists into young adulthood in 58% of the cases when DSM-IV criteria (parent
report) are used and in 66% of the cases when developmentally relative criteria (+2 SDs
above the normal mean) (parental report) (Barkley, Fischer, Smallish, & Fletcher, 2002).
These findings are higher than Lara et al. (2009) who found approximately 50% of
childhood cases, across 10 countries, continued to meet full diagnostic criteria for ADHD
into adulthood. Diagnostic stability is higher for younger (4-6) children than for late
childhood to early adolescence (Steinhausen, 2009).
Diagnostic retention studies have several significant drawbacks. They do not
clarify changes in ADHD as a function of development (Willoughby, 2003). They apply
diagnostic criteria (DSM) that is continually revised and was developed for children
(males specifically) to adolescents and adults (Willoughby, 2003). And, they are
categorical in nature and provide a narrow view of development (Willoughby, 2003).
Studies showing marked ADHD remission rates (loss of full diagnostic status) over time

34

may be deceptive because they do not distinguish levels of subclinical ADHD symptoms
and impairment (Biederman, 2011; Willoughby, 2003). As one researcher writes, “It is
technically correct that those diagnosed with ADHD in childhood who reach adulthood
with one less symptom of the disorder may no longer satisfy criteria for ADHD, but it is
clinically dubious to equate the absence of full syndromic status with full recovery”
(Biederman, 2011).
Symptom Trajectory Studies
There has been an emergence of interest in ADHD symptom trajectory research
over the past two decades and a shift away from a focus on solely identifying diagnostic
retention or outcomes. Symptom trajectory studies determine the number of ADHD
symptoms exhibited across repeated assessment time points (Willoughby, 2003).
Symptom trajectory studies of ADHD are less common than diagnostic retention studies
and often use clinic-based samples; however, they may be more useful than diagnostic
retention studies in establishing the developmental course of ADHD (Willoughby, 2003).
Hart et al, (1995) undertook the first longitudinal symptom trajectory study using
DSM-III-R diagnostic criteria, and structured diagnostic interviews in both baseline and
follow-up assessments. One hundred and six clinic-referred boys (aged 7 to 12 years at
baseline) were assessed annually for four years and results showed a decline in symptoms
of ADHD-HI over time with increasing age, whereas symptoms of ADHD-I declined
from the first to the second assessment period but remained stable after that (Hart, Lahey,
Loeber, Applegate, & Frick, 1995). Since then, other follow-up studies have shown that
inattention symptoms are more likely to persist into adolescence and adulthood (S.P.
Hinshaw, et al., 2006; Lara et al., 2009; Holbrook, 2012).
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Biederman et al. reanalyzed study data using symptom trajectories as a function
of chronological age and, similar to Hart (Hart, 1995), found hyperactivity/impulsive
symptom mean declined with age, whereas the inattentive symptom mean remained
stable (from age 8 to 15 years) (Biederman, et al., 2000). This was a change from their
previous analysis which “modeled outcome variables as a function of group (ADHD
versus control), age (child versus adolescent), and their interaction” and found no
difference in the mean number of ADHD symptoms between children and adolescents
with ADHD (Biederman et al., 1998).
Studies also show persistence rates increase when subclinical diagnoses are
included in the follow-up criterion (Bauermeister, et al., 2011; S. V. Faraone &
Biederman, 2005). A meta-analysis showed ADHD persistence rates varied from 4% to
more than 86% (S. V. Faraone, J. Biederman, & E. Mick, 2006). They demonstrated that
rates of diagnostic persistence are dependent on how persistence is defined (S. V.
Faraone, J. Biederman, & E. Mick, 2006). Including 32 prospective studies of
“syndromic persistence” (maintaining full ADHD criteria) and “symptomatic
persistence” (maintaining partial ADHD symptom criteria), results showed that if only
diagnostic retention (syndromic persistence) criteria were used only about 15% of adults
retained a diagnosis of ADHD whereas the rate increased to approximately 65% if
symptomatic persistence (ADHD-IPR) criteria were employed (S. V. Faraone, J.
Biederman, & E. Mick, 2006). Study findings since the 2006 review have been mostly
consistent (Sciberras, et al., 2009).
Hinshaw et al. (2006) prospectively assessed a sample of 126 preadolescent girls
with ADHD 5 years after their diagnosis. While the overall diagnostic retention rate was
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92%, they found a majority of girls (63%) with ADHD-IA retained that status at the 5
year follow-up. In contrast, most girls with ADHD-C at baseline either reverted to
ADHD-I subtype at follow-up due to a loss of HI symptoms (24%) or to a nonclinical
ADHD status (34%) rather than retaining the ADHD-C subtype (39%) (S.P. Hinshaw, et
al., 2006).
One study found 37% of children with ADHD-C and 50% of children with
ADHD-I met criteria for a different subtype at least twice during six years (baseline age
4-6) of follow-up assessments and almost all children with ADHD-HI either remitted or
changed to another subtype by year eight (Lahey, et al., 2005). A longitudinal study of
twins with ADHD found that the 5-year subtype stability (using DSM-IV criteria) from
childhood to adolescence was poor; 11.1% for ADHD-HI, 17.7% for ADHD-IA, and
24.0% for ADHD-C (Todd, et al., 2008). Riley et a., found no significant subtype
differences between ADHD-IA and ADHD-C for social skills or academic functioning
(Riley, et al., 2008) supporting suggestions that ADHD-HI may be a precursor to ADHDC rather than a distinct subtype (Lahey, et al., 2005; Riley, et al., 2008)
Methodological Variations Impacting ADHD Prevalence & Persistence
In addition to methodological variation resulting from the use of different
definitions for outcome terms such as persistence and remission (as discussed above in
the diagnostic retention studies section), variability in prevalence and persistence
estimates may be caused by other methodological issues such as the use of clinic versus
community samples (Woo & Rey, 2005); sample ascertainment (who is interviewed (e.g.,
parent, child, teacher); type of assessment (e.g., rating scale, observational); evaluator
status (e.g., blind to ADHD status) (Mannuzza, et al., 2003) and variation in diagnostic
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criteria (S. V. Faraone, J. Biederman, & E. Mick, 2006; Ramtekkar, Reiersen, Todorov,
& Todd, 2010). It is often not possible to determine if changes in diagnostic retention or
symptom trajectory levels are due to a combination of measurement issues and
developmental variation or to one or the other alone (Willoughby, 2003).
Treatment of impairment is an especially important methodological factor to
consider. While they differ across studies, some researchers include a definition of
impairment when assessing ADHD estimates and some do not (Polanczyk & Rohde,
2007a). Also, the treatment of impairment affects prevalence and persistence rates
(Canino et al., 2004; McKeown, 2004). One study of ADHD prevalence rates (using
DSM-IV criteria and different definitions of impairment) found ADHD rates varied from
3.7% to 8.9%, with higher rates associated with less stringent impairment criterion
(Canino, et al., 2004). Utilizing data (sample included over 10,000 children aged 4-17)
from the National Health Interview Survey, Mckeown et al. found 12.2% of boys and
5.6% of girls met criteria for ADHD using only the symptom-count criteria. The
prevalence dropped to 5.6% of boys and 2.3% of girls when the “impact” (impairment)
requirement was included (McKeown, 2004).
Measuring Magnitude of Treatment Effect (Symptom Improvement)
Several approaches are used to measure clinically important or significant level of
ADHD symptom improvement (magnitude of treatment effect or symptom remission) (P.
Hazell, Lewin, & Sly, 2005). One is to use continuous outcome measures. (P. Hazell, et
al., 2005). For example, results from a review by Swanson, et al. (2003) of 3 metaanalyses found pooled effect size estimates (of stimulant medication compared with
placebo) ranged from .75 to .90 standard deviations (considered moderate to large effect)
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(Cohen, 1988). If related to changes in units on a rating scale, effect size estimates mean
more clinically , like the approach described next, however, cut points for what are
considered normal and deviant are often arbitrary regardless of approach (P. Hazell, et
al., 2005).
Some researchers report the pre- and post- percentage change in symptoms or a
variant of this; number of youth who achieved a score in the range as youth without
ADHD (Ramos-Quiroga & Casas, 2011). In ADHD clinical trial research, definitions of
treatment effect commonly include a mean cutoff score of ≤1 on standardized symptom
scales (e.g. Swanson, Nola and Pelham, Version IV (SNAP-IV) (Steele, 2006). This
indicates minimal or no symptoms for DSM-IV diagnosis (matching similar scores of
children without ADHD) and often assumes that functioning is similar to the average
optimally functioning child without ADHD (Steele, et al., 2006). Severity of symptoms
are not taken into consideration when one only looks at the percentage of symptom
reduction and children who are classified as symptom remitters may continue to have
clinical difficulty (Ramos-Quiroga & Casas, 2011).
While approaches utilizing clinically significant change or effect size magnitude
(Greenland, 2001) are valuable, they mainly offer group level rather than individual level
information about patterns of symptom and impairment change (J. S. Owens, et al.,
2009). Further, treatment effect data, not considering impairment, may overstate
treatment success for those that would not be included as successes if functioning ratings
were also considered (J. S. Owens, et al., 2009).
Study methodological improvement can be seen in a comparison of two examples.
The Wisconsin study (Barkley, et al., 2002) reassessed 126 of the initial cohort of 158
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clinically referred children with hyperactivity and controls in adolescence. In an attempt
to examine ADHD persistence as a function of parent versus self-reported symptoms,
they created age-based referenced ADHD criteria (Barkley, et al., 2002). Using agematched controls, they identified the mean number of DSM-III-R symptoms and created
thresholds 2 standard deviations above that mean (Barkley, et al., 2002). They identified
significantly more impaired individuals using the developmentally referenced criteria
than they did using the DSM-III-R based criteria (Barkley, et al., 2002). The New York
Study, used an improved methodology by using “probably” (fewer symptoms than
required for diagnosis and clinically significant impairment) and “definite” levels of
ADHD (meeting DSM ADHD diagnostic criteria) with both categories requiring
impairment by the individual’s ADHD symptoms (Mannuzza, et al., 2003). The
categories were not dependent on a comparison group (like the Wisconsin study), which
may not be representative (Mannuzza, et al., 2003).
Measuring Persistence/Remission
ADHD developmental trajectory studies concerned with persistence and
remission should include a consideration of changes in symptoms and functional
impairment -- two different aspects of a complex measurement issue. Measuring one
without the other does not provide a complete clinical picture and may result in poor or
inaccurate treatment decisions (e.g., length, type, or dose of treatment) (J. S. Owens, et
al., 2009). In spite of a recognized need to improve nosology and adopt standard
measurement practices, disparate definitions of persistence and remission are often used
in the literature and no definitions have been widely adopted. As mentioned earlier, many
studies do not include the measurement of impairment at all when considering remission
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or persistence of ADHD. A review by Steele et al. concludes that a definition of
remission should include optimal functioning in addition to minimal or no symptoms
(Steele, et al., 2006).
FUNCTIONAL IMPAIRMENT: BACKGROUND, DOMAINS, MEASUREMENT, & PREDICTORS
Functional Impairment Background
The literature has only recently, over the last two decades, begun to consider
functional impairment's role in diagnosis or treatment in ADHD (Ramos-Quiroga &
Casas, 2011). This may be because, prior to the publication of DSM-IV, impairment
criteria were implied rather than explicit (Fabiano & Pelham, 2009). According to the
DSM-IV definition of ADHD, alongside symptom-count criteria, youth with ADHD must
also exhibit functional impairment (American Psychiatric Association, 2000) in what are
considered the most important “developmental contexts,” school and home (Deault,
2010).
One prominent ADHD researcher considers ADHD symptoms to be “the
behavioral expressions associated with the disorder,” and impairment “the consequences
that ensue for the individual as a result of these behaviors” (Gordon, et al., 2006). Canino
et al. have explained Hoagwoods (1996) definition of functioning as “a continuously
distributed characteristic, ranging from the highest levels of competence in adapting to
demands posed by the child’s home, school, neighborhood, and peers, down to levels at
which normal adaptation is not possible and functional impairment is diagnosed”
(Canino, et al., 1999). Functional impairments have also been defined as “specific deficits
in multiple domains of functioning developing subsequent to ADHD” (Winter, 2005).
Impairment can include dysfunction or an absence of adaptation in daily functioning and
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results in performance below that of normally developing peers (Fabiano & Pelham,
2009).
Similar to symptoms of ADHD which tend to change as children age, the same
may be true for functional impairment (Nijmeijer, et al., 2008), and depend on
environmental demands (Harpin, 2005). However, unlike symptoms, impairments tend to
become more noticeable as children age as they acquire more autonomy (Adler, et al.,
2008). Impairment is thought to have an additive effect over time (Adler, et al., 2008;
Wender, Wolf, & Wasserstein). For example, recent data show a negative impairment
developmental cycle whereby peer rejection was related to impaired social skills, which
in turn predicted later peer rejection, which then compromised functioning in additional
areas across development (Murray-Close et al., 2010).
Not all children and adolescents who meet ADHD symptom-count criteria are
impaired (Gordon, et al., 2006). For example, evidence from one community follow up
study of 140 girls with ADHD and 88 comparison girls, 16.4% (n=20) of girls with
childhood ADHD were considered positively adjusted during adolescence, compared to
86.4% of comparison girls as defined by meeting criteria for at least 5 of 6 impairment
domains (5 met criteria in all 6 domains) (E. B. Owens, et al., 2009). However, impaired
functioning is a very real eventuality for many (Molina et al., 2009).
Children diagnosed with ADHD have been found to show larger global, social,
academic and self-perception functional impairments compared to children without
ADHD (S.P. Hinshaw, et al., 2006). Longitudinal studies have documented that children
with ADHD have more impairment in multiple domains such as school, interpersonal,
and family functioning at follow-up compared to children without ADHD (Biederman, et
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al., 1996) While long-term outcomes are not the focus of this review, it is important to
note that subsequent impairment is a strong predictor of long-term impairment (Gordon,
et al., 2006). Youth with ADHD, compared to youth without ADHD, have poorer
educational, job-related, financial, and social outcomes (e.g., not graduating, divorce,
lower incomes) (Bussing, 2010; Klein, 2012).
Studies assessing impairment have identified high-risk groups that would go
undetected if only symptoms were assessed (Wille, Bettge, Wittchen, & Ravens-Sieberer,
2008). For example, the Bella Study (2008) found 6% of the 2,863 surveyed families
with children aged 7-17 suffered from “pronounced impairment” due to mental health
problems but were not identified by symptom screening alone (Wille, et al., 2008). In a
population-based study, 16.1% of the children who were screened were impaired but did
not meet diagnostic symptom count criteria (Burns et al., 1995).
Assessing impairment also adds important additional information about
functioning that symptom assessment alone would not. For example, in the Bella study,
twenty percent of the sample reported impairment (11-13% single domain; 4-7% two
domains; and 1.5-3% 3 or 4 domains of impairment) and most families exclusively
reported school (8-9%) or home life (1-3%) impairment, followed by both school and
home impairment (1-4%) (Wille, et al., 2008). A population-based screening identified
approximately a third of the children (those with a diagnosis and impairment (n=152) and
those with no diagnosis but with impairment (n=193)) had significant functional
impairment in three areas: school, home, and with peers (Burns et al., 1995).
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Situational ADHD
Lahey et al. (2004) compared children with ADHD, children with "situational
ADHD" (met symptom criteria but displayed impairment in only one setting), and
children without ADHD over three years (baseline age 4-6) (Lahey, et al., 2004).
Compared to 3.1% of children without ADHD, 34% of children with situational ADHD
(children meeting symptom criteria for ADHD but not cross-situational impairment
requirement) met full ADHD criteria in at least 2 of the 4 study waves and were more
impaired (Lahey, et al., 2004). The authors point out that this may be due to the fact that
school demands may not cause academic impairment to surface in early childhood
(Lahey, et al., 2004). However, they question the multiple domain requirements for
impairment and wonder why severe impairment in one domain should prevent a child
from having a diagnosis (Lahey, et al., 2004).
Domains of Functional Impairment
It is clear from the literature that deficiencies in functional impairment occur in
individuals with ADHD at all age levels across multiple domains (social, educational, and
occupational) (Sciberras, et al., 2009). Academic, motor coordination, and social skills
are the three domains of functioning most highly associated with ADHD symptoms
(Sonuga-Barke, Daley, Thompson, & Swanson, 2003). This review focuses on social,
classroom, home, leisure activity, and intrapersonal domains of functioning. An overview
of the literature in each of these areas is provided below.
Social Impairment (difficulties interfere with friendships)
A review of prospective longitudinal studies indicates a range of social difficulties
is persistent among children with ADHD compared to youth without ADHD (Sciberras,
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et al., 2009). Social impairment can be evident in peer and friendship, parent-child,
teacher, and other adult relationships, and can be related to ADHD itself, comorbid
conditions, and the result of those two factors on the social environment (Wehmeier,
Schacht, & Barkley, 2010). Compared to children without ADHD, children with ADHD
exhibit poorer social and communication skills (Klimkeit et al., 2006), antisocial behavior
(Biederman, et al., 2006), unstable friendships (Sciberras, et al., 2009), and are more
involved with deviant peer groups (Gordon, et al., 2006).
Over half of youth with ADHD have serious peer relationship impairment (Hoza
et al., 2005; Wehmeier, et al., 2010) and by the third grade, up to 70% of children with
ADHD have no close friends, especially if comorbid ODD or CD is present (Wehmeier,
et al., 2010). Youth with ADHD often exhibit self-centered, intrusive, intimidating and
adverse behavior toward other peers (Wehmeier, et al., 2010). Youth with ADHD are
frequently ignored (e.g., not invited to parties or out to play), rejected (e.g., bullied or
teased) by peers and seen by peers as being different (Fabiano & Pelham, 2009; Harpin,
2005). As a result, they often lack mutual friendships and are unpopular with peers
(Nijmeijer, et al., 2008).
School Impairment (difficulties interfere with classroom learning)
Inattention, impulsivity, and hyperactivity can lead to a number of difficulties for
children in the school domain. ADHD is associated with school impairment such as
disruptive classroom behavior, underperformance, need for tutoring, lowered
standardized test scores, repeating grades in school, increased use of school-based
services, and suspensions and expulsions (Barkley, 2004; Loe & Feldman, 2007). Several
of the core ADHD symptoms (e.g., having difficulty with organizing tasks) impair one's
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ability to study and the academic performance of children with ADHD may suffer from
behaviors such as not turning in completed assignments (Sciberras, et al., 2009). Children
with ADHD are more likely to struggle with tasks such as finishing seatwork and
remembering things needed to do homework assignments compared to children without
ADHD (Fabiano & Pelham, 2009). Comparing high school academic performance among
male youth with and without ADHD, Kent et al. found youth who were diagnosed with
ADHD in childhood continued to experience academic difficulties such as lower grades,
failing classes, and being late or absent compared to youth who did not have a diagnosis
of ADHD (Kent et al., 2011).
Interpersonal Impairment (difficulties upset or distress the child)
ADHD is associated with emotional impairment including poor self-regulation,
demoralization, learned helplessness, low self-esteem, fear and anxiety, increased
emotional expression (e.g., frustration and anger), and other emotional problems
(Gordon, et al., 2006; Wehmeier, et al., 2010). Children with ADHD are significantly
more likely to be upset or distressed by their difficulties than children without ADHD
(Strine et al., 2006). Children with probable ADHD perceive themselves as receiving less
social support from friends, classmates, and teachers compared to children without
ADHD (Demaray & Elliot, 2001). Other domain impairment (e.g., social academic)
caused by the adverse effects of ADHD symptoms likely contribute to the development
of emotional impairment (Wehmeier, et al., 2010). Strained family relationships may also
negatively affect a child’s emotional wellbeing (Harpin, 2005).
Home Impairment (difficulties interfere with home life)
Parent-child relationship impairment among ADHD youth may be apparent at
home (Harpin, 2005). Children with ADHD may not comply with parent requests or
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instructions or may exhibit argumentative behavior (Fabiano & Pelham, 2009). In one
study, children with ADHD were nine times as likely to have a high level of home life
impairment compared with children without ADHD (Strine, et al., 2006). A study by
Cuffe et al. found the second most common parent reported impairment, after classroom
impairment (94%), was impairment in the home setting (82.23% in males and 73.3% in
females) (Cuffe, Moore, & McKeown, 2005).
Leisure Impairment (difficulties interfere with leisure activities)
There is little research related to the extent to which ADHD difficulties interfere
with leisure activities. Strine et al. found children aged 4 to 17 with ADHD were
significantly more likely than those without ADHD to have a medium amount or a great
deal of impairment in their leisure activities (12.5% (ADHD) versus 1.5% (non-ADHD)
(Strine, et al., 2006). Using data from a large, nationally representative sample including
more than 10,000 children between the ages of 4 and 17, one study found about half of
youth with probable ADHD were reported to have impairment in leisure activities (Cuffe,
et al., 2005).
Measuring Impairment
The subject of impairment, while certainly not new to the field of mental health,
arguably has been neglected in child/adolescent ADHD specific research literature
(Goldstein & Naglieri, 2009). Little consensus seems to exist in the field of functional
assessment on the definitions or measures of the constructs involved (Goldstein &
Naglieri, 2009). The DSM-IV diagnostic criteria does not provide sufficient instructions
on how to measure impairment (Gordon, et al., 2006). And, researchers and clinicians are
assessing impairment in a variety of ways (Canino, et al., 1999).
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Measures of impairment provide crucial information regarding developmental
capacity, trajectory, and domain functioning. Measures of impairment also provide
important information for treatment planning purposes and help distinguish clinically
significant cases (Bird et al., 2000). Most measures of functioning concentrate on areas
like social relationships at home, at school, and in leisure time, with parents, siblings,
peers, etc. (Canino, et al., 1999). It is more clinically useful to assess multiple domain
impairment information (e.g., family and academic) because it allows for a more
comprehensive snapshot of current functioning (Fabiano & Pelham, 2009). Identifying
domain specific impairments can lead to referral and can become outcomes to measure
for targeted intervention aimed at improving long term functioning (Sayal, Goodman, &
Ford, 2006).
Impairment Measures
Impairment measures should be reliable, capture multiple domains, and
informative for clinicians and educators, but should not be costly or time consuming to
administer (Fabiano & Pelham, 2009). There are no standardized measures of
impairment similar to the DSM-based symptom assessment checklists (Gordon, et al.,
2006). What does exist is a number of disparate measures, such as ratings, reports, and
counts of negative life events, attempting to assess clinical impairment with varying
degrees reliability and validity (Goldstein & Naglieri, 2009). Some potential
measurement challenges are discussed here.
Construct validity poses specific problems in the measurement of impairment
(Canino, et al., 1999). For example, not all measures have clear cut-points for where
impairment begins and ends (Canino, et al., 1999). It is also difficult to determine if the
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cut-points of measures that exist correspond to what is considered “substantial
impairment” which is required to satisfy criterion for access to services by federal
agencies (Canino, et al., 1999).
In a review of measures designed to capture functional impairment, Canino et el.
distinguish between three measurement categories: 1. global impairment measures, 2.
domain-specific or multidimensional measures, and 3. symptom- or diagnostic-specific
impairment measures (Canino, et al., 1999). Rather than argue that one measurement
category is better than another, the authors point out that each one has utility for different
purposes (Canino, et al., 1999).
The Global Assessment of Functioning Scale (GAF) (American Psychiatric
Association, 1994) is an example of a global impairment measure. It is a measure of
overall difficulties in daily functioning (Fabiano & Pelham, 2009) and is included in the
DSM-IV-TR. The GAF allows clinicians to report an individuals highest level of
functioning using 10 point ranges from 0-100, with 90-100 being prefect functioning
(American Psychiatric Association, 2000). Global measures, unlike domain-specific
measures which are discussed next, do not evaluate functioning in different areas such as
home or school (Fabiano & Pelham, 2009).
An example of a domain-specific measure is the Strengths and Difficulties
Questionnaire (SDQ) (Goodman, 2001). The SDQ consists of 25 symptom items and
seven items assessing difficulties in functioning (e.g., school and classroom settings)
associated with reported symptoms (Goodman, 2001). The SDQ is one of a few measures
of impairment that was specifically developed to assess impairment in relation to ADHD
and other psychiatric symptomatology (Goodman, 2001). The SDQ measures difficulties
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prompting caregivers to seek help for their children and is a helpful tool for pinpointing
intervention needs (Ford, Hutchings, Bywater, Goodman, & Goodman, 2009). Domain
specific measures often include measures of multiple disorders and differentiating
impairment from specific disorders may not be possible (Canino, et al., 1999). Additional
weaknesses of using domain specific measures include the following: they can to be
lengthy, require multiple raters, or may only assess a single domain of functioning
(Fabiano & Pelham, 2009).
Symptom-specific measures assess impairment in relation to a specific symptom
or diagnosis (Canino, et al., 1999). An example is the Diagnostic Interview Schedule for
Children (DISC-IV) (Shaffer, et al.) which asks a series of impairment questions if
diagnostic criteria, including enough ADHD symptoms are endorsed. One weakness of
diagnostic specific measures is that the interviewee may not have a level of
understanding needed to differentiate impairment caused by one type of symptom (or set
of symptoms) versus another (Canino, et al., 1999).
Another major shortcoming of symptom-specific measures such the DISC is that
if the symptom criteria, duration criteria, or age of onset criteria for ADHD are not met,
the impairment questions are never asked. Unless researchers use another source to
identify functional impairment, this may result in under-identification of children and
adolescents who experience subthreshold ADHD with clinically significant levels of
impairment. Additionally, symptom-specific measures may not allow for a consideration
of impairment in control children so that impairment norms can be established and used
for comparison purposes.
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Predicting Impairment
A number of features may predict impairment among youth and when considered
together may have greater prognostic power (Steinhausen, 2009). In a prospective ADHD
study (using DSM-III-R criteria), Biederman et al. found maternal psychopathology,
larger family size, higher levels of comorbidity, and increased impulsive symptoms
predicted lower rates of normalized functioning (Biederman, Mick, et al., 1998).
Predictors of later adolescent functioning identified in the MTA study include symptom
severity, conduct problems, intellect, social advantage, and strength of symptom response
to treatment; and, to a lesser extent, type of treatment received during the 14 months
intervention (Molina, et al., 2009). CD also predicts poor academic outcomes and
relationship difficulties (Gordon, et al., 2006). Early peer problems is a predictor of
relationship difficulties in adolescence (Gordon, et al., 2006).
Mota and Schachar (2000) used the receiver-operating characteristic (ROC)
approach (combining symptoms most associated with impairment) to predict impairment
(Mota & Schachar, 2000). The algorithm used fewer symptoms than the DSM-IV criteria
and improved diagnostic sensitivity and specificity. Mota and Schachar point out that
other studies attempting to determine which symptoms best predicted ADHD impairment
often use factor analysis where symptom combinations were based on their correlation
with other symptoms rather than impairment (Mota & Schachar, 2000). For that reason,
symptom prevalence or subtype distinctions, are inadequate in predicting impairment
(Mota & Schachar, 2000).
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STUDYING PATTERNS OF SYMPTOM AND FUNCTIONAL IMPAIRMENT CHANGE
Research has demonstrated that measures of impairment generally have a
relatively modest correlation with symptom reports (Gathje, et al., 2008). These findings
supporting the argument that symptoms and impairment are two related, yet separate,
aspects of the ADHD diagnosis (Gathje, et al., 2008). Impairment is only partially
predicted by symptom severity (Barkley, 2010), accounting for only 25% of the variance
in impairment in one study (Gordon, et al., 2006).
Measurement indicators of functioning are more meaningful to patients, their
families, and teachers than measurement indicators of symptoms (J. S. Owens, et al.,
2009). Parents and teachers are less likely to consider a resulting treatment change
meaningful if the child does not show improvement in functioning (Hoagwood, Jensen,
Petti, & Burns, 1996). Research and clinical data present a strong case for using
impairment over symptom measures because, in the majority of the cases, when
impairment improves symptoms improve, where as the converse is less likely (J. S.
Owens, et al., 2009; Young & Gudjonsson, 2008). Impairment, such as declining grades,
rather than symptoms often results in referral for services (J. S. Owens, et al., 2009).
Still, recent intervention studies have shown that significant change in functioning
occurs without symptom change and visa versa (Karpenko, et al., 2009; J. S. Owens, et
al., 2009). There is value in knowing if a symptom change is associated with meaningful
change in specific domains of functioning (J. S. Owens, et al., 2009) and it is important to
study the correspondence between both constructs. To date, research is lacking in this
area.
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Analytic Approaches to Studying Patterns of Symptoms and Impairment Change
When considering patterns of individual ADHD developmental change over time,
it is important to employ fitting analytic approaches (Willoughby, 2003). Jacobson and
Traux’s methods are most often utilized in treatment and intervention studies, however,
developmental trajectory research is an ideal forum this methodological approach. One
part of Jacobson and Traux’s formula for defining “clinically significant” (CS) change,
the Reliable Change Index (RCI) (Jacobson & Truax, 1991), is one frequently used
analytical approach that is useful in considering change over time and helping to better
understand the developmental course of ADHD. RCI is a statistical approach to
measuring an individual’s change (e.g., symptomatology, impairment) in performance on
a standardized outcome measure (Jacobson & Truax, 1991). While the RCI does not
calculate clinically significant change, it is valuable because it categorizes individuals by
the direction and magnitude of change (e.g., increasing symptoms counts, decreasing
symptom counts, no change in symptoms), regardless of functioning status (the second
part of the Jacobson and Truax formula) (J. S. Owens, et al., 2009).
Using the two-part formula, CS change occurs when an individual had achieved
reliable change (using the reliable change index (RCI) from pre- to post- measurement
points and when the post-assessment score reaches the normative range (Jacobson &
Truax, 1991). Employing CS change rather than using the RCI alone, may be overly
conservative and less useful for ADHD research because, while declines in symptoms
and improvement in functioning occur, normative scores may only be achievable for a
small number of individuals (J. S. Owens, et al., 2009). Even if someone does not return
to the normal range of functioning, there is value in calculating the magnitude and
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direction of the impairment change (J. S. Owens, et al., 2009). While other comparable
methods exist, use of the Jacobson and Truax RCI method is encouraged to allow for
cross-study comparability (Karpenko, et al., 2009; J. S. Owens, et al., 2009).
SYMPTOM & FUNCTIONAL IMPAIRMENT TRAJECTORY STUDIES REVIEW ANALYSIS
A search for studies including the following five criteria yielded only three reports
(Biederman, et al., 2000; Bussing, et al., 2010; S. Faraone, et al., 2006): 1. DSM-III, IIIR or IV diagnostic criteria were used via a structured diagnostic interview or through a
validated ADHD rating scale, using parent report; 2. ADHD children were compared to a
well-matched control group; 3. Most participants were ≥4 and ≤12 years of age at the
start of the study and were followed prospectively for at least 1 year after the initial
assessment; 4. A subthreshold ADHD, ADHD NOS, subclinical ADHD, Residual Type,
ADHD in-partial remission, syndromatic remission, functional persistence, or
subsyndromal group was considered separately from the ADHD group and non-ADHD
group; and 5. Impairment status was measured and considered in relation to symptom
status. Eight additional studies are included in the review analysis because they met a
number of the inclusion criteria and offer important insight or methodological
perspectives related to the study of the patterns of symptom and impairment change
comparing youth with ADHD, subclinical ADHD and children without ADHD.
Studies included in the review analysis were examined in order to assess the
following dimensions of research and evaluation: type of study;
populations/communities/levels of focus; location of study; problem/areas of
focus/objectives; underlying theories & principles used in
design/implementation/evaluation of study; evaluation approaches; design and methods

54

for evaluation; instrumentation; data collection methods; data analysis and reporting
procedures; dissemination of results; conclusions; other comments. This strategy was
used to organize the information into specific content areas and also, later, to acquire a
sense of the gaps in the literature.
The following section first discusses studies that are relevant to the current study
but which did not meet all of the inclusion criteria listed above. Next, the three studies
meeting all of the inclusion criteria are presented followed by a summary of gaps and
shortcomings and importance of the reviewed literature.
Subclinical Group Not Considered Separately
Studies prior to Biederman et al. (1998) did not inquire if functional impairment
could normalize for youth with persistent ADHD (Mick, et al., 2004). Biederman et al.
analyzed data from a 4 year longitudinal study of referred boys (aged 6-17) with
persistent ADHD (compared to youth without ADHD to assess levels of school, social,
and emotional functioning (Biederman, Mick, et al., 1998). Normalized functioning was
defined as attaining scores above the fifth percentile of scores in the non-ADHD group
(Biederman, Mick, et al., 1998). At follow-up they found one-fifth of the children with
persistent ADHD functioned poorly in all 3 domains, one fifth did well in all domains,
and three-fifths were impaired at follow up in one or two areas, suggesting the
developmental trajectory of ADHD is associated with inconsistent functioning
(Biederman, Mick, et al., 1998).
Biederman et al., included subthreshold cases with ADHD cases when defining
persistent ADHD and defined subthreshold as fewer symptoms than was required for
ADHD (at least 5 versus at least 8 using DSM-III-R criteria) and with significant
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impairment using the GAF. They included impairment because of Barkley’s idea that the
DSM criteria for ADHD may not be developmentally appropriate for adolescents [certain
symptoms may no longer be endorsed as children age](Biederman, Mick, et al., 1998).
Since subthreshold cases were included in persistent ADHD cases, it is not known how
many of the 85 individuals classified as persistent ADHD cases were subthreshold, and
distinguishing subthreshold functional trajectories is not possible. In an earlier study
(using the same cohort), Biederman et al. (1996) found “early and late remitters” at the
four-year follow-up were less academically and socially impaired compared to
individuals with persistent ADHD. Here too, the subthreshold group (those not meeting
symptom count criteria for DSM-III-R (at least 5 symptoms) but having severe
impairment) was included with the ADHD group (Biederman, et al., 1996).
In a similar methodological study, Mick et al. found a 5-year persistence rate of
71% (N=99) among a referred sample of girls with (123) and without (112) ADHD (6 to
17 years of age at baseline ADHD screening) (Mick et al., 2011). Persistence was defined
as meeting full DSM-IV ADHD diagnostic criteria or residual criteria defined as 3-5
ADHD symptoms (fewer than full diagnostic criteria but more than half the required
symptoms) and associated impairment (i.e., GAF score, 60) (Mick, et al., 2011).
According to the researchers, that definition of persistence was used because, in line with
clinical practice, a disorder is not necessarily considered in remission when full
diagnostic criteria are not met (Mick, et al., 2011).
Findings showed girls with persistent ADHD had more functional impairment
than girls with ADHD in remission (N=44), yet remitted ADHD was associated with
more functional impairment (e.g., academic tutoring) compared to girls without ADHD
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(Mick, et al., 2011). This study, like the Biederman study above, was limited by using a
global assessment of impairment and for its inability to distinguish functional trajectories
of the residual group (as they were included with individuals meeting full DSM-IV
ADHD diagnostic criteria in the persistent ADHD group).
Retrospective Adult Study
Young & Gudjonsson compared adults in partial remission (IPR; n=43) or in full
remission (IR; n=22) to adults with ADHD (n=88) and without ADHD (n=33) and found
symptom remission is associated with improvement in psychosocial functioning (Young
& Gudjonsson, 2008). In partial remission was defined as having met criteria for ADHD
in childhood and rating fewer symptoms of ADHD on the DSM-IV checklist (1 SD above
the mean for a normal control group) (Young & Gudjonsson, 2008). While adults with
ADHD fared the worst, individuals with partial remission and full remission continued to
have difficulties with making and managing friendships compared to those who had
never had ADHD (Young & Gudjonsson, 2008). Additionally, while individuals with
IPR had fewer symptoms than the ADHD group, they had a greater number of visits to
health services compared to adults who had never had ADHD (Young & Gudjonsson,
2008). While this study used retrospective recall of clinically referred patients and
focused on adult functioning, findings show individuals continued to experience
functional impairment even though they no longer meet full diagnostic symptom criteria
(Young & Gudjonsson, 2008). Impairment was not included in the definition of IPR or
IFR.
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Cross Sectional Data
Using cross sectional data, Scahill et al. examined functioning correlates of
ADHD in a community sample of children using the Children’s Global Assessment Scale
(CGAS) (Scahill, et al., 1999). They found children with subthreshold ADHD were
significantly less impaired than children with ADHD, but significantly more impaired
than children without ADHD (Scahill, et al., 1999). The researchers defined subthreshold
ADHD by a symptom score of 13-18 using the Parent Diagnostic Interview Schedule for
children (DISC-R; based on the DSM-III-R criteria) and impairment was not used to
define ADHD, subthreshold, or non-ADHD categories (Scahill, et al., 1999). Findings
suggested it is beneficial to consider ADHD dimensionally in terms of severity of
disorder rather than categorically (Scahill, et al., 1999).
Symptom/Functioning Correspondence Studies
One of the first symptom/functioning correspondence studies examined the
interrelationship between the Child Behavior Checklist (CBCL) (symptom measure) and
the Child and Adolescent Functional Assessment Scale (CAFAS)(impairment measure)
using Jacobson and Truax’s RCI methodology (Rosenblatt & Rosenblatt, 2002).
Psychosocial domains assessed using a sum score from the CAFAS included Role
Performance, Behavior Toward Others/Self, Moods/Emotions, Substance Use, and
Thinking (Rosenblatt & Rosenblatt, 2002). The sample included 3,008 referred youth
(mean age was 12.5 years at intake) with various diagnoses, including ADHD ODD/CD,
and mood disorder receiving mental health services and “a coordinated care plan”
following intake. At follow-up, findings showed 13% of disagreement in outcomes
between symptoms (CBCL) and functioning (CAFAS). Researchers found minimal
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correspondence between reliable change in symptoms and functioning with 197 (45%)
achieving reliable positive change in functioning (CAFAS) while 59 (13%) of the 432
youth’s scores on the CBCL did not change (Rosenblatt & Rosenblatt, 2002). On the
other hand, 50 (15%) youth showed negative change and 103 (30%) showed positive
symptoms change while 329 youth did not show any reliable functioning change
(Rosenblatt & Rosenblatt, 2002). These findings suggest that a consideration of the
correspondence between symptom and functioning change has value over a consideration
of symptom change alone.
Drawing methodologically from the Rosenblatt study, Karpenko et al. analyzed
data from the Multimodal Treatment Study of Children with ADHD (MTA) to study the
correspondence between clinically significant (CS) change in symptoms and reliable
change in functioning (Karpenko, et al., 2009). Participants included 417 children (aged
7-9) with ADHD-C who received treatments (i.e., medication and/or behavioral
treatment). Using parental report, they found that children with CS symptom change were
two times more likely than children who did not reach CS symptom change to have
reliable improvement in social, academic, home, and global levels of impairment
(Karpenko, et al., 2009). Of note, functioning did improve for 14-52% of children who
did not have CS change in symptoms, depending on the measure (Karpenko, et al., 2009).
From the client’s standpoint, the researchers suggest, reliable change in impaired
functioning alone (without significant symptom change) may hold meaning (J. S. Owens,
et al., 2009).
Because the study was limited to the MTA dataset, there was no control group
and a clinical population was used (Karpenko, et al., 2009). A subclinical ADHD group
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was not identified and individuals who had worsening impairment (a small percentage)
were combined with “no-changers” (Karpenko, et al., 2009). The researchers justified the
use of measuring CS change for symptom outcomes and RCI for functional impairment
outcomes because CS change has been mainly applied to analysis of symptom change
and it may be “helpful to begin studying change in functioning by applying the less
stringent criterion (reliable change)” (Karpenko, et al., 2009). Other than to maintain
consistency with previous MTA analyses, it is not clear why they chose to treat
symptoms using the more conservative approach for symptom change.
Owens et al. studied the relationship between reliable change in symptoms and
reliable change in functioning in 64 girls with ADHD enrolled in a school-based
parent/teacher intervention program (J. S. Owens, et al., 2009). A comparison of group
and individual level analysis revealed that while both analyses indicate statistically
significant correspondence between reliable change in symptoms and reliable change in
functioning, individual analysis revealed a substantial number of children with ADHD
experienced a “change in one dimension without change in the other” (J. S. Owens, et al.,
2009). Depending on informant and functional domain, up to 40% achieved reliable
symptom change without reliable improvement in functioning and up to 16% achieved
reliable change in functioning without reliable change in symptoms (J. S. Owens, et al.,
2009). Of note, less than 50% of girls with symptom improvement showed reliable
improvement in the six domains of functioning that were assessed (symptoms, peers,
parent/teacher, academics, family/classroom/ self-esteem). This study did not include a
subclinical ADHD group nor did it include a comparison group.
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Studies Meeting all Inclusion Criteria
Biederman et al. considered three categories of remission: syndromatic (loss of
full diagnostic status; (DSM-III-R criteria), symptomatic (not meeting symptom count
criteria (36% of symptoms), regardless of impairment), and functional (not meeting
symptom count criteria (36% of symptoms), plus no impairment (GAF score higher than
60) (Biederman, et al., 2000). Measuring 128 clinically referred boys (ranging in age
from less than 6 to 20 years) at the four year follow-up, they found the following rates of
remission: syndromatic (60%), symptomatic (30%), and functional remission (10%)
(Biederman, et al., 2000). In spite of the large percentage of syndromatic remission
(60%) these individuals who no longer met symptom count criteria continued to suffer
from impairment (Biederman, et al., 2000). The 30% who fell into the symptomatic
remission category had fewer than the number of symptoms for a subthreshold diagnosis,
regardless of impairment, and no findings are presented on the levels of impairment
experienced by these individuals(Biederman, et al., 2000). Information related to domain
specific impairment was not collected. Results of this study emphasize that reported
remission rate is more a function of the definition of remission used, rather than course of
the disorder.
Faraone et al. (S. Faraone, et al., 2006) compared four adult groups: full ADHD
(127), late onset ADHD (all criteria met except onset age of 7) (79), subthreshold (never
having had ADHD using DSM-IV criteria and having a chronic history of 3 or more
ADHD-HI or ADHD-IA symptoms (41), and comparisons (123) (S. Faraone, et al.,
2006). The subthreshold group was significantly impaired compared to the comparison
group but presented with less impairment than individuals with late-onset and full ADHD
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diagnosis (S. Faraone, et al., 2006). Impairment items assessed included the need for
academic tutoring in childhood, traffic citations received, grade achieved in school, and
occupational status (S. Faraone, et al., 2006). The subthreshold group in Faraone’s study
“does not provide insight into the problems faced by adolescents and adults who are
“growing out” of the disorder by experiencing symptom remission of childhood ADHD
and/or associated lessening of functional impairment” (Young & Gudjonsson, 2008).
Bussing at al. (Bussing, et al., 2010) provide observational outcome data related
to functioning and quality of life from a diverse, prospective, longitudinal community
study. They compared 94 children at baseline (age 5–11) with full ADHD (using DSMIV criteria) to 75 children with subthreshold, and 163 low-risk peers at an 8-year followup assessment (Bussing, et al., 2010). Based on combined parent and child reports using
the Columbia Impairment Scale, youth with ADHD, but not children without ADHD in
childhood, was associated with increased functional impairment and lower quality of life
at follow-up (Bussing, et al., 2010). ADHD and subthreshold ADHD in childhood were
associated with lower average grades compared to children without ADHD (Bussing, et
al., 2010). Both ADHD and subthreshold ADHD were associated with increased risk of
juvenile justice system involvement and failure to graduate and subthreshold but not full
ADHD was associated with being held back in school (Bussing, et al., 2010).
GAPS SHORTCOMINGS AND STRENGTHS OF THE ANALYSIS REVIEW LITERATURE
It was not possible to distinguish functional trajectories of the subclinical groups
in the Biederman and Mick Studies, as they were included with individuals meeting full
DSM-IV ADHD diagnostic criteria (Biederman, et al., 1996; Mick, et al., 2011).
Additionally, global assessment of impairment did not allow for domain specific
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assessment of functional impairment. The researchers did inquire if functioning could
normalize for youth with persistent ADHD and learned the developmental trajectory of
ADHD is often associated with inconsistent functioning.
Young & Gudjonsson retrospectively demonstrated individuals continued to
experience functional impairment even though they no longer meet full diagnostic
symptom criteria (Young & Gudjonsson, 2008). Using cross-sectional data, Scahill found
children with subthreshold ADHD were significantly less impaired than children with
ADHD, but significantly more impaired than children without ADHD and demonstrated
the usefulness of treating ADHD dimensionally rather than categorically(Scahill, et al.,
1999). In line with both Young & Gudjonsson and Scahill, all three studies that did meet
inclusion criteria also demonstrated that youth with subclinical ADHD who no longer
met symptom count criteria continued to suffer from impairment (Biederman, et al.,
2000; Bussing, et al., 2010; S. Faraone, et al., 2006). Further, Biederman et al.,
emphasize that reported remission rate is more a function of the definition of remission
used, rather than course of the disorder.
Methodologically, the symptom/functioning correspondence studies provide
detailed information related to percentages of individuals who make reliable
improvement in functioning but not symptoms and visa versa and make a compelling
case for using similar methodology to uncover symptom and/or functioning
developmental trajectories (Karpenko, et al., 2009; J. S. Owens, et al., 2009; Rosenblatt
& Rosenblatt, 2002) among youth with subclinical ADHD to compared to youth with and
without ADHD. The Owens et al. study, highlighted a need for research that considers
profiles of children who show no change in symptoms or a reduction in symptoms (J. S.
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Owens, et al., 2009). The Karpenko study pinpoints a need to compare nontreated
individuals with treated individuals when considering corresponding symptom and
impairment, as they did not consider nontreated individuals (a limitation of using the
MTA dataset) (Karpenko, et al., 2009). These studies also contribute to an understudied
area in ADHD research; the relation between patterns of change in symptoms and
functioning (J. S. Owens, et al., 2009). Given the potential importance of subclinical
ADHD and the almost complete absence of longitudinal research on this subcategory of
ADHD, further research is in this area is warranted.
ADHD AND SUBCLINICAL ADHD TREATMENT SEEKING
Medication Treatment and Developmental Trajectories
Research evidence shows that early identification and treatment can improve
developmental trajectories (Magyary & Brandt, 2002). Recommended treatment for
ADHD includes medication and/or behavior therapy (Adler, et al., 2008) to improve
targeted outcomes (Vierhile, et al., 2009). There are a variety of ADHD medications and
stimulant medications thought to be better than nonstimulant medications (Vierhile, et al.,
2009). Stimulant medications such as methylphenidate (the active ingredient in Ritalin)
and mixed amphetamine salts (Adderall) are a first-line treatment for ADHD, with
methylphenidate being the best-studied (Ramos-Quiroga & Casas, 2011). When stimulant
medication is ineffective, atomoxetine, a non-stimulant medication, is recommended
(Vierhile, et al., 2009). Behavior therapy includes various interventions designed to
modify the physical and social environment in order to reward achievement of desired
goals or assign consequences for not meeting goals (Perrin et al., 2001). Other
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psychosocial interventions do not have evidence-based support (W. Pelham & Fabiano,
2008).
In 2007, 66% of youth (ages 4-17) were treated with medication for a current
ADHD diagnosis (Visser & Lesesne, 2005). Youth aged 11-17 had higher mediation rates
compared to children aged 4-10 and boys were more likely than girls to take medication
(Visser & Lesesne, 2005). Medication treatment compliance may be as low as 50% in
children with ADHD (Johnston & Fine, 1993). Regarding behavioral intervention, recent
findings suggests that treatment effects from school-based intervention and parent
training for young children with ADHD symptoms was not sustained two years following
treatment (Shelton et al., 2000).
The ultimate goal of treatment for ADHD is to achieve remission (Steele, et al.,
2006). Remission should include reducing impairment in emotional, academic, and social
domains, not just reducing ADHD core symptoms (Adler, et al., 2008; Steele, et al.,
2006). The efficacy of stimulant medication in reducing core symptoms of ADHD (P. L.
Hazell et al., 2010) as well as improving function in a number of domains is well
documented in the literature (Perrin, et al., 2001). In fact, in about 70% of cases, ADHD
medication reduces ADHD symptoms (e.g., interrupting and fidgeting) as well as
improves impairment (e.g., relationships at home with parents) (Action, 2002).
Steele et al. (2006) reviewed studies and found achievement of symptomatic
remission rates in ADHD children treated with methylphenidate (highest remission rates)
and atomoxetine, but did not find remission rates in the literature for amphetamines. Most
clinical trials, they found, define remission by taking symptoms, but not impairment, into
account(Steele, et al., 2006). They reviewed various studies that have assessed
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improvements in functioning and found medication use versus no medication use is
associated with greater rates of symptom remission and increased social and academic
functioning (Steele, et al., 2006).
Improved functioning was greater with medication that offered higher symptom
remission rates (Steele, et al., 2006). Perwein et al., found children with ADHD who
received atomoxetine showed significantly greater improvement in psychosocial
functioning compared to those children taking a placebo (Perwien et al., 2004). Academic
impairments have been shown to be effectively treated with stimulants, while social
impairment have been shown to be effectively treated with nonstimulant medication
(Wehmeier, et al., 2010). Quality of life research has shown medication treatment
resulted in improvements in family functioning as well as improvements in social and
self esteem (Harpin, 2005).
Treating Children with Subclincial ADHD
The subject of treating children with subclinical ADHD is a controversial one.
Data suggests that compared to children meeting full ADHD symptom counts, fewer
children meeting subthreshold symptoms counts are treated with medication (Bussing, et
al., 2010). One study looking at community treatment data considered four subgroups
(full ADHD/subthreshold/last-onset ADHD/controls) and found among the subthreshold
group 19% had received psychotropic medication for ADHD (lifetime), and 15% were
currently taking medication (S. Faraone, et al., 2006). In another study, 25% of youth
with subthreshold ADHD reported ever being treated with medication for ADHD,
compared to 50% of youth with ADHD (Bussing, et al., 2010). While one would expect
lower rates of medication treatment among individuals with diminished forms of ADHD
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compared to ADHD, some question the appropriateness of treating this group (S.
Faraone, et al., 2006) while others reason that increasing medication rates among
subthreshold cases may reduce the risk for negative functional outcomes (Bussing, et al.,
2010).
Family Impairment
Research evidence indicates family functioning difficulties are associated features
of ADHD (Barkley, 2004; Deault, 2010; Johnston & Mash, 2001; Schroeder & Kelley,
2009) and many parents find parenting a child with ADHD to be difficult and
psychologically distressing (Harrison & Sofronoff, 2002). A recent community-based
study found parents of children with ADHD or CD/ODD (though CD/ODD with or
without ADHD had a greater influence) were more likely to report problems with
parental support, involvement, communication, and limit-setting compared to parents of
children without those disorders (Geryk et al., 2012). An eight-year follow-up study of
interaction patterns of 100 children with hyperactivity and 60 comparison children found
among families with a hyperactive child, negative parent-child interactions predicted
continuing parent-teen conflicts, and parents of hyperactive children reported more
personal distress at outcome compared to parents without a child with hyperactivity
(Barkley, Fischer, Edelbrock, & Smallish, 1991).
Predictors of Treatment Seeking
Several studies (Angold, et al., 1998; Farmer, Stangl, Burns, Costello, & Angold,
1999; Sayal, et al., 2006; Sayal, Taylor, & Beecham, 2003) and data from the National
Health Interview Survey (NHIS) (Simpson, Cohen, Bloom, & Blumberg, 2009) suggest a
strong relationship between the impact of youth’s behavioral difficulties and mental
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health service use. Other findings suggest burden resulting from a child’s mental health
condition strongly predicts mental health service use (Angold, et al., 1998) and
continuing care (Farmer, et al., 1999). Results from the NHIS survey found families were
almost two times as likely to have contact with a mental health provider if the child’s
difficulty was considered a “burden on the family” (Simpson, et al., 2009). Hispanic,
black, and younger children (aged 4-7 years), with emotional or behavioral difficulties
were less likely to use mental health services compared to white and older children
(Simpson, et al., 2009).
Children with ADHD compared to children without ADHD are more likely to
utilize health care services (e.g., visit mental health professionals, take medication, and
have frequent visits) (Pastor & Reuben, 2008). Research shows referral for treatment or
services for ADHD is usually a result of functional impairment rather than symptoms
(Angold, et al., 1999). Angold et al. found that children, regardless of meeting symptom
criteria or not, who had impaired function were likely receiving services (Angold, et al.,
1999). One study found more “costly and restrictive treatment” was associated with a
child and adolescents severity of impairment in multiple domains (McDermott,
McKelvey, Roberts, & Davies, 2002). In a study by Bourdon et al. comparing four
Strengths and Difficulties Questionnaire (SDQ) scoring methods, scoring method using
parent perceived severity of difficulties identified the highest percentage of children with
“service contact/use” (Bourdon, Goodman, Rae, Simpson, & Koretz, 2005). Parent’s
perception of problems and report of impairment are strong predictors of child mental
health service use (Sayal, et al., 2003). Sayal et al, collected data from 232 parents of
children with ADHD and found rather than severity of disorder and comorbidity, impact
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of the disorder on caregivers best predicted recognition of problems (perceived burden)
which were the main correlate of service contact(Sayal, et al., 2006).
Additional predictors of treatment seeking and service use have been identified in
the literature. In a study of 268 clinic referred and 137 community-based children with
ADHD and 268 controls, aged 6-15, Gau et al. found the most associated variables for
psychiatric referral were male gender (OR=3.58), maternal education level as college or
higher (OR=2.46), and interfering with friendship (OR=2.28). Interestingly, among
community-based children with ADHD, data did not show differences in symptom
severity and degree of impairment between those seeking medical services and those who
did not (Gau et al., 2010). A study of Puerto Rican children aged 4-17 found ADHD,
ADHD-NOS, impairment and male gender predicted stimulant medication use during the
past year (Bauermeister, et al., 2003). Similarly, another study found ADHD, ADHDNOS and male gender was associated with stimulant medication use, as well as younger
age (Leslie, et al., 2005). After controlling for symptom severity, Jensen at al. found
parental mental health history, level of stress, family size, and marital status predicted
service use (Jensen, Bloedau, & Davis, 1990).
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Chapter 3
METHODOLOGY
PURPOSE
The overall purpose of this study is to investigate developmental ADHD symptom
and functioning profiles in a community sample of children and adolescents participating
in the South Carolina Project to Learn about ADHD in Youth (SCPLAY) using data from
baseline and follow-up assessments. This study employs the Jacobson & Traux reliable
change index (RCI) methodology to examine patterns of Attention-Deficit/Hyperactivity
Disorder (ADHD) functioning change. This method is clinically relevant in that it allows
for a determination of the proportion of youth who improve or do not improve
functionally, and who improve in one area but not the other. This research is also
concerned with subthreshold ADHD as having potential risk for having or developing
subsequent impairment problems as children age and demands on attention and
performance increase. Patterns of symptom and functioning change are considered for
children with ADHD, children with subthreshold ADHD and children without ADHD, as
well as for children with ADHD and subthreshold ADHD who are and are not medicated.
This study examines functional impairment in five individual domains of functioning, as
well as overall impairment. Additionally, predictors of impairment severity and service
utilization are examined. It is hoped that through improved understanding of the
correspondence between these constructs, resources can be targeted to help children and
adolescents with ADHD and subthreshold ADHD lead less impaired lives.
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THEORETICAL/CONCEPTUAL FRAMEWORK
Developmental psychopathology is a multidisciplinary framework used to
understand symptoms and functional impairments associated with mental disorders in the
context of change over time and in relation to normal development (Cicchetti, 1990;
Cicchetti & Toth, 1995). This perspective emphasizes a longitudinal perspective as
essential to understanding development, as well as an appreciation of underlying
biological predisposition and environmental contexts (Hinshaw & Blachman, 2005).
While there is ample research stemming from the developmental perspective focusing on
associations between aspects of the family and symptomatology, there is a lack of
research conceptualizing ADHD in terms of ongoing difficulties that children and
adolescents with ADHD experience in multiple domains of functioning at different points
in time (Deault, 2010).
The developmental perspective is also a useful framework to invoke when asking
questions such as “What factors contribute to the development of more severe forms of
impairment?” and “Are the predictors of treatment-seeking the same for children
experiencing subthreshold ADHD as for children with ADHD?”- questions this research
seeks to answer. Answers to these questions provide guidance for interventions in clinical
practice and enhance parents’ efforts to help their children reduce social and academic
impairments (Deault, 2010). A developmental psychopathology approach also helps
clarify the developmental course and diversity in course of ADHD and subclinical
ADHD (Cicchetti & Toth, 1995).
Stemming from developmental psychopathology, developmental epidemiology is
the study of patterns of disease distribution (in this case, ADHD) over time as a tool for
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understanding specific aspects of the developmental course (Costello et al., 2006). It is
specifically concerned with individual trajectories and requires researchers to take
symptoms and impairment, as well as developmental stage, into account when
considering the line between normal and abnormal behavior (Costello & Angold, 1993).
This research is guided by that principle and, as an example, does not apply strict DSMIV diagnostic criteria to youth of differing ages. Developmental epidemiology is both a
descriptive and an analytic approach (Costello, Foley, & Angold, 2006). This framework
is useful for attempting to understand developmental trajectories of impairment
associated with ADHD over time because it is based on the premise that core features of
ADHD change over time, and stresses the importance of interpreting aspects of that
change (e.g. symptom expression) in relation to normal development (Mick, et al., 2004).
Developmental epidemiology emphasizes the need to use consistent methodology when
analyzing change over time (Youngstrom, Meyers, Youngstrom, Calabrese, & Findling,
2006).
Finally, impairment resulting from having ADHD extends beyond the individual,
and should be conceptualized through an ecological perspective (Goldstein & Naglieri,
2009). This research considers both individual and social environmental functional
domains that can help with targeted planning and treatment for individuals with ADHD
and subthreshold ADHD. Such an approach is similar to the DSM-IV-TR, which uses a
multi-axial classification system designed to consider biological and psychosocial aspects
(in addition to ADHD diagnostic criteria) that are related to diagnosing an individual (e.g.
medical conditions that are relevant to the disorder, co-morbidity, and relevant
psychosocial and environmental problems).
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The International Classification of Functioning, Disability, and Health Model
(ICF) was developed by the WHO working group, and classifies functioning and
disability according to three levels of functioning (impairments at the body function
level, limitations at the personal activity level, and participation restrictions at the societal
level). The ICF is useful for describing children’s behavior and functioning (Lollar,
2008). These three levels in the ICF model are all affected by aspects of the environment
(Lollar, 2008) and relate directly to the domains of functioning that are targeted in this
study.
This study uses the ICF-CY perspective, along with developmental
psychopathology and developmental epidemiology frameworks to consider patterns of
change in ADHD symptoms and functioning and predictors of impairment and ADHD
medication use. Taken together, these perspectives provide a developmental framework
that guides this research, and offer perspective on conceptualizing research questions and
conducting analysis.
SPECIFIC STUDY RESEARCH AIMS/QUESTIONS
MANUSCRIPT 1:
The purpose of this study is to examine patterns of change between symptoms and
functioning among youth with ADHD, with subthreshold ADHD (having three to five
symptoms of ADHD), and without ADHD across two time-points, and to evaluate
predictors of impairment.
Manuscript 1 Aim 1 (M1A1): To examine patterns of change between symptoms
and functioning among youth with ADHD, with subthreshold ADHD, and without
ADHD across two time-points.
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Research Question 1 (M1A1RQ1): How do youth with subthreshold ADHD,
youth with ADHD, and youth without ADHD change from baseline to follow-up
with regard to patterns of change in symptoms and domains (both specific and
aggregate) of functioning? The 5 domains of functioning include social
(friendships), school (classroom learning), home (home life), intrapersonal (self),
and free time (leisure activities).
Manuscript 1 Aim 2 (M1A2): To examine baseline demographic and psychiatric
variables associated with severe levels of functional impairment at follow-up.
Research Question 2 (M1A2RQ2): Are the risk factors (child factors: age, gender,
comorbidity, medication; family factors: exposure to parental psychopathology,
primary parents educational attainment, marital status) that are associated with
more severe forms of ADHD impairment similar for youth with ADHD, youth
with subthreshold ADHD, and youth without ADHD?
MANUSCRIPT 2:
The purpose of this study is to examine patterns of symptom and functional
impairment change from baseline and follow-up for youth with subthreshold ADHD and
youth with ADHD based on treatment status, and to evaluate predictors of treatment
utilization for youth with subthreshold ADHD compared to youth with ADHD.
Manuscript 2 Aim 1 (M2A1): To examine patterns of symptom and functioning
change from baseline to follow-up for youth with subthreshold ADHD and youth with
ADHD based on treatment status [taking ADHD medication versus not taking ADHD
medication (within the last year)].
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Research Question 1 (M2A1RQ1): How do youth with subthreshold ADHD,
and youth with ADHD change from baseline to follow-up with regard to patterns
of change in symptoms and functioning (both specific domains and aggregate),
based on treatment status (taken medication within the last year versus not taken
medication in the last year)? The 5 specific domains of functioning include social
(friendships), school (classroom learning), home (home life), intrapersonal (self),
and free time (leisure activities).
Manuscript 2 Aim 2 (M2A2): To examine baseline demographic and psychiatric
variables that are associated with ADHD medication use at follow-up.
Research Question 2 (M2A2RQ2): Are the risk factors (child factors:
impairment, gender, race, age, comorbidity; family factors: parent reported
burden, insurance, parent educational level, exposure to parental
psychopathology) of ADHD medication use (past year) similar for youth with
subthreshold ADHD compared to youth with ADHD?
RESEARCH DESIGN
This South Carolina Project to Learn about ADHD in Youth (SCPLAY) utilized a
two-phase research design involving school district-wide, voluntary teacher and parent
screenings (phase I), and in-person assessments including a structured diagnostic
interview with participants and parents/caregivers (phase II). Study procedures were
reviewed and approved by the Institutional Review Board of the University of South
Carolina and the Centers for Disease Control and Prevention. Informed consent was
obtained from parents for children under the age of 18. Assent forms were read aloud and
signed by children and parents.
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SCREENING (PHASE I)
Research Population
In Phase I, the sampling population included all 15 elementary schools in a large
school district in SC. At the time of the screening, the school district had approximately
8,700 elementary school students attending Pre-K through grade 5. The school district
population was culturally and racially diverse, and included rural, suburban, and some
urban neighborhoods. The behavioral screening was conducted in classrooms (excluding
special education classes) during the 2003-2004 school years. Teachers and/or parents
(n=4606) completed Phase I screens.
Screening Overview
Participating parents and teachers answered two questions, one about previous
ADHD diagnosis (teacher question:“To your knowledge, has this child been diagnosed
with ADHD?”; parent question: “Has a doctor or health professional ever told you that
your child had ADHD or ADD?”) and one question about current ADHD medication
treatment (teacher question:“Is this child on stimulant medication such as
methylphenidate (Ritalin)?”; parent question: “Is your child currently taking medication
for ADHD/ADD?”). Additionally, teachers completed the Vanderbilt ADHD Diagnostic
Teacher Rating Scale (VADTRS) (M. L. Wolraich, Feurer, Hannah, Baumgaertel, &
Pinnock, 1998), and rated associated functioning by completing the “impact supplement”
of the Strengths and Difficulties Questionnaire (SDQ) (Goodman, 1999). These two
measures are explained in greater detail below.
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Vanderbilt ADHD Diagnostic Teacher Rating Scale (VADTRS), teacher version
(Wolraich, Feurer, Hannah, Baumgaertel, & Pinnock, 1998)
The VADTRS scale is a DSM-IV based rating scale used to assess children for
symptoms of ADHD (includes all 18 symptoms), ODD (eight symptoms), CD (12
symptoms), and anxiety/depression (7 symptoms). For the present study, only items
assessing ADHD symptoms were utilized. Teachers were asked to rate the 18 items
using a Likert scale (“Never”; “Occasionally”; “Often”; and “Very Often”) reflecting the
child’s behavior “since the beginning of the school year.” (M. L. Wolraich, et al., 1998)
The Strengths and Difficulties Questionnaire (SDQ) (Goodman, 2001)
The SDQ is a screening tool for multiple behavioral disorders and includes a
rating of functioning (impact supplement). For the present study, the impact supplement
was used to identify impaired functioning. The SDQ is described in more detail in the
Interviews (Phase II) section below. The teacher version of the SDQ differs from the
parent version only in terms of wording referencing "your child" versus "this child," and
the teacher version does not have the family life or leisure impairment items (as teachers
often cannot report on those domains of functioning) (Goodman, 1999).
Classification of High and Low Screen
Children were categorized as probable ADHD cases (high-screen): (1) if teachers
rated six or more ADHD symptoms in either or both inattentive and hyperactiveimpulsive ADHD subtype domains on the VADTRS with intermediate impairment
ratings on the SDQ, or (2) if parents or teachers reported the child had received an
ADHD diagnosis or were taking medication for ADHD. Otherwise, children were
considered probable non-ADHD cases (low screen). All high screens and a sample of low
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screens, frequency matched on gender, were randomly selected (n=2206) and eligible for
Phase II. A letter from the school district was sent home to eligible families asking for
permission to have study recruitment staff contact them. If a letter was returned,
indicating consent to be contacted for the study, interested families (n=633) were then
invited for an in-person structured assessment of ADHD, other mental disorders,
treatment history, demographics, and other factors.
INTERVIEWS (PHASE II)
Baseline and follow-up (Phase II) in-person interviews were conducted with
consenting families (n=481 baseline; n=292 follow-up). Baseline interviews were
administered 13 months (mean time) following the screening (from 9/03 to 1/06 and
follow-up interviews began 20 months later (9/07-2/09). The participating caregiver was
often the child’s mother. Interviews (baseline and follow-up) were completed primarily
in-person; written questionnaires for parents were sent home in advance of the interview
and collected and checked for completeness during the interview. Interviews were
conducted via telephone and parent measures returned by mail if families moved away,
did not wish to meet at the study interview site or the child’s school, or have interviewers
come to their home. Participants were given an incentive (gift cards at baseline or cash at
follow-up) for participation in the study. Following each interview, diagnostic data were
independently reviewed by a project child psychiatrist. Parents were sent a findings letter,
and referral information was provided if findings suggested a probable diagnosis.
Protocols were followed when parents or children reported “risks of harm to self or others
or reported abuse.”
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Baseline/Follow-up Measures (Detailed)
Measures were selected to assess ADHD, CD, and ODD symptomatology and
associated functional impairment (core domains of functioning), along with other
disorders and measures related to treatment history, demographics, and other factors.
Diagnostic Interview Schedule for Children, Parent Version (NIMH DISC-IV-P;
Shaffer, Fisher, Lucas, Dulcan, & Schwab-Stone, 2000)
Parents completed selected modules of the Diagnostic Interview Schedule IV
(DISC-IV) (Shaffer, et al., 2000), a highly-structured computer-based investigation of
child psychopathology during the past 12 months. Selected modules included generalized
anxiety disorder, separation anxiety disorder, obsessive compulsive disorder, posttraumatic stress disorder, major depression/dysthymic disorder, mania/hypomania,
ADHD, ODD, and CD. The DISC-IV interview is based on DSM-IV diagnostic criteria
and was administered to the parent by a trained project staff member during baseline and
all follow-up assessments. If stem questions (symptom questions) were endorsed,
contingent questions followed which determined if a participant met frequency, duration,
and intensity criteria as specified by DSM diagnostic criteria (Grills-Taquechel &
Ollendick, 2008). If enough stem questions were answered positively and DSM
diagnostic criteria symptom counts met, further questions were asked assessing DSM-IV
impairment criteria. However, if not enough DSM symptoms were endorsed by parents
through the DISC-IV stem questions, the impairment questions were not asked. For this
reason, the DISC-IV was only used to assess past year ADHD symptom counts and not to
assess functional impairment. For all other psychiatric disorders assessed, past year
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categorical probable diagnoses were obtained using the DISC-IV scoring algorithm based
on DSM-IV diagnostic criteria.
The DISC is a reliable and valid interview with clinical value (Grills-Taquechel &
Ollendick, 2008). The DISC has excellent inter-rater reliability (Shaffer, et al., 2000) and
the test-retest reliability (k statistic) of the ADHD DISC-IV module (parent report) in a
clinical sample and community sample (past year) among children aged 9-17 years is
k=.79 and k=.60, respectively (Shaffer, et al., 2000). The sensitivity of the DISC is found
to be excellent (range = 0.73 to 1.0) and one community-based study shows DISC
correspondence to clinically meaningful ADHD symptomatology (ADHD; k =.72)
(Schwab-Stone, Shaffer, Dulcan, & Jensen, 1996). The DISC showed moderate to good
validity across a number of diagnoses, including ADHD (Schwab-Stone, et al., 1996).
Parent interview was used because research has shown test-retest is unreliable on the
child DISC interview (Schwab-Stone, et al., 1996).
The Strengths and Difficulties Questionnaire (SDQ) (Goodman, 2001)
The Strengths and Difficulties Questionnaire (SDQ) (Goodman, 2001), comprised
of 25 symptom items, was developed for parents, teachers, and youth to assess emotional,
social, and behavioral difficulties and prosocial strengths. The symptom/difficulty
subscales include symptoms of ADHD, conduct disorder, emotional problems, peer
problems, and prosocial behavior. Parents are asked about their child’s
symptoms/behavior during the past six months and response variables include a threepoint Likert scale (“not true,” “somewhat true,” and “certainly true”) that indicates
applicability of each symptom to the child (Goodman, 1999). The extended version of the
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Strengths and Difficulties Questionnaire includes a rating of the impact of those
symptoms/difficulties on specific areas of functioning (Goodman, 1999).
Only the eight items assessing “impact” or impairment associated with the
symptom items from the extended version of the SDQ were examined in these analyses.
The parent version of this measure was completed at baseline and follow-up. The SDQ
impairment section contains one item related to parental perceived severity of problems
(“Overall, do you think that your child has difficulties in one or more of the following
areas: emotions, concentration, behavior or being able to get on with other people?”) with
responses including “no,” “yes, minor difficulties,” “yes, definite difficulties,” and “yes,
severe difficulties,” and one item assessing the length of time the difficulties have been
present (Goodman, 2001). Additionally, the impairment section consists of six items
related to functioning associated with the reported difficulties with Likert scale responses
ranging from “not at all” to “a great deal” . The five areas (or domains) of functioning
assessed related to the child include child distress, home life, friendships, classroom
learning, leisure activities. The last item asks about the difficulties being a burden to the
caregiver or family.
For these analyses, the parent perceived burden item was treated dichotomously,
coded as “present” (“medium amount” or “great deal”) = 1, and, “absent” (“not at all” or
“a little”) = 2. The five functioning items (also referred to as impairment items) were
summed to derive a “total impairment score,” categorizing impairment as
abnormal/severe (high) if at least two impairment items were endorsed as a “medium
amount” or one item was endorsed as a “great deal” (total impairment score ≥2) or
normal/low/moderate (total impairment score ≤1). Total impairment scores were used to
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consider predictors of service utilization, as an outcome variable, and to assess change
from baseline to follow-up in relation to change in symptom categories. Individual
functioning items were used to assess reliable change in functional impairment from
baseline to follow-up using a reliable change index (described in detail below).
Normative data on the SDQ parent version have been obtained for both child
(Stone, Otten, Engels, Vermulst, & Janssens, 2010) and adolescent (Bourdon, et al.,
2005) populations. The SDQ is well-validated and was selected because it is widely used
in both research and practice, and assesses domains of functioning in children and
adolescents with ADHD. Reliability and validity data are summarized in two reports by
the SDQ author (Goodman, 1999, 2001), and indicate that the parent version has high
internal consistency for the total impact/impairment score (Cronbach alpha coefficient
=.85), good four- to six-month retest stability for the parent version (Impact/impairment
score; .57), and good validity for the impact/impairment score (negative predictive value
(NPV) = .95; positive predictive value (PPV) = .53). Internal reliability has been reported
to be .82 (Goodman, 2001).
Medication Status & Service Use
The DISC-IV was used to ascertain use of ADHD medication, including stimulant
and non-stimulant medication, during the preceding year. The parent-reported mental
health history questionnaire was used to identify if the parent has ever been told by a
doctor or other health professional that they have a psychiatric disorder.
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Demographic Survey
Socio-demographic information (age, gender, race, insurance status, primary
parent’s educational attainment, and marital status) was obtained from parent self-report
on a demographic questionnaire.
STATISTICAL PROCEDURES FOR RESEARCH QUESTIONS
SAS version 9.2 was used for data management and, when necessary, analyses
were conducted using SAS-callable SUDAAN 10.0.
Procedures for Research Questions 1 for Manuscript 1
Part I: JT Method: Looking for Reliable Change
The data used to analyze question 1 for manuscript 1 were drawn from parent
DISC-IV and SDQ data from baseline and follow-up assessments. Procedures outlined in
Jacobson and Traux’s (1991) methodology for creating a reliable change index (RCI)
were used to determine which children met criteria for reliable change in functioning
(using the five functional domains from the SDQ data) in relation to symptom category
(non-ADHD, subthreshold ADHD, and probable ADHD) change from baseline to followup. While other comparable statistical methods exist, researchers are encouraging the use
this method for comparability purposes (Karpenko, et al., 2009). The following formula
for reliable change (RC) as outlined by Jacobson and Traux was used:
;

Xpost = individual’s score at follow-up
Xpre = individual’s score at baseline
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rxx = test-retest reliability of the measure
Sdiff = standard error of the difference between the two scores
SD1 = standard deviation of the sample at baseline
SE = standard error of measurement
Categories of change:
Scores ≥ to 1.96 = positive change (e.g. impairment increased/worsened)
Scores ≤ to -1.96 = negative change (e.g. impairment decreased/improved)
Scores between 1.96 and -1.96 = no change
Scores ≥ to 1.96 are unlikely to be due to chance (p<.05) (Karpenko, et al., 2009).
Follow-up data for each measure of functioning was subtracted from the baseline data to
find the difference scores for each of the 5 domains of functioning that are included in
question 1. For each measure of functioning a participant was classified as having
increased, decreased, or stayed the same. Total impairment scores were used when
considering change in overall functional impairment from baseline to follow-up with
abnormal/severe (high) impairment being at least two impairment items were endorsed as
a “medium amount” or one item was endorsed as a “great deal.” These criteria were used
because they follow the DSM-IV impairment criteria, yet may be overly stringent
considering that situational ADHD (severe impairment in only one domain) may be an
equally valid measure of impairment.(Lahey, et al., 2004)
This first step, using the RCI, distinguished individuals who made a statistically
reliable change from those who had not. It was performed to account for any error in
measurement when analyzing change from the pre- to the post-time point (Rosenblatt &
Rosenblatt, 2002). “Reliable change” is achieved when the “magnitude of change
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sufficiently exceeds the random fluctuation associated with measurement error”
(Rosenblatt, 2002).
Part II: Chi-square tests
Next, to analyze the correspondence between symptoms (parent report using the
DISC-IV) and functioning (parent report using SDQ), the two categorical variables of
interest, Chi-square tests were conducted on the symptom groups (increase in symptoms
(symptom deterioration), no change in symptoms, and decrease in symptoms (symptom
improvement)) and functioning (increase in functional impairment (functional
deterioration), no change in functioning, and decrease in functional impairment
(functional improvement)) for each domain of functioning (i.e., friendships/classroom
learning/home life/intrapersonal/leisure activities) and overall impairment (question 1,
manuscript 1) for youth with ADHD, youth with subthreshold ADHD, and youth without
ADHD. At baseline, participants were categorized into one of three main groups: those
identified as having six symptoms from either the inattentive or hyperactive/impulsive
symptom list (probable ADHD), those as identified as having three-to-five symptoms
from either list (probable subthreshold ADHD), and those individuals identified as having
none-to-two from either list (probable non-ADHD). Overall impairment was categorized
as abnormal (high/severe impairment), borderline (moderate impairment), and normal
(no/low impairment). The domains considered together for overall impairment were
social, school, home, intrapersonal, and free time.
Procedures for Research Question 1 for Manuscript 2
The same methods described above were utilized to answer research question 1
for manuscript 2. Two differences, however, are noted here. Participants were further
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categorized by ADHD medication status (medicated versus not medicated during the
previous year) and individuals with probable subthreshold ADHD were compared to
individuals with probable ADHD.
Procedures for Research Questions 2 for Manuscripts 1 & 2
Predictors of More Severe forms of Functional Impairment
Research question 2, manuscript 1, examined the predictors (or risk variables) of
more severe forms of impairment at baseline, to see if they were similar for youth with
ADHD, youth with subthreshold ADHD, and youth without ADHD. The outcome
variable, “severe” (abnormal/high) impairment was met if at least two functional domain
items were endorsed as a “medium amount” or one item was endorsed as a “great deal.”
Five of the functional impairment questions above were summed and a total impairment
score was treated dichotomously, with “severe impairment present” = 1, and, “absent” =
2. The predictor variables included in the regression analysis include child factors (age,
gender, comorbidity, and medication use) and family factors (exposure to parental
psychopathology, primary parent’s educational attainment, marital status). Age
(calculated from the DISC-IV interview date and date of birth) was treated as a
continuous variable. Gender was treated dichotomously (male versus female). Two of the
risk variables, co-morbid mental disorders and exposure to parental psychopathology
were dichotomously coded as “present” (1) or “absent” (2). Co-morbid conditions are
listed in the DISC-IV section above and were considered dichotomously. Medication use
was considered dichotomously [if parent/caregiver reported that their child had or had not
taken any ADHD medication in the last 12 months (prior to the baseline interview)].
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Parental psychopathology was considered dichotomously and included any parent
report of previous diagnosis (12 of the most common mental disorders were reported,
with depression reported most frequently). Primary parent’s educational attainment was
considered dichotomously, as college degree or higher educational attainment versus
some college education without a degree or lower education attainment. Marital status
was considered dichotomously as a parent endorsing a family history of divorce or not.
Predictors of Treatment Utilization
Research question 2, manuscript 2, examines the predictors of treatment
utilization (taken ADHD medication within the last year) for youth with subthreshold
ADHD, compared to youth with ADHD. Data regarding medication use within the last
year were obtained from the DISC-IV. Predictor variables included child factors [total
impairment score (including social, academic, home, intrapersonal and leisure), gender,
race, age, comorbidity] and family factors (parent reported burden, insurance, parent
educational level, exposure to parental psychopathology). Individual functioning items
were summed to create a total impairment score and treated dichotomously, with
abnormal/severe (high) impairment = 1 if at least two functional impairment items were
endorsed as a “medium amount” or one item was endorsed as a “great deal,” and less
than that as “absent” = 2. Specific demographic characteristics (gender, race, age,
insurance) were also considered as predictors, with gender treated dichotomously (male
versus female); age (calculated from the DISC-IV interview date and date of birth)
treated continuously; and race categorized as non-Hispanic white, non-Hispanic black,
and other.
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Parent reported burden (“do the difficulties put a burden on you or the family as a
whole”) scores were treated dichotomously coded as either “present” (1) or “absent” (2).
Insurance was considered in the following three categories: Medicaid vs. private
insurance vs. no insurance. Primary parent’s educational attainment was considered
dichotomously, as college degree or higher educational attainment versus some college
education without a degree or lower education attainment. Exposure to parental
psychopathology was treated dichotomously coded as either “present” (1) or “absent” (2).
Logistic regression was used to explore the predictor variables explained above
and the binary outcome variables (more severe impairment and ADHD medication use
within the last year). Variables were selected for inclusion in a regression analysis based
on literature indicating they are significantly related to the outcome variables for youth
with ADHD compared to youth without ADHD. Participants were categorized into one of
three main symptom groups: those identified as having six symptoms from either the
inattentive or hyperactive/impulsive symptom list (probable ADHD), those as identified
as having three to five symptoms from either list (probable subthreshold ADHD) and
those individuals identified as having zero to two symptoms from either list (probable
non-ADHD). Based on those categories, the baseline sample consisted of 211 nonADHD, 84 subthreshold, and 186 probable ADHD cases. All models were analyzed for
goodness of fit, and statistically sound models were retained.
Demographic and psychosocial characteristics of the interviewed sample,
symptom count categories, symptom patterns, distribution of impairment item selection,
and impairment changes by ADHD symptom baseline status are presented in the tables
below.
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Table 3.1 Demographic and Psychosocial Variables of Sample by Data Collection
Wave (raw frequencies and weighted percents)
Baseline
n
%
Total
Gender
Boys
Girls
Race/Ethnicity
Non-Hispanic White
Non-Hispanic Black
Other
Age in years (mean, range)

481

100.0

292

100.0

323
158

49.1
50.9

191
101

49.3
50.7

269
184
28

44.2
50.6
5.2

169
114
9

46.3
51.4
2.4

9.1 (5-13)

Insurance
None
Private insurance
Medicaid
CD/ODD
Yes
No
Any psychiatric comorbidity
Yes
No
ADHD medication
Yes
No
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Follow-up
N
%

11.8 (7-15)

49
305
100

11.8
69.9
18.3

20
203
58

6.6
76.6
16.7

90
389

11.5
88.5

40
252

7.8
92.2

123
356

17.4
82.6

54
238

12.4
87.6

141
340

14.4
85.6

92
200

17.1
83.0

Table 3.2 Representation of Symptom Count Categories by Data Collection
Wave
Symptom Category
Baseline
Follow-up
Probable ADHD cases (≥6 IA symptoms or
186
106
≥6 HI symptoms)
Subthreshold ADHD cases (not a probable
84
57
case, but had 3-5 IA symptoms or 3-5 HI
symptoms)
Non-ADHD cases (<3 IA symptoms and <3
211
129
HI symptoms)
481
292
Total
Symptom count categories by data collection wave (only including those
who were re-interviewed at the follow-up)
Symptom category
Probable ADHD cases (≥6 IA symptoms or
≥6 HI symptoms)
Subthreshold ADHD cases (not a probable
case, but had 3-5 IA symptoms or 3-5 HI
symptoms)
Non-ADHD cases (<3 IA symptoms and <3
HI symptoms)
Total

90

Baseline

Follow-up

113

106

46

57

133

129

292

292

Table 3.3 Change in Symptom Categories from Baseline to Follow-up
Baseline
symptom
count
category

% who
decreased
from
category

% who
remained
in
category

% who
increased
from
category

Probable ADHD cases (≥6 IA
symptoms or ≥6 HI symptoms)
Subthreshold ADHD cases (not
a probable case, but had 3-5 IA
symptoms or 3-5 HI symptoms)

113

34

66

-

46

28

33

39

Non-ADHD cases (<3 IA
symptoms and <3 HI symptoms)

133

-

77

23

Total

292

Symptom Category
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Table 3.4 Distribution of Item Selection within Strengths and Difficulties
Questionnaire Impairment (percentages)
Not at
all

A
little

A medium
amount

A great
deal

Difficulties upset/distress child

62.2

21.9

10.9

5.0

Difficulties interfere with home life

64.0

20.2

11.0

4.9

Difficulties interfere with friendships
Difficulties interfere with classroom
learning
Difficulties interview with leisure
activities

74.9

17.1

6.3

1.8

62.5

13.2

11.4

13.0

75.1

17.7

5.4

1.8

BASELINE (n=468)
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Table 3.5 Impairment Changes for SDQ Domains of Functioning by Baseline
ADHD Symptom Status

Domains of
Functioning
Decrease
(improve)
Distress/
intrapersonal

No change
Increase
(deteriorate)
Decrease
(improve)

Home life

No change
Increase
(deteriorate)
Decrease
(improve)

Friendships

No changers
Increase
(deteriorate)
Decrease
(improve)

Classroom
learning

No change
Increase
(deteriorate)
Decrease
(improve)

Leisure
activities

No change
Increase
(deteriorate)

Baseline ADHD status (n=279)
Probable
Non-ADHD
Subthreshold
ADHD
case
(n=130)
(n=46)
(n=103)
column %
column %
column %
74.4 (63.1,
55.5 (37.2,
47.1 (33.7,
83.1)
72.5)
60.9)
17.6 (10.7,
28.3 (14.4,
33.7 (22.6,
27.5)
48.0)
47.0)
19.2 (11.0,
8.1 (3.4, 17.9) 16.2 (8.8, 28.0)
31.5)
72.2 (61.9,
40.0 (22.7,
42.8 (29.7,
80.6)
60.3)
57.0)
23.1 (15.5,
47.5 (29.9,
45.1 (32.0,
32.8)
65.8)
58.8)
12.1 (6.7,
4.7 (1.9, 11.2) 12.4 (5.0, 27.8)
21.1)
76.5 (65.8,
36.4 (20.1,
31.5 (20.1,
84.6)
56.6)
45.7)
50.3 (32.1,
48.8 (35.4,
16.1 (9.9, 25.0)
68.4)
62.5)
19.6 (12.7,
7.5 (3.0, 17.6) 13.3 (6.6, 24.9)
29.1)
72.8 (61.7,
48.7 (30.7,
52.4 (39.2,
81.7)
67.0)
65.4)
18.2 (12.0,
30.7 (15.2,
36.7 (25.2,
26.9)
52.7)
50.0)
20.5 (10.7,
10.8 (6.2,
9.0 (3.6, 20.5)
35.6)
18.2)
77.5 (67.6,
30.8 (18.0,
40.3 (27.6,
85.1)
47.5)
54.5)
17.0 (11.1,
57.8 (40.0,
41.9 (29.0,
25.1)
73.7)
56.1)
17.7 (11.1,
5.5 (1.8, 15.6) 11.5 (4.5, 26.5)
27.1)
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Chapter 4
RESULTS
This chapter includes two manuscripts based on the analyses described in Chapter
3. The first manuscript: Developmental differences in patterns of symptom and
impairment change among a community sample of youth with ADHD, subthreshold
ADHD and without ADHD; has been formatted for submission to the Journal of Child
Psychology and Psychiatry and focuses on research questions 1 and 2. The second
manuscript: Medication use within the context of ADHD and subthreshold ADHD:
Developmental course and predictors in a community sample; focuses on research
questions 3 and 4 and has also been formatted for submission to the Journal of Child
Psychology and Psychiatry.
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MANUSCRIPT I: DEVELOPMENTAL DIFFERENCES IN PATTERNS OF SYMPTOM AND
IMPAIRMENT CHANGE AMONG A COMMUNITY SAMPLE OF YOUTH WITH ADHD,
SUBTHRESHOLD ADHD, AND WITHOUT ADHD

1

1

Lorie L. Geryk, MPH, Ken W. Watkins, PhD, Joseph R Holbrook, PhD, Steven P.
Cuffe, MD, Daniela B. Friedman, PhD, Robert E. McKeown, PhD. Formatted for
submission to the Journal of Child Psychology and Psychiatry
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Abstract
Background: Despite a substantial prevalence of subthreshold AttentionDeficit/Hyperactivity Disorder (ADHD) and research indicating that many youth with
this disorder have impaired functioning and negative outcomes, few studies have
considered patterns of symptom and functioning change for youth with probable ADHD,
subthreshold ADHD and youth without ADHD transitioning from childhood to
adolescence. Methods: A community-based sample composed of children at high-risk
for ADHD and low-risk peers (frequency-matched on gender) were identified through
screening and invited to in-person interviews. At two assessment periods, baseline
(N=481) and follow-up (N=292) (starting 20 months after baseline), parents/caregivers
completed measures related to the youths’ psychiatric symptom and impairment status,
and supplemental questionnaires examined socio-demographic information and child and
family risk factors. At baseline, children were identified who met symptom criteria for
subthreshold ADHD (N=84), probable ADHD (186), and non-ADHD (n=211) and
patterns of change in symptoms and impairment were examined at follow-up using a
Reliable Change Index (RCI) and Chi Square tests. A supplementary analysis
investigated predictors of severe impairment. Percents are weighted to reflect the
complex sampling design. Results: Subthreshold ADHD symptoms were seen in as
many as 18% (N = 84) of the youth studied at baseline. Youth who were non-ADHD at
baseline who were probable cases at follow-up were significantly more likely to decline
functionally in four of the five impairment domains and total impairment (62% overall
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impairment decline) compared to youth who were non-ADHD at baseline and either nonADHD or subthreshold ADHD at follow-up (4% and 9% decline in overall impairment,
respectively). Thirty three percent of youth who were subthreshold at baseline remained
in that category at follow-up and 15%-27% of those individuals showed significant
decline in at least one domain of functioning and 47% declined in overall impairment at
follow-up. Conclusions: The findings show the importance of examining symptom and
impairment constructs separately in the consideration of their unique contributions to
ADHD and subthreshold ADHD diagnoses and of acknowledging the need to examine
nuanced changes in diagnostic status during development; especially functional declines.
These findings may be relevant to efforts to intervene earlier in childhood and to help
identify high-risk individuals who may be good candidates for targeted interventions.
Key words: Attention Deficit Hyperactivity Disorder, Subthreshold ADHD, symptom
and impairment trajectories, predictors of impairment. Abbreviations: RCI, reliable
change index; ADHD, attention-deficit/hyperactivity disorder; DISC-IV, Diagnostic
Interview Schedule for Children version IV; SDQ, Strengths and Difficulties
Questionnaire; DSM-IV, Diagnostic and Statistical Manual-IV; OR, odds ratio; 95% CI,
95% confidence interval.
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Introduction
Health professionals and educators who consider Attention-Deficit/Hyperactivity
Disorder (ADHD) syndrome only in the context of full presentation of symptoms may
overlook an important group of subclinical children, and oversimplify nuanced problems
(Barnow, et al., 2006). Recent studies have challenged the validity of current diagnostic
criteria including ADHD subtype classifications (hyperactive-impulsive, inattentive, and
combined) (Lahey, et al., 2005; Riley, et al., 2008; Todd, et al., 2008; Valo & Tannock,
2010), age of onset criteria (Applegate, et al., 1997; Barkley & Biederman, 1997), and the
need to have impairment present in two or more settings (Lahey, et al., 2004).
Researchers have called for the replacement of categorical subtypes with a focus on
dimensional case identification of ADHD using severity or counts of symptoms (Lahey &
Willcutt, 2010; Lubke, et al., 2009; Rowland, et al., 2008; Valo & Tannock, 2010), for
elimination or extension of the age of onset criteria (Barkley & Biederman, 1997; Bell,
2011; McGough & Barkley, 2004), and for focus more on impairment type and severity
than on number of settings (Lahey, et al., 2004; Ramsay & Rostain, 2006).
Subthreshold ADHD
A growing body of evidence indicates that a sizable number of youth who meet
less than full symptom criteria for a diagnosis of ADHD experience significant functional
impairment that may require intervention (Mick, et al., 2011). This subthreshold group
has been shown to express the same set of genes as ADHD (Levy, et al., 1997) and to be
at increased risk of developing ADHD (Bussing, et al., 2010). Subthreshold ADHD is
more prevalent than ADHD (Lewinsohn, et al.), with up to 22% of youth exhibiting
inattentive and/or hyperactive subthreshold symptoms (Scahill, et al., 1999), yet little

98

research has been devoted to understanding developmental trajectories of youth with
subthreshold ADHD. To be clinically meaningful, any reduced form of ADHD (e.g.
meeting fewer than the required DSM-IV symptoms for a full diagnosis) should include
consideration of impairment (Mick, et al., 2004).
ADHD Associated Impairment
Similar to symptoms of ADHD, functional impairment may tend to change as
children age, and such change may be affected by environmental demands (Harpin,
2005). However, unlike symptoms which tend to diminish over time (Biederman, et al.,
2000), impairment tends to become more noticeable as children age and acquire more
autonomy, and is thought to have an additive effect (Adler, et al., 2008; Wender, et al.),
with impairment in one domain predicting later compromised functioning in other
domains (Murray-Close, et al., 2010).
Measuring Patterns of Symptom and Impairment Change
Research has demonstrated that measures of impairment generally have a
relatively modest correlation with symptom reports, supporting the argument that these
are two related yet separate aspects of the ADHD diagnosis (Gathje, et al., 2008) and
cannot be validly equated (Bell, 2011). Measuring either impairment or symptoms
without the other does not provide a complete clinical picture and may result in poor or
inaccurate treatment decisions (e.g. length, type, or dose of treatment) (J. S. Owens, et al.,
2009). Further, research shows that decreasing symptom burden is not always associated
with improved functional status, whereas increasing symptom burden is more likely to be
associated with functional decline (J. S. Owens, et al., 2009).
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Recently, in the ADHD literature, two studies have emerged focusing on the
poorly understood connection between reliable change in symptoms relative to reliable
change in functioning (E. B. Owens, et al., 2009; Rosenblatt & Rosenblatt, 2002). Using
a reliable change index (RCI) (Jacobson, 1991) studies confirm that change in
functioning (both improved functioning and worsened functioning) often occurs when
there is no reliable or significant change in symptoms (Karpenko, et al., 2009; E. B.
Owens, et al., 2009; Rosenblatt & Rosenblatt, 2002). Heterogeneity in patterns of change
is an understudied area, (Willoughby, 2003) and Jacobson and Traux’s RCI method,
while most often utilized in treatment and intervention studies, is an ideal method for
exploring patterns of symptom and impairment change among community-based youth
with ADHD, subthreshold ADHD, and without ADHD.
Predictors of Impairment
There is a large body of research considering predictors of ADHD persistence, but
few studies have explored predictors of impaired functioning. Though not well
understood, a number of child and family risk factors may contribute to impairment
among ADHD youth (Healey, 2010). Child-related factors including gender (Gathje, et
al., 2008), higher levels of comorbidity, increased impulsive symptoms (Biederman,
Mick, et al., 1998) and treatment (Molina, et al., 2009) were found to be associated with
functioning. Researchers analyzing ADHD symptoms most associated with impairment
showed symptom prevalence or subtype distinctions are inadequate for predicting
impairment (Mota & Schachar, 2000).
Family factors associated with functioning among ADHD youth include: maternal
psychopathology (Biederman, Mick, et al., 1998), social advantage (Molina, et al., 2009),
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and marital status (Healey, Gopin, Grossman, Campbell, & Halperin, 2010). No study
was found examining predictors of impairment for youth with subthreshold ADHD. This
is a needed area of study, given that subthreshold ADHD may follow a similar, persistent
impairment trajectory as ADHD.
Study Purpose
The main purpose of this study is to consider the complex processes through
which impairment trajectories unfold in relation to symptoms. This study is a novel
extension to previous RCI studies, and examines the relationship between change in
symptoms and reliable change in functioning in children and adolescents with ADHD,
subthreshold ADHD, and children without ADHD who participated in the South Carolina
Project to Learn about ADHD in Youth (SCPLAY). Additionally, predictors associated
with more severe forms of ADHD impairment will be explored to see if they are similar
for youth with ADHD and youth with subthreshold ADHD.
Methods
Recruitment and Sampling
SCPLAY utilized a two-phase research design involving school district-wide,
voluntary teacher and parent screenings (phase I) and in-person assessments (phase II).
In-person assessments involved (structured diagnostic interviews with youth and
parents/caregivers at baseline and four follow-up points. The sampling population
included 15 elementary schools (pre-k through grade five) in SC with approximately
8,700 students from culturally and racially diverse rural, suburban, and urban
neighborhoods. Children in non-self-contained classrooms were screened for risk of
ADHD through two approaches: 1. teacher rated symptoms of inattention, hyperactivity,
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and impulsivity using the Vanderbilt ADHD Diagnostic Teacher Rating Scale
(VADTRS) (M. L. Wolraich, et al., 1998), impairment ratings by using the “impact
supplement” of the Strengths and Difficulties Questionnaire (SDQ) (Goodman, 1999),
and reported history of ADHD diagnosis and ADHD medication use; and, 2. parentreported history of ADHD diagnosis and ADHD medication use. The behavioral
screening was conducted during the 2003-2004 school years and 4606 teachers and/or
parents completed Phase I screens.
All high-risk children (high-screen for ADHD) and a sample of low-risk children
(low-screen for ADHD), frequency matched on gender, were randomly selected (n=2206)
and invited, along with their parent/caregiver, by letter to participate in Phase II in-person
structured assessments. Six hundred and thirty-three families returned forms indicating an
interest in being contacted about Phase II assessments. Baseline interviews were
conducted with consenting parents/caregivers and children 13 months (mean time)
following the screening.
A detailed description of the SCPLAY study population, design, sampling frame,
and methods are described elsewhere (M. L. Wolraich, et al., 2012). SCPLAY study
procedures were approved by the Institutional Review Board of the University of South
Carolina and the Centers for Disease Control and Prevention, and informed parental
consent was obtained for all interviews. The institutional review board of the University
of South Carolina determined this study exempt from its review.
Participants
Data for these analyses were obtained from SCPLAY baseline (n=481; 9/03-1/06)
and follow-up 1 parent assessments (n=292; 9/07-2/09). Parent/caregiver, a biological

102

parent in 426 out of 481 (89%) baseline families, provided family demographic and
psychosocial information, mental health history, information about the selected child
related to ADHD symptoms and impairment, other psychiatric disorders, and treatment
history via computer-based (interviewer administered) interview and paper and pencil
(self-administered) questionnaires. The final sample for this report is 292 of the original
481, with 285 parents/caregivers completing the SDQ impact supplement at follow-up.
Comparison of the retained sample versus those lost to attrition revealed no statistically
significant differences related to baseline demographic variables.
Using the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)
(American Psychiatric Association, 2000) symptom criteria for ADHD, youth were
categorized into two symptom groups: probable ADHD cases (≥ 6 Inattentive (IA)
symptoms or ≥ 6 hyperactive/impulsive (HI) symptoms) and subthreshold ADHD cases
(3-5 IA symptoms or 3-5 HI symptoms). After categorization, 39% of the sample met
inclusion criteria for probable ADHD, 18% for subthreshold, and 44% for non-ADHD at
baseline; at follow-up, 36% of the sample met inclusion criteria for probable ADHD,
19% for subthreshold, and 44% for non-ADHD. The baseline samples are introduced in
Table 4.1. There were no significant differences between the probable ADHD,
subthreshold ADHD, and non-ADHD groups on demographic characteristics at baseline.
Measures
The Diagnostic Interview Schedule for Children (DISC-IV; Shaffer et al.,
2000). The DISC-IV, based on the Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV-TR) (Association & DSM-IV., 2000), is a well-validated, fully-structured
diagnostic interview developed to diagnosis psychopathology in children (Shaffer, et al.,
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2000). Parents were administered the DISC-IV by a trained interviewer during baseline
and the first follow-up annual assessment to obtain past year ADHD symptom counts and
past year categorical probable diagnosis for generalized anxiety disorder, separation
anxiety disorder, social phobia, post-traumatic stress disorder, obsessive compulsive
disorder, major depression/dysthymic disorder, mania/hypomania, oppositional defiant
disorder, and conduct disorder. The test-retest reliability of the ADHD DISC symptom
count (parent report) in a community sample (past year) among children aged 9-17 years
was ICC=.84 (Shaffer, et al.). The DISC showed moderate to good validity across a
number of diagnoses, including ADHD (Schwab-Stone, et al., 1996). Parent interview
was used because research has shown low test-retest reliability in the child disc interview
(Schwab-Stone, et al., 1996).
ADHD Medication Status. One dichotomous medication status variable was
coded (1 (yes) or 0 (no)) from the following item on the DISC-IV interview, “In the past
twelve months, has your child taken any medicine for being overactive, being
hyperactive, or having trouble paying attention?” Based on a subsample on whom we
have detailed medication data (n=458), 14.6% of the subthreshold ADHD sample at
baseline were taking stimulant medication and 4.3% were taking non-stimulant
medication. 32.6% of the probable ADHD sample at baseline were taking stimulant
medication and 13.6% were taking non-stimulant medication.
The Strengths and Difficulties Questionnaire (SDQ) (Goodman, 2000). The
SDQ (extended version) is a domain-specific behavioral screener consisting of 25
symptom items assessing five subscales (behavioral problems, emotional problems,
hyperactivity, peer-problems, and prosocial behavior) and seven “impact questions”
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assessing difficulties in functioning (i.e. school and classroom settings) associated with
reported symptoms (Goodman, 1999). The SDQ is one of a few measures that was
specifically developed to assess impairment in relation to ADHD and other psychiatric
symptoms. For these analyses, only the parent version impact questions of the SDQ
extended version were examined (baseline and follow-up).
For the first impact question “Overall, do you think that (child’s name) has
difficulties in any of the following areas: emotions, concentration, behavior, or being able
to get along with other people?” (responses included ‘no,’ ‘minor,’ ‘severe,’ and
‘definite’), if respondents reported at least “minor” problems, then further impact
questions related to five domains of functioning were asked. The impairment variables
were defined by using parent responses to the following questions: 1. “Do the difficulties
upset or distress the child?”; 2-5. “Do the difficulties interfere with the child’s life in the
following areas: 2. Home life?; 3. Friendships?; 4. Classroom learning?; leisure
activities?; and 6. “Do the difficulties put a burden on you or the family as a whole?”
Response options for these items were coded (“not at all”=0; “a little”=0; “a medium
amount”=1; “a great deal”=2). . Individual impairment items were used to assess reliable
change in functioning from baseline to follow-up using a reliable change index (RCI;
described below) (Jacobson & Truax, 1991).
The SDQ is well-validated, and reliability and validity data are summarized in
two reports by the author (Goodman, 1999, 2001). For the impact supplement, the parent
version has high internal consistency (Cronbach alpha coefficient =.85), good 4-6 month
retest stability (Impact/impairment score; .57), good validity (negative predictive value
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(NPV) = .95; positive predictive value (PPV) = .53), and internal reliability has been
reported to be .82 (Goodman, 2001).
Predictors of Impairment
Outcome Variable: The five impairment items were summed to derive a “total
impairment score,” and dichotomously treated as abnormal/severe if at least two
impairment items were endorsed as a “medium amount” or one item was endorsed as a
“great deal” (total impairment score ≥2) or normal/low/moderate (total impairment score
≤1). Predictor Variables: Several baseline factors were examined as predictors of severe
impairment. Child demographic and psychosocial variables included age and gender
(ascertained from parental reports on the demographic questionnaire), comorbidity
[considered dichotomously as either having or not having had a comorbid disorder
(baseline, past year) as reported on parent DISC-IV report], and medication use,
considered dichotomously [parent/caregiver report that their child had or had not taken
any ADHD medication in the last 12 months (prior to the baseline interview)].
Additionally, the following family factors were examined as predictors of severe
impairment: marital status (dichotomized into married or divorced); primary caregiver’s
education level (dichotomized into less than a bachelor degree or a bachelor degree or
higher); and, history of parent psychopathology (considered dichotomously and
ascertained from parent report on a mental health history questionnaire).
Procedures/Analysis
All analyses were performed using SAS-callable SUDAAN version 10.0 software
to adjust for the complex sampling design. Basic descriptive statistics were calculated
and prevalence of treatment utilization reported. Raw frequencies and weighted
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percentages are reported for all results. Procedures outlined in Jacobson and Traux’s
(1991) methodology for creating a reliable change index (RCI) were used to determine
which youth met criteria for reliable change in impairment (using the five domains of
functioning from the SDQ data) in relation to symptom category (non-ADHD,
subthreshold ADHD, and probable ADHD) change from baseline to follow-up. While
other comparable statistical methods exist, researchers are encouraging the use this
method for comparability purposes (Karpenko, et al., 2009). The following formula for
reliable change (RC) as outlined by Jacobson and Traux was used:
;

The RCI method described by Jacobson and Traux (1991) was used to divide the
baseline by follow-up differences for each participant by the standard error (SE) of the
difference score for each domain of functioning. This allowed for the identification of
individual change (significance level set to p ≤ 0.05) that is greater than what would be
attributed to chance or measurement error (Jacobson, Roberts, Berns, & McGlinchey,
1999).
Descriptive percentages were used to compare proportions of change (i.e.,
improvement, no change, and decline) in symptom categories and functional impairment
measures (five domains and overall impairment) among symptom groups (Jacobson, et
al., 1999). SDQ scores ≥ to 1.96 reflected positive change (i.e., impairment increased),
scores ≤ to -1.96 reflected negative change (e.g. impairment decreased), and scores
between 1.96 and -1.96 reflected no impairment change. Participants were then classified
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as “functionally improved” (i.e. changed statistically significantly in a positive direction),
“no changers” (i.e. did not change statistically significantly), and “functionally declined”
(changed statistically significantly in a negative direction). Further, chi-square tests were
used to determine if there was a significant association between improvement in
symptoms and improvement in functioning.
A multivariable logistic regression analysis was used to examine the relative
impact of all covariates on the likelihood of having severe impairment at follow-up. Odds
ratios and 95% confidence intervals (CIs) were computed to investigate the strength of
the relationships between risk factors and severe impairment. All covariates were initially
screened through interaction models and those that were poorly associated with ADHD
medication use were excluded in the final multiple logistic regression models.
Results
The baseline sample was ethnically and gender diverse, with non-Hispanic blacks
and girls being well-represented, 38% and 33%, respectively. At baseline, youth ranged
in age from 5-13 (mean 9.1) and at follow-up youth ranged in age from 7-15 (mean 11.8).
Twenty six percent of youth had one or more comorbid psychiatric disorder at baseline
and 19 of youth had one or more comorbid psychiatric disorder at follow-up. Twenty
nine percent of youth were taking ADHD medication at baseline and 32% at follow-up.
Twenty six percent of youth had co-occurring mental disorder(s) at baseline and 18% at
follow-up.
Patterns of Symptom and Functioning Change
After establishing symptom category change form baseline to follow-up, RCI was
used to distinguish individuals who made a statistically reliable change in each domain of
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functioning (and overall impairment) from baseline to follow-up. The relation between
symptom category change (decrease, no change, and increase) for individuals with
probable ADHD, subthreshold ADHD, and non-ADHD and impairment change
(individual domains of functioning and overall impairment) was analyzed through a
series of chi-square tests. The percentage of children demonstrating patterns of symptom
change (increased, no change, and decreased) and impairment change (five domains of
functioning and overall impairment) is shown in Tables 4.2 (functional decline) and 4.3
(functional improvement).
Youth who were non-ADHD at baseline, who were probable ADHD cases at
follow-up, were significantly more likely to decline functionally than either subthreshold
ADHD or non-ADHD at follow-up in 4 domains of functioning and total impairment:
distress/intrapersonal, x2 (2, N = 14) = 53.10, p < 0.001; friendships, x2 (2, N = 13) =
46.20, p < 0.001; classroom learning, x2 (2, N = 14) = 32.93, p < 0.001; leisure activities,
x2 (2, N = 10) = 50.90, p < 0.001; total impairment, x2 (2, N = 14) = 41.71, p < 0.001.
Youth who were subthreshold ADHD at baseline, who were probable ADHD at followup, were significantly more likely to decline functionally than subthreshold ADHD at
follow-up in classroom learning, x2 (2, N = 13) = 14.74, p < 0.001. Youth who were
subthreshold ADHD at baseline, who were subthreshold at follow-up, were significantly
more likely to decline functionally than probable ADHD youth in total impairment, x2 (2,
N = 15) = 8.78, p < 0.02. Youth who were probable ADHD at baseline, were not
significantly more likely to decline functionally at follow-up compared to the two other
symptom categories.
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Youth who were non-ADHD at baseline who were probable ADHD cases at
follow-up were significantly less likely to improve functionally than either subthreshold
ADHD or non-ADHD at follow-up in 4 domains of functioning: distress/intrapersonal, x2
(2, N = 94) = 23.37, p < 0.001; friendships, x2 (2, N = 96) = 21.62, p < 0.001; classroom
learning, x2 (2, N = 91) = 28.92, p < 0.001; and leisure activities, x2 (2, N = 97) = 20.32,
p < 0.001. Youth who were subthreshold ADHD at baseline who were probable ADHD
cases at follow-up were significantly less likely to improve functionally than either
subthreshold ADHD or non-ADHD at follow-up in distress/intrapersonal functioning, x2
(2, N = 22) = 7.13, p < 0.05. Finally, youth with probable ADHD at baseline who
remained probable ADHD at follow-up were significantly less likely to improve
functionally compared to youth with non-ADHD and subthreshold youth at follow-up in
two areas: distress/intrapersonal, x2 (2, N = 45) = 8.90, p < 0.02; friendships, x2 (2, N =
31) = 7.66, p < 0.05; and significantly less likely to improve functionally compared to
youth with subthreshold ADHD at follow-up in two areas: classroom learning, x2 (2, N =
51) = 9.40, p < 0.01; and leisure activities, x2 (2, N = 42) = 16.99, p < 0.001.
Predictors of Severe Impairment
Multivariable Models – Non-ADHD, Subthreshold ADHD and Probable ADHD
Covariates that were found to be associated with severe impairment include the
following: male gender, taking ADHD medication, psychiatric comorbidity, and having a
primary parent with a psychiatric history. Marital status and age were not significantly
related to severe impairment at follow-up and were dropped from the final logistic
regression models. Table 4.4 presents results of the 3 multivariable logistic regression
models. In model 1, among non-cases, ADHD medication use (OR = 9.8; 95% CI: 1.8–
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54.6) was the strongest significant predictor of severe impairment, followed by primary
parent psychiatric problem history (OR = 4.1; 95% CI: 1.4–12.3).
In model 2, among subthreshold cases, females (OR = 0.3; 95% CI: 0.1–1.0) were
significantly less likely than males to have severe impairment at follow-up. Though not
statistically significant, those whose parent/s had less than a college bachelors degree
(OR = 3.0; 95% CI: 0.9-10.6) were more likely to be severely impaired at follow-up than
those youth whose parents had a bachelors degree or higher education. In model 3,
among probable ADHD cases, severe impairment at follow-up was more likely in those
who met criteria for a comorbid psychiatric disorder (OR 5.2; 95% CI: 2.2-11.9)
compared to those who did not. Non-cases, subthreshold cases, and probable ADHD
cases did not share any of the same significant predictors.
Discussion
This study is one of the relatively few prospective community-based studies
following subthreshold cohorts of youth to examine patterns of change in symptoms and
functional impairment. This was achieved by following a diverse sample of youth with
subthreshold ADHD, probable ADHD, and without ADHD over a period of
approximately 3 years to study the course of ADHD functional impairment in five areas –
intrapersonal, home life, friendships, classroom learning, and leisure activities, with the
majority of children entering adolescence at follow-up. In an attempt to consider the
ADHD syndrome in a more nuanced way, this study considered symptom and
functioning change without narrowly defined DSM subtype, age of onset, and
impairment (two or more settings) diagnostic criteria.
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Findings show that decreasing symptom burden is not always associated with
improved function, whereas increasing symptom burden is more likely to be associated
with functional decline. A portion of youth who were probable ADHD cases at baseline
and decreased symptoms (subthreshold ADHD at follow-up), 21% (N=22) experienced
significant functional decline in at least one functional domain; whereas, 39% (N=18) of
youth with baseline subthreshold ADHD whose symptoms increased (probable ADHD
at follow-up) declined functionally at follow-up. These findings are in line similar
methodological research (J. S. Owens, et al., 2009) and show the importance of
examining both symptom and functioning constructs in the consideration of their unique
contributions to ADHD and subthreshold ADHD diagnoses.
Subthreshold ADHD symptoms were seen in as many as 17% (N = 84) of the
youth studied here at baseline. This is similar to the Scahill et al. (1999) study finding
that 22% of youth exhibited subthreshold symptoms. The prevalence of subthreshold
ADHD increased slightly at follow-up to 20% (N = 57). Thirty three percent of youth
who were subthreshold at baseline remained in that category at follow-up (compared to
77% and 66% of youth remaining in non- and probable ADHD categories, respectively);
whereas, 28% decreased to non-ADHD, and 39% increased into the ADHD category.
These findings have important implications. First, they support research showing youth
with subthreshold ADHD are at increased risk of developing ADHD (Bussing, et al.,
2010). Second, the subthreshold ADHD category was not as stable as the non-ADHD and
probable ADHD symptom categories (at follow-up).
Among the 33% of youth (baseline and follow-up subthreshold ADHD), 33%
declined functionally at follow-up in at least on of the five domains of functioning and
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47% declined in overall impairment. This finding supports recent research showing a
sizable number of subthreshold ADHD youth had significant functional impairment that
may require intervention (Mick et al., 2011; Young & Gudjonsson, 2008; Scahill, et al.,
1999; J. S. Owens, et al., 2009; Biederman, et al., 2000; Bussing, et al., 2010)
Additionally, early identification of subthreshold ADHD with associated functional
decline may help identify youth at high-risk for “converting” to full ADHD.
Findings from the series of chi-square tests suggest that youth (both non-ADHD
and subthreshold ADHD at baseline) who achieve probable ADHD status at follow-up
are more likely to decline functionally than individuals achieving subthreshold ADHD or
non-ADHD status at follow-up. This was especially true of youth with non-ADHD at
baseline who were significantly more likely to decline functionally in total impairment
and four of the five domains of functioning (all but home life). Baseline youth with
subthreshold ADHD who were probable ADHD cases at follow-up were significantly
more likely to decline functionally than subthreshold ADHD at follow-up in classroom
learning and overall functioning. Baseline youth with non-ADHD and subthreshold
ADHD who achieved probable ADHD status at follow-up were also significantly less
likely to improve functionally at follow-up than youth with either subthreshold ADHD or
non-ADHD at follow-up.
Finally, baseline youth with probable ADHD who remained probable ADHD at
follow-up were significantly less likely to improve functionally compared to youth with
non-ADHD at follow-up in distress/intrapersonal and friendships and significantly less
likely to improve functionally compared to youth with subthreshold ADHD at follow-up
in classroom learning and leisure activities. This finding is expected as youth with
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probable ADHD would likely exhibit elevated levels of impairment at baseline and
follow-up, thus less likely to achieve functional improvement from baseline to follow-up
assessments.
Taken together it is clear that achieving probable ADHD status at follow-up is
associated with the most functional decline. Achieving subthreshold status at follow-up
was associated with less functional decline than probable ADHD status, but more
functional decline than non-ADHD status at follow-up. This is in line with
epidemiological evidence supporting a dimensional view of ADHD, where symptoms
and impairments are continuously distributed in the general population, with more severe
disorder lying at the upper end of the continuum (Buitelaar & Rothenberger, 2004; Shaw
et al., 2011).
The longitudinal data used here offered the opportunity to consider predictors of
severe impairment among non-ADHD, subthreshold, and probable ADHD symptom
categories. Most notable among the findings is that probable ADHD and subthreshold
ADHD did not share any significant predictors in common; not an expected finding based
on the supposition that subthreshold youth would share a similar impairment predictor
profile as individuals with probable ADHD. Regression analysis, controlling for all other
covariates, revealed four significant predictors for subsequent severe impairment: ADHD
medication use and primary parent psychiatric history in the non-ADHD model; gender
in the subthreshold model, and psychiatric comorbidity in the probable ADHD case
model.
The finding that ADHD medication use among the non-ADHD symptom group is
a highly significant predictor of severe impairment is notable, but may be partially or
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wholly explained by different reasons including the following:1.treatment with ADHD
mediation for another problem; 2. misdiagnosis; or 3. ADHD medication treatment is
effective for reducing symptoms but not impairment. The subthreshold ADHD model
showed being male significantly predicted severe impairment is not inline with results
from a meta-analysis which found no gender differences in social and peer and academic
performance functioning (Gaub & Carlson, 1997). Based on the lack of similar predictor
findings for subthreshold and probable ADHD youth, it is reasonable to assume children
with subthreshold ADHD tend not to be similar to children with ADHD with regard to
risk profiles for severe impairment. The probable ADHD model results are consistent
with prior findings showing comorbid psychopathology was negatively associated with
normalized functioning (Biederman, Mick, et al., 1998). The identification of only one
significant predictor for the probable ADHD group was not expected, since the predictor
variables were selected based on prior study findings among individuals with ADHD.
Study Limitations & Strengths
As with any study, the current findings are not without limitations. The SDQ is a
domain specific measure (assessing functional impairment in relation to symptoms of
multiple disorders) (Canino, et al., 1999) so there is no way to know which symptoms, if
any, are directly related to the reported impairment. However, using the DISC-IV (a
symptom specific measure), was not possible because if the symptom criteria, duration
criteria, or age of onset criteria for ADHD are not met, the impairment questions are
never asked and subthreshold impairment and control children’s impairment could not be
assessed. Symptom specific measures of impairment are needed that are not constrained
by an inability to assess the impairment of youth with subthreshold ADHD and
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comparison youth. Additionally, domains of functioning were measured using a single
SDQ item. While this does not allow for complete detail, the SDQ is a well validated
measure often used to assess functioning, is practical to administer, and provides
information about multiple domains of functioning that can help inform developmental
trajectory research as well as treatment and service decisions.
The use of only parent/caregiver report is another limitation, as the DSM-IV
recommends the use of multiple informants and the American Academy of Pediatrics
recommends the need for both parent and teacher report of functional impairment
(American Psychiatric Association, 2000; M. Wolraich, Brown, & Brown, 2011).
Teacher reports of functional impairment were collected, but due to poor response rates,
not used. Parent subjectivity may also be biased (e.g., underreport due to social
desirability, over-report due to help-seeking, endorse symptoms that affect them the most,
and may be more reliable reporters for younger children) (Barkley, 2006). While there is
often disagreement among multiple informants and subjective bias in parent report,
parents are thought to be crucial for a valid assessment of ADHD (Barkley, et al., 2002;
Cantwell, Lewinsohn, Rohde, & Seeley, 1997).
Symptom decreases over time might reflect true developmental changes, but also
may be due to other things such as artifacts of repeated measurement (Hart, et al., 1995)
and diagnostic inadequacies (e.g., applying symptoms that are not developmentally
sensitive (Willoughby, 2003)). Additionally, the relationship between symptom change
and impairment in specific domains of functioning may be a function of the treatment or
care that individuals were provided, comorbidity, or other factors. While the impact of
those things is not known, and the findings are constrained by unadjusted percents and
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small numbers, this represents some of the only data available describing symptoms and
functional impairment for youth in a community setting.
Another limitation of this study is the proportion of baseline participants lost to
follow-up. If those individuals were less likely to have ADHD symptoms or more likely
to have ADHD symptoms, the findings are less likely to be representative of the initial
sample. Finally, as the course of ADHD and subthreshold ADHD is continually
changing, one’s symptom and impairment status at baseline and follow-up may not be
static and future studies exploring changes in patterns of ADHD symptoms and
impairment are needed that use repeated observations.
This study adds to an absence of population-based longitudinal impairment data
of children with subthreshold ADHD who are identified in early childhood and followed
into adolescence. While most ADHD trajectory studies consider only patterns of
symptom change over time, this study considered patterns of change for both symptoms
and functioning. It utilized well validated instruments, trained data collectors, and
extensive data quality control measures. Study sampling design increased case finding
and analysis accounted for sampling design to give unbiased estimates. It used a
prospective design with a retention rate of 61% at follow-up. In addition to being cross
sectional in nature, most studies focus on children, and this study followed youth up to
age 15. This was a community-based rather than clinic-based study, which is a strength,
as clinic-based youth are likely to have more severe symptom and functional impairments
than youth in the community (Gau, et al., 2010) and may result in higher treatment
seeking rates (Rowland, Lesesne, & Abramowitz, 2002). White boys account for the
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majority of research related to ADHD in youth (Hartung & Widiger, 1998 )and girls and
African American youth are well represented in this study.
Clinical Implications
Based on current policies, individuals with subthreshold ADHD may not qualify for
treatment and services (Canino, et al., 1999) yet it seems clinically questionable to
disqualify individuals for services because they fall below symptom threshold for the
recommended DSM criteria if they present with significant and developmentally
inappropriate functional impairment. Current findings help inform our understanding of
impairment persistence associated with symptom change and highlight the importance of
considering subthreshold ADHD in efforts to understand the trajectories through which
risk factors may affect the expression of, or impaired functioning associated with,
ADHD. Evaluating the patterns between symptoms and impairment change provides
direct comparisons between individuals for a better understanding of individual needs
which can help in the treatment decision making process to continue or discontinue
treatment/intervention or to focus on specific domains of impaired functioning.
As part of the evaluation process, it is important to educate parents and youth that
ADHD is a chronic condition shaped by biological and environmental factors (Halfon,
2002) with associated impairments that may last into adulthood. ADHD education should
stress that as the child/adolescent grows, develops and confronts different environmental
challenges it is important to recognize that different symptoms and impairment may be
exhibited. Targeted interventions should be tailored and flexible in addressing differences
in individual symptom and impairment profiles.
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Finally, the regressions revealed that severe impairment was significantly
predicted by psychiatric comorbidity among probable ADHD cases, being male among
subthreshold ADHD, and primary parent psychiatric problem history and psychiatric
medication use among individuals without ADHD at follow-up. These findings may be
relevant to efforts to intervene earlier in childhood and to help identify high-risk
individuals who may be good candidates for targeted interventions.
Clinically, pinpointing areas of individual need may help in the design of targeted
treatment strategies, improve patient outcome, and aid the clinician’s ability to clearly
and meaningfully inform caregivers and children. From a public health perspective, this
knowledge can help focus scarce societal resources toward ADHD children at higher risk
for persistent and severe impairment. This has implications for early intervention and
secondary prevention initiatives, with the goal in mind of improving functioning of
children and adolescents with subthreshold ADHD and ADHD.
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Table 4.1 Demographics of Sample by Baseline ADHD Status; Raw Frequencies
and Weighted Percents
Non-ADHD Cases

Total

Subthreshold Cases

Probable
ADHD Cases

N

%

N

%

N

%

211

100.0

84

100.0

186

100.0

Age in years (mean, range)

9.0 (5-12)

9.5 (5-12)

9.4 (5-13)

Gender
Boys

136

41.9

59

65.0

128

60.2

Girls

75

58.1

25

35.0

58

39.8

Non-Hispanic White

119

45.3

49

46.7

101

39.8

Non-Hispanic Black

81

48.6

34

51.4

69

55.6

Other

11

6.1

1

1.9

16

4.7

Yes

13

6.8

18

22.8

92

43.4

No

197

93.3

66

77.2

93

56.6

Yes

11

3.3

21

19.1

109

42.1

No

200

96.7

63

80.9

77

57.9

Yes

32

12.1

14

18.6

53

24.3

No

176

87.9

69

81.4

122

75.7

Less than bachelors degree

99

45.2

54

59.4

120

62.8

At least bachelors degree

107

54.8

28

40.6

57

37.2

Race/Ethnicity

Any psychiatric comorbidity

ADHD medication

Parent mental health history

Parent education level
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Table 4.2 Percentages of Youth with Decrease in Symptoms, No change in
Symptoms, and Increase in Symptoms Who Achieved Reliable Change
DECLINE on SDQ Functional Measures (Increased Impairment)

Baseline SDQ
Impairment
Distress/intrapersonal**
Home life
Friendships**
Classroom learning**
Leisure activities**
Total impairment**

Baseline SDQ
Impairment
Distress/intrapersonal
Home life
Friendships
Classroom learning**
Leisure activities
Total impairment*

Baseline SDQ
Impairment
Distress/intrapersonal
Home life
Friendships
Classroom learning
Leisure activities
Total impairment

Non-ADHD at baseline (n=130)
No change in sx
Increase in sx
Increase in sx
(non-ADHD at
(subthreshold ADHD
(probable ADHD
follow-up)
at follow-up)
cases at follow-up)
(n=100)
(n=17)
(n=13)
% who declined
functionally (95%
% who declined
% who declined
CI)
functionally (95% CI)
functionally (95% CI)
4.0 (1.2, 12.3)
3.6 (0.6, 19.0)
69.1 (32.9, 91.0)
4.6 (1.6, 12.7)
3.6 (0.6, 19.0)
7.9 (1.6, 31.6)
3.8 (1.1, 12.2)
3.6 (0.6, 19.0)
62.4 (25.2 (89.1)
5.7 (1.6, 17.7)
5.4 (1.4, 19.0)
57.9 (20.3, 88.1)
1.8 (0.5, 7.1)
3.6 (0.6, 19.0)
57.2 (19.7, 87.9)
4.0 (1.2, 12.3)
9.0 (2.9, 25.0)
62.3 (25.0, 89.1)
Subthreshold ADHD at Baseline (n=46)
No change in sx
Increase in sx
Decrease in sx (non(subthreshold ADHD
(probable ADHD
ADHD at follow-up)
at follow-up)
cases at follow-up)
(n=13)
(n=15)
(n=18)
% who declined
functionally (95%
% who declined
% who declined
CI)
functionally (95% CI)
functionally (95% CI)
3.5 (0.6, 18.6)
18.2 (6.7, 40.9)
37.2 (18.0, 61.4)
1.7 (0.3, 9.6)
27.4 (6.4, 67.6)
19.6 (7.3, 42.9)
3.5 (0.6, 18.6)
19.2 (6.3, 45.8)
25.9 (10.4, 51.2)
0.0
16.6 (5.5, 40.5)
59.7 (36.2, 79.5)
0.0
15.3 (5.0, 38.1)
28.7 (9.4, 60.8)
0.0
47.2 (21.1, 75.0)
43.8 (21.3, 69.1)
ADHD at baseline (n=103)
Decrease in sx
No change in sx
Decrease in sx (non(subthreshold ADHD
(probable ADHD
ADHD at follow-up)
at follow-up)
cases at follow-up)
(n=13)
(n=22)
(n=68)
% who declined
functionally (95%
% who declined
% who declined
CI)
functionally (95% CI)
functionally (95% CI)
17.7 (5.3, 45.3)
31.4 (11.0, 62.9)
13.2 (7.5, 22.3)
8.4 (1.9, 30.2)
4.9 (1.2, 17.6)
17.2 (8.6, 31.6)
18.1 (5.5, 45.8)
20.7 (7.3, 46.5)
19.6 (12.2, 29.9)
5.5 (0.9, 28.7)
1.6 (0.3, 9.0)
17.6 (9.8, 29.6)
18.1 (5.5, 45.8)
23.6 (8.9, 49.4)
14.5 (8.5, 23.8)
7.8 (1.7, 29.0)
0.0
15.5 (8.1, 27.7)

** p < .01 for Chi-square analyses
* p < .05 for Chi-square analyses

127

Table 4.3 Percentages of Youth with Decrease in Symptoms, No Change in
Symptoms, and Increase in Symptoms Who Achieved Reliable Change
IMPROVEMENT on SDQ Functional Measures (Decreased Impairment)
Non-ADHD at Baseline (n=130)
Increase in sx
Increase in sx (probable
No change in sx (non- (subthreshold ADHD at ADHD cases at followADHD at follow-up)
follow-up)
up)
(n=100)
% who improved
Baseline SDQ Impairment
functionally (95% CI)
Distress/intrapersonal**
78.6 (66.5, 87.2)

(n=17)
% who improved
functionally (95% CI)

(n=13)
% who improved
functionally (95% CI)

76.3 (51.0, 90.9)

14.8 (3.8, 43.7)

Home life

75.0 (63.2, 84.0)

55.1 (28.5, 79.0)

59.7 (22.2, 88.5)

Friendships**

80.7 (69.6, 88.4)

76.1 (50.1, 91.0)

20.7 (5.8, 52.5)

Classroom learning**

77.7 (65.8, 86.4)

74.5 (50.0, 89.5)

5.3 (0.8, 28.8)

Leisure activities**

82.2 (72.6, 89.0)

70.6 (44.8, 87.7)

24.9 (7.2, 58.7)

Total impairment

5.7 (2.7, 11.6)
5.1 (0.9, 25.0)
5.3 (0.8, 28.8)
Subthreshold ADHD at Baseline (n=46)
No change in sx
Increase in sx (probable
Decrease in sx (non- (subthreshold ADHD at ADHD cases at followADHD at follow-up)
follow-up)
up)

(n=13)
% who improved
Baseline SDQ Impairment
functionally (95% CI)
Distress/intrapersonal*
73.5 (38.1, 92.6)

(n=15)
% who improved
functionally (95% CI)

(n=18)
% who improved
functionally (95% CI)

53.1 (26.4, 78.1)

25.7 (11.2, 48.6)

Home life

56.7 (26.1, 82.9)

14.8 (4.4, 39.6)

30.7 (11.3, 60.7)

Friendships

38.6 (13.5, 71.7)

56.7 (29.9, 80.1)

16.5 (5.6, 39.6)

Classroom learning

59.7 (26.9, 85.6)

49.4 (23.1, 76.0)

28.6 (12.7, 52.5)

Leisure activities

19.1 (7.0, 42.5)

56.3 (29.6, 79.8)

31.3 (14.4, 55.2)

Total impairment

28.8 (9.7, 60.4)

21.3 (6.8, 50.3)
21.1 (8.7, 42.7)
Probable ADHD at baseline (n=103)
Decrease in sx
No change in sx
Decrease in sx (non- (subthreshold ADHD at (probable ADHD cases
ADHD at follow-up)
follow-up)
at follow-up)

(n=13)
% who improved
Baseline SDQ Impairment
functionally (95% CI)
Distress/intrapersonal*
75.0 (45.7, 91.4)

(n=22)
% who improved
functionally (95% CI)

(n=68)
% who improved
functionally (95% CI)

54.3 (27.1, 79.2)

33.8 (22.0, 48.1)

Home life

44.6 (13.8, 80.3)

41.5 (17.1, 71.0)

42.9 (28.3, 58.8)

Friendships*

62.3 (27.3, 87.9)

23.8 (9.4, 48.3)

25.2 (15.4, 38.6)

Classroom learning**

49.0 (15.9, 83.0)

77.7 (56.9, 90.2)

40.1 (25.8, 56.4)

Leisure activities**

80.1 (52.1, 93.7)

10.2 (3.8, 24.3)

42.9 (28.5, 58.7)

Total impairment

35.0 (8.7, 75.3)

43.9 (18.7, 72.7)

32.1 (18.3, 50.1)

** p < .01 for Chi-square analyses
* p < .05 for Chi-square analyses
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Table 4.4 Results of Multivariate Logistic Regression for Prediction of Impairment
OR (95% Confidence Interval) p value
Non-cases

Subthreshold cases

Probable cases

Gender
1.5 (0.5,
4.7)

0.49

0.3 (0.1,
1.0)

0.05

0.7 (0.3,
1.7)

0.38

1.0

-

1.0

-

1.0

-

Yes

9.8 (1.8,
54.6)
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Abstract

Background. Despite a substantial prevalence of subthreshold ADHD and research
indicating that many youth with subthreshold ADHD are being treated with ADHD
medication, little is known about patterns of symptom and impairment change in relation
to medication status and predictors of medication use. Methods. A community-based
sample composed of children at high-risk for ADHD and low-risk peers (frequencymatched on gender) were identified through screening and invited to in-person
interviews. At two assessments periods, baseline (N=270) and follow-up (N=163)
parents/caregivers of youth with probable ADHD or subthreshold ADHD completed
measures related to the youth’s psychiatric symptom and functional impairment status
and supplemental questionnaires examined socio-demographic information and child and
family risk factors. At baseline, children were identified who met symptom criteria for
subthreshold ADHD (N=84) and probable ADHD (186) and patterns of change in
symptoms and functioning based on medication status were examined at follow-up
(starting 20 months years later) using a Reliable Change Index (RCI) and Chi Square
tests. A supplementary analysis investigated predictors of ADHD medication use.
Results. ADHD medication data for this cohort showed that 19% (n=21) of youth with
subthreshold ADHD at baseline and 27% (n=14) of youth with subthreshold ADHD at
follow-up) and 42% (n=109) of youth with probable ADHD at baseline and 41% (n=65)
of youth with probable ADHD at follow-up had taken medication in the year prior to
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assessment. Thirty three percent (N=15) of youth who were subthreshold ADHD at
baseline retained that status at follow-up and showed significant decline in function.
When considering medication status among those individuals, 50% of the medicated
youth declined in overall functioning at follow-up compared to 10% of those who where
not medicated the year prior to follow-up. Baseline youth with probable ADHD who
were not medicated the year prior to follow-up and who were non-ADHD cases at
follow-up were significantly more likely than probable ADHD at follow-up to decline
functionally in distress/intrapersonal and friendships; they were also more likely to
decline in leisure activities compared to youth with subthreshold ADHD at follow-up.
Parent perceived burden was predictive of ADHD medication use for youth with probable
ADHD but significantly so for youth with subthreshold ADHD. Conclusions. The
findings show the importance of examining symptom and functional impairment
constructs separately in the consideration of their unique contributions to ADHD and
subthreshold ADHD diagnoses and of acknowledging the need to more closely examine
nuanced changes in diagnostic status and medication needs during development, taking
impairment, more so than symptoms into account. These findings may be relevant to
efforts to intervene earlier in childhood and to help identify high-risk individuals who
may be good candidates for targeted interventions. Key words: Attention Deficit
Hyperactivity Disorder, Subthreshold ADHD, symptom and impairment trajectories,
predictors of impairment. Abbreviations: RCI, reliable change index; ADHD, attentiondeficit/hyperactivity disorder; DISC-IV, Diagnostic Interview Schedule for Children
version IV; SDQ, Strengths and Difficulties Questionnaire; DSM-IV, Diagnostic and
Statistical Manual-IV; OR, odds ratio; 95% CI, 95% confidence interval.
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Introduction
Inattention, hyperactivity/impulsivity, or the combination of the two impairs an
individual's ability to adjust to a continually changing environment; and impairment may
be a direct consequence (Nijmeijer et al., 2008). It is clear from the literature that
deficiencies in functional impairment occur in individuals with ADHD at all ages across
multiple domains (e.g. social, academic) (Sciberras, Roos, & Efron, 2009). ADHD is a
persistent condition for many, and although symptoms tend to diminish and show
different patterns over time (Holbrook, 2012), symptom declines do not necessarily result
in a return to normal function (Willoughby, 2003).
Children and adolescents who fail to achieve full ADHD diagnosis or full
remission, a group referred to as subclinical, subsyndromal, or subthreshold(among other
terms), are at risk for developing ADHD (Barnard-Brak, To, & Fearon, 2011; Bussing,
Mason, Bell, Porter, & Garvan, 2010). While the literature lacks clear definitions of these
terms, the ADHD literature often considers subthreshold ADHD to be three to five
symptoms of either the inattentive or hyperactive/impulsive symptoms (using the DSMIV ADHD diagnostic criteria) and the current analyses adopts this specific definition.
Subthreshold ADHD is more common than ADHD (Lewinsohn, Shankman, Gau, &
Klein) with up to 22% of youth exhibiting subthreshold ADHD symptoms (Scahill, et al.,
1999). Compared to individuals without ADHD, individuals with subclinical ADHD have
worse educational, occupational, economic, and social outcomes (e.g. grade retention, not
graduating, divorce, lower incomes) (Bussing, et al., 2010; Klein et al., 2012). Further,
children with subthreshold ADHD may be denied treatment and services based on current
policies (Bussing, Mason, Bell, Porter, & Garvan, 2010; Canino, Costello, & Angold,
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1999 1999). Recent ADHD treatment intervention studies have shown that change in
function occurs in the absence of symptom change and vice versa (Karpenko, Owens,
Evangelista, & Dodds, 2009; Owens, Johannes, & Karpenko, 2009). Further, research
shows that decreasing symptom burden is not always associated with improved
functional status, whereas increasing symptom burden is more likely to be associated
with functional decline (Owens, et al., 2009). For research, referral, treatment, and
intervention purposes it is important to identify children who make reliable change in
both symptom and impairment change, as well as those who make change in only one
area (Owens, et al., 2009). To date, research is lacking in this area and very little is
known about longitudinal patterns of symptom and functional impairment change for
youth with subthreshold ADHD.
Symptom and impairment developmental trajectories can be improved through
early identification and appropriate treatment of ADHD (Magyary & Brandt, 2002). A
range of medication options exists for the treatment of ADHD, with stimulant
medications [e.g. Ritalin (i.e., methylphenidate) and Adderall (i.e., dextroamphetamine)]
generally considered superior to nonstimulant medications (e.g. Strattera (i.e.,
atomoxetine)) (Action; Vierhile, Robb, & Ryan-Krause, 2009). ADHD medication
reduces ADHD symptoms (e.g., fidgeting and interrupting) as well as impairment (e.g.,
relationships at home with parents) in about 70% of youth (Action, 2002). In 2007, 66%
of youth (ages 4-17) received medication treatment for a current ADHD diagnosis (Visser
& Lesesne, 2005). Youth aged 11-17 had higher mediation rates than children aged 4-10,
and boys were more likely than girls to take medication (Visser & Lesesne, 2005).
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Treating Children with Subclincial ADHD
The subject of treating children diagnosed as subthreshold ADHD is
controversial. Data suggest that, compared to children meeting full ADHD symptom
counts, fewer children meeting subthreshold symptoms counts are treated with
medication (Bussing, et al., 2010). One study, using retrospective recall data among
adults, considered four subgroups (full ADHD/subthreshold ADHD/late-onset
ADHD/controls) and found among the subthreshold group, 19% had ever received
psychotropic medication for ADHD, compared to 58% of the group with full ADHD
(Faraone et al., 2006). In another study, 25% of youth with subthreshold ADHD reported
ever being treated with medication for ADHD, compared to 50% of youth with ADHD
(Bussing, et al., 2010). While one would expect lower rates of medication treatment
among individuals with diminished forms of ADHD compared to ADHD, some question
the appropriateness of treating this group at all (Faraone, et al., 2006), while others reason
that increasing medication rates among subthreshold cases may reduce the risk for
negative functional outcomes (Bussing, et al., 2010).
Predictors of Service Use
Several studies have examined predictors of treatment utilization for youth with
ADHD and only a few studies have examined predictors of treatment utilization for youth
with subthreshold ADHD. Research shows service contact for ADHD is often made
because of parent’s perception of problems (perceived burden) or parental strain rather
than child factors such as comorbidity (Angold et al., 1998; Bussing et al., 2003; Sayal,
2006). Additional predictors of treatment seeking and service use for children with
ADHD include male gender (Beuermeister, 2003; Gau et al., 2010; Bussing, 2005),
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maternal education (college or higher) (Gau et al., 2010), parental mental health history,
marital status (divorced) (Jensen, Bloedau, and Davis, 1990), and younger age (Leslie et
al., 2005).
Of the few studies that have considered a subclinical ADHD group, two studies
found subclinical ADHD (defined three different ways, and not including individuals
who met impairment criteria) predicted stimulant medication use (Bauermeister et al.,
2003; Leslie, et al., 2005). Reich et al. found that among comparison children, ADHD
symptom counts and presence of impaired functioning were significant treatment
correlates (Reich, Huang, & Todd, 2006). Similarly, Angold et al. found among the
ADHD-NOS group, stimulant medication use was significantly related to number of
symptoms and comorbid Oppositional Defiant Disorder (ODD) (Angold, Erkanli, Egger,
& Costello, 2000). To our knowledge, no study has examined parent perceived burden as
a predictor of medication use for youth with subthreshold ADHD.
Study Purpose
It is not clear from the literature if youth with subthreshold ADHD who are
unmedicated fare particularly worse over time compared to individuals with subthreshold
ADHD who are taking ADHD medication. To our knowledge, there are no published
studies that have examined how medication use within the context of ADHD and
subthreshold ADHD unfolds with regard to patterns of symptom and impairment change.
The main purpose of this study is to discern prospective patterns of symptoms and
functional impairment change in a community sample of youth with subthreshold ADHD
and youth with ADHD, with regard to medication status (taking medication versus not
taking medication). Additionally, this study evaluates predictors of ADHD medication
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use for youth with subthreshold ADHD compared to youth with ADHD. This research
adds to the existing understanding of subthreshold ADHD and explores symptom and
functioning correspondence methodology that can be useful in identifying patterns that
have important implications for conceptualizing treatment in research and practice for
youth with subthreshold ADHD. It is also designed to identify more homogeneous
subgroups with a higher likelihood of experiencing service utilization.
METHODS
Recruitment and Sampling
SCPLAY utilized a two-phase research design involving school district-wide,
voluntary teacher and parent screenings (phase I) and in-person assessments (phase II). In
person assessments involved (structured diagnostic interviews with youth and
parents/caregivers at baseline and four follow-up points. Baseline interviews were
conducted with consenting parents/caregivers and children 13 months (mean time)
following the screening. Further explanation of the SCPLAY study population, design,
sampling frame, and methods can be found elsewhere (M. L. Wolraich et al., 2012).
SCPLAY study procedures were approved by the Institutional Review Board of the
University of South Carolina and the Centers for Disease Control and Prevention and
informed parental consent obtained for all interviews.
Participants
Data for these analyses were obtained from SCPLAY baseline (n=481; 9/03-1/06)
and follow-up parent assessments (n=292; 9/07-2/09). Parent/caregiver [a biological
parent in 426 out of 481 (89%) baseline families] provided family demographic and
psychosocial information, mental health history, information about the selected child
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related to ADHD symptoms and impairment, other psychiatric disorders, and treatment
history via computer-based (interviewer administered) interview, and paper and pencil
(self-administered) questionnaires.
Using the Diagnostic and Statistical Manual of Mental Disorders, 4th edition,
(DSM-IV-TR) symptom criteria for ADHD, youth were categorized into two symptom
groups: probable ADHD cases (≥ 6 Inattentive (IA) symptoms or ≥ 6
hyperactive/impulsive (HI) symptoms) and subthreshold ADHD cases (3-5 IA symptoms
or 3-5 HI symptoms). After categorization, 69% (n=186) of the sample met inclusion
criteria for probable ADHD and 31% (n=84) met inclusion criteria for subthreshold
ADHD. These categories only consider symptoms counts and do not correspond to
previously published prevalence estimates that used a strict DSM-IV-TR ADHD case
definition (Wolraich et al., 2012). The final baseline sample for these analyses is 270 of
the original 481, with 260 parents/caregivers completing the SDQ impact supplement at
follow-up. The baseline samples are introduced in Table 4.2.1. Comparison of the
retained sample versus those lost to attrition revealed no statistically significant
differences related to baseline demographic and psychosocial variables.
Measures
The Diagnostic Interview Schedule for Children (DISC-IV; Shaffer et al.,
2000). The DISC-IV, based on the Diagnostic and Statistical Manual of Mental
Disorders, 4th edition (DSM-IV-TR) (Association & DSM-IV., 2000), is a well-validated,
fully-structured diagnostic interview developed to diagnosis psychopathology in youth
(Shaffer, Fisher, Lucas, Dulcan, & Schwab-Stone, 2000). Parents were administered the
DISC-IV by a trained interviewer during baseline and the first follow-up annual
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assessments to obtain past year ADHD symptom counts and past year categorical
probable diagnosis for ODD and CD. The test-retest reliability of the ADHD DISC-IV
module (parent report) in a clinical sample and community sample (past year) among
children aged 9-17 years was k=.79 and k=.60, respectively (Shaffer, et al.). The DISC
showed moderate to good validity across a number of diagnoses, including ADHD
(Schwab-Stone, Shaffer, Dulcan, & Jensen, 1996). Parent interview was used because
research has shown low test-retest reliability in the child DISC interview (Schwab-Stone,
et al., 1996).
ADHD Medication Status. One dichotomous medication status variable was
created from the following item on the DISC-IV interview, “In the past twelve months,
has your child taken any medicine for being overactive, being hyperactive, or having
trouble paying attention?” Based on a subsample on whom we have detailed medication
data (n=458), 14.6% of the subthreshold ADHD sample at baseline were taking stimulant
medication and 4.3% were taking non-stimulant medication; 32.6% of the probable
ADHD sample at baseline were taking stimulant medication and 13.6 were taking nonstimulant medication.
The Strengths and Difficulties Questionnaire (extended version) (SDQ)
(Goodman, 2000). The SDQ (extended version) is a domain-specific behavioral screener
consisting of 25 symptom items assessing five subscales: behavioral problems, emotional
problems, hyperactivity, peer-problems, and prosocial behavior and seven “impact
questions” assessing difficulties in functioning (i.e., school and classroom settings)
associated with reported symptoms (Goodman, 1999). The SDQ is one of a few measures
of functional impairment that was specifically developed to assess impairment in relation
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to ADHD and other psychiatric symptomatology. For these analyses, only the parent
version impact questions from the extended version of the SDQ were examined (baseline
and follow-up assessments).
For the first impact question “Overall, do you think that (child’s name) has
difficulties in any of the following areas: emotions, concentration, behavior, or being able
to get along with other people?”, responses included ‘no,’ ‘minor,’ ‘severe,’ and
‘definite’; if respondents reported at least “minor” problems, then the following impact
questions related to five domains of functioning were asked: Question 1. “Do the
difficulties upset or distress the child?”; Questions 2.-5. “Do the difficulties interfere with
the child’s life in the following areas: 2. home life?; 3. friendships?; 4. classroom
learning?; 5. leisure activities? One additional impact supplement item asked if the
reported difficulties put a burden on the family (response options are the same as for the
five functional impairment questions). The five impairment items scores were summed to
create a total impairment score. Individual domains of functioning and total impairment
were used to assess reliable change in functioning from baseline to follow-up using a
reliable change index (RCI; described below) (Jacobson & Truax, 1991).
The SDQ is well-validated, and reliability and validity data are summarized in
two reports by the author (Goodman, 1999, 2001). For the impact supplement, the parent
version has high internal consistency (Cronbach alpha coefficient =.85), good 4-6 month
retest stability (Impact/impairment score; .57), and good validity (negative predictive
value (NPV) = .95; positive predictive value (PPV) = .53)(Goodman, 2001).
Predictors of taking ADHD medication during the last year. Predictor
Variables: Several baseline factors were examined as predictors of ADHD medication
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utilization. Child demographic and psychosocial variables included age, gender, race
(Non-Hispanic white vs. Non-Hispanic Black vs. Other) (all three variables ascertained
from parental reports on the demographic questionnaire); comorbidity (ODD/CD were
coded as separate dichotomous variables) (ascertained form parent DISC-IV report); and,
severe impairment (present if at least one of the five SDQ domain question responses was
“a great deal” or if two or more question responses were “a medium amount”)
(ascertained using parent SDQ report). Additionally, the following family factors were
examined as predictors of ADHD medication utilization: marital status (dichotomized as
married or unmarried), primary caregiver’s education level (dichotomized as less than a
bachelor degree or a bachelor degree and higher), insurance (none vs. private insurance
vs. Medicaid), (all three variables ascertained from parental reports on the demographic
questionnaire); parental psychopathology (coded as a dichotomous variable) (ascertained
from parent report on a mental health history questionnaire); and, parent-reported burden
based on the SDQ question (treated dichotomously coded as “present” (“medium
amount” or “great deal”) or “absent” (“not at all” or “a little”).
Procedures/Analysis:
All analyses were performed using SAS-callable SUDAAN version 10.0 software
to adjust for the complex sampling design. Basic descriptive statistics were calculated
and prevalence of treatment utilization reported. Raw frequencies and weighted
percentages accounting for the sampling scheme are reported for all results. Procedures
outlined in Jacobson and Traux’s (1991) methodology for creating a reliable change
index (RCI) were used to determine which youth met criteria for reliable change in
impairment (using the five functional domains from the SDQ data) in relation to
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symptom category (subthreshold ADHD and probable ADHD) change from baseline to
follow-up (considering ADHD medication status).
While other comparable statistical methods exist, researchers encourage use of
this method for study comparison purposes (Karpenko, et al., 2009). The following
formula for reliable change (RC) as outlined by Jacobson and Traux was used:
;

The RCI method described by Jacobson and Traux (1991) was used to divide the
baseline by follow-up differences for each participant by the standard error (SE) of the
difference score for each domain of functioning. This allowed for the identification of
individual change (significance level set to p ≤ 0.05) that is greater than what would be
attributed to chance or measurement error (Jacobson, Roberts, Berns, & McGlinchey,
1999).
Descriptive percentages were used to compare proportions of change (i.e.,
improvement, no change, and decline) in symptom categories and functional impairment
measures (five domains and overall impairment) among symptom groups. SDQ scores ≥
to 1.96 reflected positive change (i.e., impairment increased); scores ≤ to -1.96 reflected
negative change (e.g. impairment decreased); and, scores between 1.96 and -1.96
reflected no impairment change. Participants were then classified as “functionally
improved” (i.e., significant positive change), “no change” (i.e., no significant change),
and “functionally declined” (significant negative change). Further, chi-square tests were
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used to determine if there was a significant association between improvement in
symptoms and improvement in functioning.
A multivariable logistic regression analysis was used to examine which variables
were independently predictive of ADHD medication use in multivariate models, using
forward stepwise entry of variables of most interest to this study. Adjusted odds ratios
and 95% confidence intervals (CIs) were computed to investigate the strength of the
relationships.
Results
The sample was ethnically and gender diverse with non-Hispanic blacks and girls
being well represented at baseline (38% and 31%) and follow-up (39% and 34% ),
respectively. At baseline, youth ranged in age from 5-13 (mean 9.4) and at follow-up
youth ranged in age from 7-15 (mean 11.8). Thirty two percent of youth had comorbid
ODD and/or CD at baseline and 30% of youth had comorbid ODD and/or CD at followup. Forty eight percent of youth were taking ADHD medication at baseline and 50% of
the follow-up sample was taking ADHD medication. Among youth with subthreshold
ADHD at baseline, 19% were taking ADHD medication the year prior to baseline
compared to 42% of probable ADHD youth who where taking ADHD medication the
year prior to baseline. At follow-up, 27% of youth with subthreshold ADHD and 41% of
youth with probable ADHD were taking ADHD medication the year prior to follow-up.
After establishing medication status and symptom category change from baseline
to follow-up, RCI was used to distinguish individuals who made a statistically reliable
change in each domain of functioning (and overall impairment) from baseline to followup. The relation between symptom category change (decrease, no change, and increase)
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for individuals with probable ADHD and subthreshold ADHD, and functional
impairment change (individual domains and overall impairment) was analyzed through a
series of chi-square tests. The percentage of children demonstrating patterns of symptom
change (increased, no change, and decreased) (based on medication status) and
impairment change (five domains of functioning and overall impairment) is shown in
Tables 4.2.2 (functional decline/subthreshold at baseline), 4.2.3 (functional
decline/probable ADHD at baseline), 4.2.4 (functional improvement/subthreshold at
baseline), and 4.2.5 (functional improvement/probable ADHD at baseline).
Baseline youth with subthreshold ADHD who were not medicated the year prior
to follow-up and who were probable ADHD cases at follow-up were significantly more
likely to improve functionally than subthreshold ADHD at follow-up in classroom
learning. Baseline youth with subthreshold ADHD who were not medicated the year prior
to follow-up and who were subthreshold ADHD cases at follow-up were significantly
more likely to improve functionally than probable ADHD at follow-up in total
impairment. Baseline youth with subthreshold ADHD who were not medicated the year
prior to follow-up and who were non-ADHD cases at follow-up were significantly more
likely to decline functionally than probable ADHD cases and subthreshold cases at
follow-up in distress/intrapersonal impairment. Baseline youth with probable ADHD who
were not medicated the year prior to follow-up and who were non-ADHD cases at
follow-up were significantly more likely to decline functionally than probable ADHD
and subthreshold ADHD at follow-up in distress/intrapersonal impairment and
friendships; they were also more likely to decline in leisure activities compared to youth
with subthreshold ADHD and probable ADHD at follow-up.
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PREDICTORS OF MEDICATION USE
Multivariable Models – Subthreshold ADHD and Probable ADHD
Multivariate regression models were used to identify whether any of the measured
independent variables (overall impairment, parent perceived burden, conduct disorder
and/or oppositional defiant disorder, gender, race/ethnicity, parent mental health history,
age, primary parent education, and insurance) might predict ADHD medication use for
youth with subthreshold ADHD and probable ADHD (Table 4.2.6). In the subthreshold
ADHD model, parent perceived burden was positively associated with medication use. In
the probable ADHD model, females were less likely than males to take medication.
Overall impairment and comorbid CD/ODD were not significantly related to ADHD
medication use. Race/ethnicity, parent mental health history, age, primary parent
education, and insurance were also added to the models individually but were dropped
due to lack of change in the point estimates of other variables before and after their
addition to the models.
Discussion
In an attempt to consider ADHD dynamics in a more nuanced way, this study
considered symptom and functioning change without using narrowly-defined DSM
subtype, age of onset, and impairment (two or more settings) diagnostic criteria. This
study is one of a relatively few prospective community-based studies following a diverse
sample of youth with ADHD and subthreshold ADHD examining patterns of change in
symptoms and functioning, considering ADHD medication status. Chi-square analyses
showed that youth with subthreshold ADHD at baseline (and not medicated the year prior
to follow-up) who were probable ADHD cases at follow-up were significantly more
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likely to improve functionally in classroom learning compared to subthreshold ADHD
cases at follow-up. Youth at baseline with subthreshold ADHD (and not medicated the
year prior to follow-up who were subthreshold ADHD at follow-up were significantly
more likely to improve functionally overall compared to youth with probable ADHD at
follow-up. Considering medication status, one would expect individuals in the probable
ADHD unmedicated group, who had increased symptoms from baseline subthreshold
status) to show less improvement than individuals with unmedicated subthreshold ADHD
at follow-up (no change from baseline); and this is evident in overall impairment
(significant in chi square testing) and other measures of functioning (while not significant
in chi-square testing), with more subthreshold youth (than probable ADHD youth) at
follow-up showing greater positive change in improvement in the areas of home life and
friendships.
A different trend was seen among youth with probable ADHD at baseline who
were not medicated the year prior to follow-up and non-ADHD cases at follow-up. Those
individuals were significantly more likely to decline functionally than probable ADHD at
follow-up in distress/intrapersonal and friendships domains and more likely to decline in
leisure activities compared to youth with subthreshold ADHD and probable ADHD at
follow-up. These findings, that decreasing symptoms are associated with functional
decline may be explained by research suggesting that although symptoms tend to
diminish over time, symptom declines do not necessarily result in a return to normal
function (Willoughby, 2003). Further, impairment may increase over time as demands
increase and through an additive process; with impairment becoming more noticeable as
children age and acquire more autonomy (Adler, Spencer, Stein, & Newcorn, 2008).
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In line with the declining symptom with increasing impairment trend, baseline
youth with subthreshold ADHD who were not medicated the year prior to follow-up and
who decreased symptoms (i.e., were non-ADHD cases at follow-up) were significantly
more likely to decline functionally than probable ADHD cases at follow-up in
distress/intrapersonal impairment. This group (N=11) of youth with non-ADHD at
follow-up showed some functional decline in the areas investigated (e.g. 75% in
classroom learning and 34% in overall impairment) which is concerning. It may be that
these individuals, while they no longer meet symptom criteria for subthreshold ADHD,
are suffering from remaining ADHD symptoms and/or other impairing disorders or
psychosocial circumstances.
Considering the medicated versus nonmedicated groups, the subthreshold baseline
group who were probable ADHD at follow-up (and taking ADHD medication the year
prior to follow-up) improved more functionally in the areas of intrapersonal, friendships,
and classroom than those youth with probable ADHD at follow-up who were not
medicated. The subthreshold baseline group who were subthreshold ADHD at follow-up
and were taking medication the year prior to follow-up improved more functionally in the
intrapersonal domain compared to those youth with subthreshold ADHD at follow-up
who were not medicated. Youth who were probable ADHD at baseline and subthreshold
ADHD at follow-up who were medicated the year prior to follow-up declined 14% in
overall impairment at follow-up compared to those who were not medicated the year
prior to follow-up (53% decline in overall impairment). This trend was similar for youth
who were probable ADHD at baseline and remained probable ADHD at follow-up; 23%
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of the medicated group declined in overall impairment compared to 44% of the
unmedicated group.
While most ADHD medication treatment studies only consider symptom change,
a review of the literature including studies assessing improvements in functioning found
medication use versus no medication use is associated with greater rates of symptom
remission and increased social and academic functioning (Steele, Jensen, & Quinn,
2006). While those findings show evidence of improvements in functioning with
medication use, as described in the previous paragraph, this analysis showed youth with
subthreshold ADHD at baseline and medicated the year prior to follow-up tended to
decline functionally to a greater degree in four out of five domains of functioning and
overall functioning compared to youth with subclinical ADHD at follow-up who were not
medicated. Youth who were subthreshold ADHD who were probable ADHD at follow-up
and medicated the year prior to follow-up also tended to decline functionally to a greater
degree in three out of the five domains and overall functioning compared to youth with
probable ADHD at follow-up who were not medicated. Individuals presenting with
severe impairment may show less overall improvement in functional impairment
measures over time. Additionally, medication treatment compliance may be as low as
50% in children with ADHD (Johnston & Fine, 1993) which may result in poor
management of symptoms and functional impairment (Perwien et al., 2004).
In the present study we calculated a reliable change index (RCI) (Jacobson and
Truax, 1991) to determine statistically significant functional impairment change. RCI has
been applied to intervention and drug trial studies in the ADHD literature, and these data
show the value of considering longitudinal community based symptom and functioning
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trajectory data using the RCI method. RCI should not be confused with clinical
significance which is often defined as a return to normal functioning (Jacobson, et al.,
1999). With the understanding that ADHD is a persistent neurobiological disorder, we
did not calculate clinical significance. If, in fact, remission should be the goal of ADHD
medication treatment (Steele, et al., 2006), future research should evaluate if the Jacobson
& Traux CS method would be too stringent a criterion to use with medicated and nonmedicated youth with ADHD and subthreshold ADHD in community samples.
Predictors of Medication Use
The longitudinal data used here offered the opportunity to consider predictors of
ADHD medication use among subthreshold ADHD and probable ADHD symptom
categories. Self-referral in childhood is rare and only a small proportion of children with
ADHD are receiving treatment, so having ADHD does not fully explain treatment
seeking (Angold, et al., 1998). Most notable among the findings in this study was parent
perceived burden was predictive of ADHD medication use for youth with probable
ADHD but significantly so for youth with subthreshold ADHD. In these data, parent
burden more so than youth clinical factors (i.e., comorbidity and overall impairment)
predicted medication use. This finding for subthreshold ADHD is novel and in line with
research showing parental strain or perceived burden more than symptoms (Angold, et
al., 1998) or comorbid conditions (including ODD and CD) (Angold, et al., 1998;
Bauermeister, et al., 2003) is a major reason for service contact for ADHD (Farmer,
Stangl, Burns, Costello, & Angold, 1999). Additionally, the finding that overall
impairment was not a significant predictor of medication use for either youth with
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subthreshold ADHD or probable ADHD was surprising, and not in line with other
research findings (Reich, et al., 2006; Zuvekas, Vitiello, & Norquist, 2006)
Similar to other studies, these data show being male significantly predicted
ADHD medication use for youth with probable ADHD (Bauermeister, 2003; Gau et al.,
2010; Bussing, 2005), however, while not significant, females with subthreshold ADHD
were more likely to take ADHD medication than males with subthreshold ADHD. This
finding was not expected as girls, especially those with inattention problems are more
likely to be under-referred, and less likely to be treated than boys (Hinshaw & Blachman,
2005; Staller & Faraone, 2006).
Study Limitations & Strengths
As with any study, the current findings are not without limitations. The SDQ is a
domain specific measure (assessing impairment in relation to symptoms of multiple
disorders) (Canino, et al., 1999) so there is no way to know which symptoms, if any, are
directly related to the reported impairment. However, using the DISC-IV (a symptom
specific measure), was not possible because if the symptom criteria, duration criteria, or
age of onset criteria for ADHD are not met, the functional impairment questions are
never asked and subthreshold ADHD impairment could not be assessed. Symptom
specific measures of impairment are needed that are not limited by those constraints.
Additionally, domains of functioning were measured using a single SDQ item. While this
does not allow for extensive detail, the SDQ is a well validated measure, is practical to
administer, and captures multiple domains of functioning that can help inform
developmental trajectory research as well as referral and service decisions.
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The use of only parent/caregiver report is another limitation, as the DSM-IV
recommends the use of multiple informants and the American Academy of Pediatrics
recommends the need for both parent and teacher report of functional impairment
(American Psychiatric Association, 2000; M. Wolraich, Brown, & Brown, 2011).
Teacher reports of functional impairment were collected, but not used due to poor followup response rates. Parent subjectivity introduces bias (e.g., underreport due to social
desirability, over-report due to help-seeking, endorse symptoms that affect them the most,
and may be more reliable reporters for younger children) (Barkley, 2006). While there is
often disagreement among multiple informants and subjective bias in parent report,
parents are thought to be crucial for a valid assessment of ADHD (Barkley, Fischer,
Smallish, & Fletcher, 2002; Cantwell, Lewinsohn, Rohde, & Seeley, 1997).
Symptom decreases over time might reflect true developmental changes, but also
may be due to other things such as artifacts of repeated measurement (Hart, Lahey,
Loeber, Applegate, & Frick, 1995) and diagnostic inadequacies (e.g., applying symptoms
that are not developmentally sensitive) (Willoughby, 2003). Additionally, the relationship
between symptom change and impairment in specific domains may be a function of the
treatment or care that individuals were provided, comorbidity, or other factors. While the
impact of such factors is not known, and the findings are constrained by unadjusted
percents and small numbers, this study provides some of the only data available
describing symptoms and functional impairment for youth in a community setting.
Another limitation of this study is the number of participants lost to follow-up. If
those individuals were less or more likely to have ADHD symptoms or to take
medication, the findings are less likely to be representative of the initial sample. Also,
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due to the low prevalence rate of ADHD medication use in this sample the estimates of
these predictor variables may not be precise. Finally, as the course of ADHD and
subthreshold ADHD is continually changing, one’s symptom and impairment status at
baseline and follow-up may not be static and future studies exploring changes in patterns
of ADHD symptoms and functioning are needed that use repeated observations.
This study adds to an absence of population-based longitudinal impairment data
of children with subthreshold ADHD who are identified in early childhood and followed
into adolescence. While most ADHD trajectory studies consider only patterns of
symptom change over time, this study considered patterns of change for both symptoms
and functioning. It utilized well validated instruments, trained data collectors, and
extensive data quality control measures. Study sampling design increased case finding
and analysis accounted for sampling design to give unbiased estimates. It used a
prospective design with a retention rate of 61% at follow-up. In addition to being cross
sectional in nature, most studies focus on children, and this study followed youth up to
age 15. This was a community-based rather than clinic-based study, which is a strength,
as clinic-based youth are likely to have more severe symptom and functional impairments
than youth in the community (Gau, et al., 2010) and may result in higher treatment
seeking rates (Rowland, Lesesne, & Abramowitz, 2002). White boys account for the
majority of research related to ADHD in youth (Hartung & Widiger, 1998 )and girls and
African American youth are well represented in this study.
Clinical Significance
Improved understanding of functional improvements and declines in the
developmental characteristics related to symptom and impairment change in individuals
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with ADHD and individuals with subthreshold ADHD will help clinicians who advise
caregivers on matters related to treatment course and prognosis. Impairments are
multidimensional in nature and not static. Assessing specific domains of functioning
helps identify impaired areas to be used for referral, intervention starting points (Sayal,
2006) and modifications in ongoing treatment plans. Considering overall impairment
provides a global assessment of functioning which can be clinically beneficial (Fabiano
& Pelham, 2009), especially when considering overall degree of improvement or decline
over time. In addition to helping define intervention needs and to show functional change
over time, the SDQ impact supplement is a useful measure of difficulties prompting
caregivers to seek help for their children and their impact (Ford, Hutchings, Bywater,
Goodman, & Goodman, 2009). This study highlights the need for clinicians to consider
diagnosis in a nuanced way, paying particular attention to unique individual changes in
both symptom and functioning over time.
Logistic regression findings underscore the importance of understanding child and
family factors associated with taking ADHD medication. Prior work has not included
parent perception of burden when assessing risk factors of medication use for youth with
subthreshold ADHD. Identifying parent burden provides an opportunity for clinicians to
discuss parental perceptions of burden and address parent support needs alongside
discussion and consideration regarding medication therapy need. Additionally the
identified significant predictors of medication use are child and family factors that are not
difficult for clinicians to ascertain and add to the small existing data available in the
literature on this subject.
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Table 4.5 Demographics of Sample by Baseline ADHD Status;
Raw Frequencies and Weighted Percents

Total
Age in years (mean, range)
Gender
Boys
Girls
Race/Ethnicity
Non-Hispanic White
Non-Hispanic Black
Other
Insurance
None
Private insurance
Medicaid
CD/ODD
Yes
No
ADHD medication
Yes
No
Parent mental health history
Yes
No
Parent education level
Less than bachelors degree
At least bachelors degree

Subthreshold Cases Probable cases
N
%
N
%
84
100.0
186
100.0
9.5 (5-12)
9.4 (5-13)
59
25

65.0
35.0

128
58

60.2
39.8

49
34
1

46.7
51.4
1.9

101
69
16

39.8
55.6
4.7

12
45
24

16.7
54.1
29.2

13
113
45

8.1
66.2
25.8

13
70

17.9
82.2

72
114

34.6
65.5

21
63

19.1
80.9

109
77

42.1
57.9

14
69

18.6
81.4

53
122

24.3
75.7

54
28

59.4
40.6

120
57

62.8
37.2
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Table 4.6 Baseline to Follow-up Symptom Change and Corresponding SDQ
Impairment Change (Functionally Improved) by Medication Status
Subthreshold at Baseline (n=46)
Medicated year prior to follow-up (n=14)
Decrease in sx (nonADHD at follow-up)

No change in sx
(subthreshold ADHD
at follow-up)

Decrease in sx (nonADHD at follow-up)

No change in sx
(subthreshold ADHD
at follow-up)

(n=11)
% who improved
functionally (95% CI)

(n=9)
% who improved
functionally (95% CI)

0.0
2.2 (0.4, 12.6)
0.0
0.0

15.3 (3.8, 45.5)
38.6 (9.7, 78.6)
27.1 (8.1, 60.9)
18.1 (4.7, 50.0)

Leisure activities

0.0

21.5 (6.5, 52.1)

Total impairment**

0.0

56.7 (23.6, 84.8)

Baseline SDQ Impairment

Distress/intrapersonal
Home life
Friendships
Classroom learning
Leisure activities
Total impairment

Baseline SDQ Impairment

Distress/intrapersonal
Home life
Friendships
Classroom learning**

Increase in sx
(probable
ADHD cases
at follow-up)
(n=2)
(n=6)
(n=6)
% who improved
% who improved
% who
functionally (95% CI) functionally (95% CI)
improved
functionally
(95% CI)
14.2 (1.2, 68.5)
25.2 (6.3, 62.8)
56.5 (23.7,
84.5)
0.0
0.0
18.0 (3.2, 59.3)
14.2 (1.2, 68.5)
0.0
35.0 (10.6,
70.8)
0.0
12.9 (2.1, 51.0)
72.8 (36.4,
92.6)
0.0
0.0
0.0
0.0
24.0 (6.0, 61.0)
18.0 (3.2, 59.3)
Not Medicated year prior to follow-up (n=32)

** p < .01 for Chi-square analyses
* p < .05 for Chi-square analyses
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Increase in sx
(probable
ADHD cases
at follow-up)
(n=12)
% who
improved
functionally
(95% CI)
28.6 (9.8, 59.7)
20.3 (6.0, 50.5)
21.9 (5.8, 56.1)
54.0 (25.0,
80.5)
41.3 (14.5,
74.5)
55.2 (26.1,
81.1)

Table 4.7 Baseline to Follow-up Symptom Change and Corresponding SDQ
Impairment Change (Functionally Improved) by Medication Status
ADHD at baseline (n=103)
Medicated year prior to follow-up (n=58)

Baseline SDQ
Impairment
Distress/intrapersonal
Home life
Friendships
Classroom learning
Leisure activities
Total impairment

Baseline SDQ
Impairment
Distress/intrapersonal
Home life
Friendships
Classroom learning
Leisure activities
Total impairment

Decrease in sx
(non-ADHD at
follow-up)

Decrease in sx
(subthreshold ADHD
at follow-up)

No change in sx
(probable
ADHD cases at
follow-up)
(n=4)
(n=11)
(n=43)
% who improved
% who improved
% who improved
functionally (95%
functionally (95% CI)
functionally
CI)
(95% CI)
51.0 (15.5, 85.6)
17.6 (3.3, 57.3)
17.2 (9.1, 30.1)
31.1 (5.8, 76.7)
7.3 (1.3, 32.7)
19.5 (10.6, 32.9)
31.1 (5.8, 76.7)
37.3 (14.7, 67.2)
21.9 (12.6, 35.2)
0.0
7.0 (1.2, 32.1)
18.7 (8.4, 36.5)
55.3 (17.9, 87.5)
32.5 (11.6, 63.7)
19.6, 10.8, 32.8)
0.0
0.0
18.8 (8.3, 37.0)
Not Medicated year prior to follow-up (n=45)
Decrease in sx
(non-ADHD at
follow-up)

Decrease in sx
(subthreshold
ADHD at follow-up)

(n=9)
% who improved
functionally (95%
CI)
14.3 (3.3, 44.8)
6.1 (0.9, 31.7)
16.7 (4.3, 47.1)
6.1 (0.9, 31.7)
14.3 (3.3, 44.8)
8.6 (1.8, 32.4)

(n=11)
% who improved
functionally (95% CI)

** p < .01 for Chi-square analyses
* p < .05 for Chi-square analyses
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35.4 (10.4, 72.0)
4.3 (0.7, 22.4)
16.0 (3.3, 51.1)
0.0
21.1 (5.7, 54.2)
0.0

No change in sx
(probable
ADHD cases at
follow-up)
(n=25)
% who improved
functionally
(95% CI)
8.0 (2.4, 23.0)
14.2 (2.6, 51.1)
16.5 (6.9, 34.7)
16.0 (6.8, 33.4)
7.7 (2.4, 22.1)
11.1 (4.1, 27.0)

Table 4.8 Baseline to Follow-up Symptom Change and Corresponding SDQ
Impairment Change (Functionally Declined) by Medication Status
Subthreshold at Baseline (n=46)

Baseline SDQ
Impairment
Distress/intrapersonal
Home life
Friendships
Classroom learning
Leisure activities
Total impairment

Baseline SDQ
Impairment
Distress/intrapersonal*
Home life
Friendships
Classroom learning
Leisure activities
Total impairment

Medicated year prior to follow-up (n=14)
Decrease in sx (nonNo change in sx
Increase in sx
ADHD at follow-up)
(subthreshold at
(probable cases
follow-up)
at follow-up)
(n=2)
(n=6)
(n=6)
% who declined
% who declined
% who declined
functionally (95% CI) functionally (95% CI)
functionally
(95% CI)
85.8 (31.5, 98.8)
62.5 (25.9, 88.9)
43.5 (15.5, 76.3)
85.8 (31.5, 98.8)
11.1 (1.7, 47.0)
25.5 (6.9, 61.2)
85.8 (31.5, 98.8)
74.8 (37.2, 93.7)
21.6 (4.0, 64.7)
14.2 (1.2, 68.5)
64.3 (27.5, 89.5)
27.2 (7.4, 63.6)
0.0
53.2 (18.2, 85.3)
37.8 (11.8, 73.5)
14.2 (1.2, 68.5)
49.7 (15.5, 84.2)
27.2 (7.4, 63.6)
Not Medicated year prior to follow-up (n=32)
Decrease in sx (nonNo change in sx
Increase in sx
ADHD at follow-up)
(subthreshold
(probable
ADHD at follow-up) ADHD cases at
follow-up)
(n=11)
(n=9)
(n=12)
% who declined
% who declined
% who declined
functionally (95% CI) functionally (95% CI)
functionally
(95% CI)
69.5 (30.6, 92.1)
49.3 (17.4, 81.7)
17.8 (4.9, 47.9)
47.1 (18.7, 77.5)
16.2 (3.6, 50.0)
33.0 (9.1, 70.9)
23.1 (8.0, 50.7)
49.3 (17.4, 81.7)
14.3 (3.5, 43.4)
74.6 (42.3, 92.2)
43.3 (15.3, 76.4)
29.3 (10.2,
60.0)
25.3 (9.3, 53.0)
57.6 (24.6, 85.0)
28.4 (9.9, 58.7)
33.6 (10.7, 68.0)
9.8 (1.6, 42.0)
18.3 (5.5, 46.2)

** p < .01 for Chi-square analyses
* p < .05 for Chi-square analyses
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Table 4.9 Baseline to Follow-up Symptom Change and Corresponding SDQ
Impairment Change (Functionally Declined) by Medication Status
ADHD at baseline (n=103)
Medicated year prior to follow-up (n=58)

Baseline SDQ
Impairment
Distress/intrapersonal
Home life
Friendships
Classroom learning
Leisure activities
Total impairment

Baseline SDQ
Impairment
Distress/intrapersonal*
Home life
Friendships*
Classroom learning
Leisure activities**
Total impairment

Decrease in sx
(non-ADHD at
follow-up)

Decrease in sx
(subthreshold ADHD
at follow-up)

No change in sx
(probable
ADHD cases at
follow-up)
(n=4)
(n=11)
(n=43)
% who declined
% who declined
% who declined
functionally (95%
functionally (95% CI)
functionally
CI)
(95% CI)
49.0 (14.4, 84.5)
36.3 (15.5, 63.8)
38.6 (23.1, 56.7)
49.0 (14.4, 84.5)
43.2 (18.9, 71.4)
35.5 (21.0, 53.3)
68.9 (23.3, 94.2)
26.3 (10.3, 52.7)
30.1 (16.5, 48.3)
44.8 (12.5, 82.1)
57.9 (29.0, 82.2)
30.9 (17.4, 48.7)
24.9 (4.3, 70.8)
24.1 (8.4, 52.5)
32.7 (20.2, 48.4)
24.9 (4.3, 70.8)
13.9 (3.9, 39.0)
23.4 (11.2, 42.3)
Not Medicated year prior to follow-up (n=45)
Decrease in sx
(non-ADHD at
follow-up)

Decrease in sx
(subthreshold ADHD
at follow-up)

(n=9)
% who declined
functionally (95%
CI)
77.6 (46.2, 93.4)
44.2 (11.8, 82.4)
61.6 (24.1, 89.1)
49.4 (14.1, 85.3)
85.7 (55.2, 96.7)
36.0 (7.9, 78.6)

(n=11)
% who declined
functionally (95% CI)

** p < .01 for Chi-square analyses
* p < .05 for Chi-square analyses
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59.5 (25.1, 86.6)
41.0 (12.7, 76.9)
23.0 (7.0, 54.5)
83.4 (59.7, 94.5)
6.2 (1.4, 23.1)
52.5 (20.4, 82.6)

No change in sx
(probable
ADHD cases at
follow-up)
(n=25)
% who declined
functionally
(95% CI)
27.4 (13.2, 48.5)
52.8 (27.6, 76.7)
18.8 (8.4, 36.7)
52.6 (27.4, 76.5)
56.7 (31.2, 79.1)
43.9 (19.6, 71.5)

Table 4.10 Results of Multivariate Logistic Regression for Prediction of ADHD
Medication Use
OR (95% Confidence Interval) p value
Subthreshold ADHD
Probable ADHD cases
cases

Independent
Variables
Overall impairment
Abnormal
0.5 (0.1, 2.2)
Normal/borderline
1.0
Parent perceived burden
Medium amount/ 5.5 (1.3, 23.7)
great deal
Not at all, a little
1.0
CD or ODD
Yes
2.5 (0.7, 9.9)
No
1.0
Gender
Female
1.4 (0.5, 4.5)
Male
1.0

0.37
-

1.4 (0.5, 3.4)
1.0

0.51
-

0.02

1.8 (0.7, 4.6)

0.19

-

1.0

-

0.18
-

1.2 (0.5, 2.5)
1.0

0.72
-

0.54
-

0.4 (0.2, 0.8)
1.0

<0.01
-

CD, conduct disorder; ODD, oppositional defiant disorder
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Chapter 5
DISCUSSION
This study considered patterns of symptom and functional impairment change and
predictors of severe impairment and medication use among children in the community
with probable ADHD, subthreshold ADHD, and children without ADHD transitioning
from childhood to adolescence. This chapter revisits the study aims as a framework for
providing a summary and discussion of the pertinent results and conclusions of this study.
This chapter also covers a discussion of study implications, an acknowledgement of
inherent study limitations, strengths, and implications for future research and practice.
RELATED PREVIOUS RESEARCH FINDINGS, MAIN RESULTS, IMPLICATIONS
Research Aims I & III: Aim I: To examine patterns of change between symptoms and
functional among youth with ADHD, with subthreshold ADHD and without ADHD
across two time-points; Research Aim III: To examine patterns of symptom and
functional impairment change from baseline to follow-up for youth with subthreshold
ADHD and youth with ADHD based on treatment status [taking ADHD medication
versus not taking ADHD medication within the last year].
Striving to make meaningful sense of patterns of symptom and impairment
trajectories is an important endeavor for the many reasons including: (1) ADHD and
subthreshold ADHD are highly prevalent conditions; (2) The significant long-term
functionally impairing nature of the disorder; (3) ADHD is under-diagnosed and
undertreated; (4) Research shows impairment rather than symptoms are the main reason
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for treatment referrals (Owens, Johannes, & Karpenko, 2009); and, (5) Federal agencies
have adopted impairment criteria for access to treatment and services and individuals
with subthreshold ADHD are unlikely to qualify for services (Bussing, Mason, Bell,
Porter, & Garvan, 2010).
The analysis portion of the review of the literature revealed two studies which
investigated whether function could normalize for youth, and found that the
developmental trajectory of ADHD is often associated with inconsistent function
(Biederman et al., 1996; Mick et al., 2011). These studies included subclinical groups
with the ADHD groups and were unable to distinguish functional trajectories of youth
with subclinical ADHD. Additionally, global assessment of impairment did not allow for
domain specific assessment of functional impairment.
Young & Gudjonsson (2008) retrospectively demonstrated individuals continued
to experience functional impairment even though they no longer meet full diagnostic
symptom criteria. Using cross-sectional data, Scahill found children with subthreshold
ADHD were significantly less impaired than children with ADHD, but significantly more
impaired than children without ADHD and demonstrated the usefulness of treating
ADHD dimensionally rather than categorically (Scahill et al., 1999). In line with both
Young & Gudjonsson and Scahill, all three studies that did meet inclusion criteria in the
analysis review of the literature also demonstrated that youth with subclinical ADHD
who no longer met symptom count criteria continued to suffer from impairment
(Biederman, Mick, & Faraone, 2000; Bussing, et al., 2010; Faraone, et al., 2006).
The studies mentioned above, were constrained methodologically for at least one
of the following reasons: not including a subclinical group; use of retrospective recall;
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use of cross-sectional data; or not providing detailed information related to percentages of
individuals who make reliable improvement in functioning but not symptoms and visa
versa. Correspondence studies identified in the literature, while they did not meet all of
the analysis review criteria, made a compelling case for using similar methodology to
uncover symptom and functioning developmental trajectories (Karpenko, Owens,
Evangelista, & Dodds, 2009; Owens, et al., 2009; Rosenblatt & Rosenblatt, 2002) among
youth with subthreshold ADHD to compared to youth with and without ADHD in this
study.
The Owens et al. study highlighted a need for research that considers profiles of
children who show no change in symptoms or a reduction in symptoms (Owens, et al.,
2009). The Karpenko study pinpointed a need to compare nontreated individuals with
treated individuals when considering corresponding symptom and impairment, as they
did not consider nontreated individuals (a limitation of using the MTA dataset)
(Karpenko, et al., 2009). These studies also contributed to an understudied area in ADHD
research; the relation between patterns of change in symptoms and change in function
(Owens, et al., 2009). Given the potential importance of subthreshold ADHD and the
almost complete absence of longitudinal research on this subcategory of ADHD, the
literature review analysis helped identify gaps in the current literature that this study was
designed to address.
Further, it is not clear from the literature if youth with subthreshold ADHD who
are unmedicated fare particularly worse over time compared to individuals with
subthreshold ADHD who are taking ADHD medication. To our knowledge, there are no
published studies that have examined how medication use within the context of ADHD
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and subthreshold ADHD unfolds with regard to patterns of symptom and impairment
change. This study sought to discern prospective patterns of symptoms and functional
impairment change in a community sample for youth with subthreshold ADHD and youth
with ADHD depending on medication status (taking medication versus not taking
medication).
This study is a novel extension to previous RCI studies examining the relationship
between change in symptoms and reliable change in functioning and considered
longitudinal data from the South Carolina Project to Learn about ADHD in Youth
(SCPLAY). Findings from RCI and chi square analyses showed a trend among baseline
youth with subthreshold ADHD or probable ADHD who were not medicated the year
prior to follow-up and who were subthreshold ADHD or non-ADHD cases at follow-up;
that decreasing symptoms are associated with functional decline. This may be explained
by research suggesting that although symptoms tend to diminish over time, symptom
declines do not necessarily result in a return to normal function (Willoughby, 2003).
Further, impairment may increase over time as demands increase and through an additive
process; with impairment becoming become more noticeable as children age and acquire
more autonomy (Adler, et al., 2008).
While most ADHD medication treatment studies only consider symptom change,
a review of the literature including studies assessing improvements in functioning found
medication use versus no medication use is associated with greater rates of symptom
remission and increased social and academic functioning (Steele, et al., 2006). While
these study findings show evidence of improvements in functioning with medication use,
findings here show youth with subthreshold ADHD at baseline and medicated the year
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prior to follow-up tended to decline functionally to a greater degree in four out of five
domains of functioning and overall functioning compared to youth with subthreshold
ADHD at follow-up who were not medicated. Individuals presenting with severe
impairment may be show less overall improvement in functional impairment measures
over time. Additionally, medication treatment compliance may be as low as 50% in
children with ADHD (Johnston & Fine, 1993) which may result in poor management of
symptoms and functioning (Perwien, et al., 2004).
It should not be assumed that a reduction in symptoms equates with a reduction in
impairment; nor should it be assumed that if a child continues to meet symptom criteria
for ADHD that he/she is impaired by the disorder’s symptoms (Owens, et al., 2009). It is
well documented that symptomatic remission does not equate with recovery of function
(Biederman, 2011; Gordon et al., 2006; S.P. Hinshaw, Owens, Sami, & Fargeon, 2006;
Mick, Faraone, & Biederman, 2004). Identifying children who make reliable change in
both symptom and impairment change, as well as those who make change in one but not
the other is an important distinction (Owens, et al., 2009). For research, referral,
treatment, and intervention purposes it is important to identify children and adolescents
who fail to meet symptom count criteria for ADHD or who fail to achieve full remission
but continue to struggle with functional burden. Additionally, because subthreshold
childhood ADHD symptoms predict the presentation of adolescent ADHD (Bussing, et
al., 2010) a better understanding of the relationship between patterns between symptom
and impairment change, especially among youth with subthreshold ADHD is warranted
and is useful in identifying targets for early intervention.
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Research Aim II: To examine baseline demographic and psychiatric variables (child
factors: age, gender, comorbidity, medication; family factors: exposure to parental
psychopathology, primary parents educational attainment, marital status)
associated with severe levels of functional impairment at follow-up.
As discussed in Chapter 2, a review of the literature revealed few studies
exploring predictors of impaired functioning among youth with ADHD. Though not well
understood, a number of child and family risk factors have been explored. Child-related
factors including (Gathje, Lewandowski, & Gordon, 2008), higher levels of comorbidity,
increased impulsive symptoms (Biederman, Mick, & Faraone, 1998) and treatment use
(Molina et al., 2009) were found to be associated with impaired functioning. Researchers
analyzing ADHD symptoms most associated with impairment showed symptom
prevalence or subtype distinctions are inadequate in predicting impairment (Mota &
Schachar, 2000).
Family factors associated with functioning among ADHD youth cited in the
ADHD literature include: maternal psychopathology (Biederman, et al., 1998), social
advantage (Molina, et al., 2009), and marital status (Healey, Gopin, Grossman, Campbell,
& Halperin, 2010). No study was found examining predictors of impairment for youth
with subthreshold ADHD. Given that subthreshold ADHD may follow a very similar
impairment trajectory as ADHD that is likely to persist, the current study address this gap
in the literature and exploring predictors associated with more severe forms of ADHD
impairment to see if they were similar for youth with ADHD and youth with subthreshold
ADHD the current study.
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Findings showed probable ADHD and subthreshold ADHD did not share any
significant predictors in common. This was an expected finding based on the supposition
that subthreshold youth would share a similar impairment predictor profile as ADHD
youth. ADHD medication use and primary parent psychiatric history in the non-ADHD
model; gender in the subthreshold model, and psychiatric comorbidity in the probable
ADHD case model were all found to be predictors of severe impairment. These findings
may be relevant to efforts to intervene earlier in childhood and to help identify high-risk
individuals who may be good candidates for targeted interventions.
Research Aim III: To examine baseline demographic and psychiatric variables (child
factors: impairment, gender, race, age, comorbidity; family factors: parent reported
burden, insurance, parent educational level, exposure to parental psychopathology)
that are associated with ADHD medication use at follow-up.
A review of the literature showed several studies that examined predictors of
treatment utilization for youth with ADHD and only a few studies that examined
predictors of treatment utilization for youth with subthreshold ADHD. Service contact for
ADHD is often made because of parent’s perception of problems (perceived burden) or
parental strain rather than child factors such as comorbidity (Angold et al., 1998; Bussing
et al., 2003; Sayal, 2006). Additional predictors of treatment seeking and service use for
children with ADHD include male gender (Beuermeister, 2003; Gau et al., 2010;
Bussing, 2005), maternal education (college or higher) (Gau et al., 2010), parental mental
health history, marital status (divorced) (Jensen, Bloedau, and Davis, 1990) and younger
age (Leslie et al., 2005).
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Among the few studies considering a subclinical ADHD group, two studies found
subclinical ADHD predicted stimulant medication use (Bauermeister et al., 2003; Leslie,
et al., 2005). Reich et al. found that among comparison children, ADHD symptom counts
and presence of impaired functioning were significant treatment correlates (Reich,
Huang, & Todd, 2006). Similarly, Angold et al. found among the subclinical group,
stimulant medication use was significantly related to level of symptoms and was more
common in individuals with a diagnosis of ODD (Angold, Erkanli, Egger, & Costello,
2000). No studies were found examining parent perceived burden as a predictor of
medication use for youth with subthreshold ADHD.
The longitudinal data used here offered the opportunity to consider predictors of
ADHD medication use among subthreshold ADHD and probable ADHD symptom
categories. Most notable among the findings was that parent perceived burden was
predictive of ADHD medication use for youth with probable ADHD but significantly so
for youth with subthreshold ADHD. In these data, parent burden more so than youth
clinical factors (i.e., comorbidity and overall impairment) predicted medication use. This
finding for subthreshold ADHD is novel and in line with research showing parental strain
or perceived burden more than symptoms (Angold, et al., 1998) or comorbid conditions
(including ODD and CD) (Angold, et al., 1998; Bauermeister, et al., 2003) is a major
reason for service contact for ADHD (Farmer, Stangl, Burns, Costello, & Angold, 1999).
Similar to other studies, these data show being male significantly predicted
ADHD medication use for youth with probable ADHD (Bauermeister, 2003; Gau et al.,
2010; Bussing, 2005), however, while not significant, females with subthreshold ADHD
were more likely to take ADHD medication than males with subthreshold ADHD. This
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finding was not expected as girls, especially those with inattention problems are more
likely to be under-referred, and less likely to be treated than boys (Stephen P. Hinshaw &
Blachman, 2005; Staller & Faraone, 2006).
Findings underscore the importance of understanding child and family factors
associated with taking ADHD medication. Identifying parent burden provides an
opportunity for clinicians to discuss parental perceptions of burden and address parent
support needs alongside a discussion and consideration of medication therapy.
Additionally the identified significant predictors of medication use are child and family
factors that are not difficult for clinicians to ascertain and add to the small existing data
available in the literature on this subject.
Possible Areas of Future Research
This study focused on five important domains of functioning (child distress, home
life, friendships, classroom learning, and leisure activities) and used the first follow-up
wave of four waves. Further investigation of these issues is warranted in teens
transitioning into high school and young adulthood. A consideration of multiple time
points using this same methodology is also warranted.
In the present study we calculated a reliable change index (RCI) (Jacobson and
Truax, 1991) to determine statistically significant impairment change. RCI should not be
confused with clinical significance which is often defined as a return to normal
functioning (Jacobson, Roberts, Berns, & McGlinchey, 1999). With the understanding
that ADHD is a persistent neurobiological disorder, further tests of clinical significance
were not performed. Future research should consider if the two-method approach put
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forth by Jacobson & Traux would be too stringent a criterion to use with ADHD and
subthreshold ADHD populations.
STUDY STRENGTHS & LIMITATIONS
This study adds to an absence of population-based longitudinal impairment data
of children with subthreshold ADHD who are identified in early childhood and followed
into adolescence. While most ADHD trajectory studies consider only patterns of
symptom change over time, this study considered patterns of change for both symptoms
and functioning. It utilized well validated instruments, trained data collectors, and
extensive data quality control measures. Study sampling design increased case finding
and analysis accounted for sampling design to give unbiased estimates. It used a
prospective design with a retention rate of 61% at follow-up. In addition to being cross
sectional in nature, most studies focus on children, and this study followed youth up to
age 15. This was a community-based rather than clinic-based study, which is a strength,
as clinic-based youth are likely to have more severe symptom and functional impairments
than youth in the community (Gau, et al., 2010) and may result in higher treatment
seeking rates (Rowland, Lesesne, & Abramowitz, 2002). White boys account for the
majority of research related to ADHD in youth (Hartung & Widiger, 1998 )and girls and
African American youth are well represented in this study.
This study is not without limitations. The SDQ is not a symptom-specific measure
(assessing impairment in relation to a specific symptom or diagnosis) (Canino, Costello,
& Angold, 1999) so there is no way to know which symptoms, if any, are directly related
to the reported impairment. However, using the DISC-IV (a symptom specific measure),
was not possible because if the symptom criteria, duration criteria, or age of onset criteria
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for ADHD are not met, the impairment questions are never asked and subthreshold
impairment and control children’s impairment could not be assessed. Using the
standardized diagnostic interview (DISC-IV) alone, would not have allowed for a
consideration of subthreshold youth and youth without ADHD. Symptom specific
measures are needed that are not constrained by this limitation.
The use of only parent/caregiver report is another limitation, as the DSM-IV
recommends the use of multiple informants and the American Academy of Pediatrics
recommends the need for both parent and teacher report of functional impairment
(American Psychiatric Association, 2000; Wolraich, Brown, & Brown, 2011). Teacher
reports of functional impairment were collected, but due to poor response rates, not used.
Parent subjectivity may also be biased (e.g., underreport due to social desirability, overreport due to help-seeking, endorse symptoms that affect them the most, and may be
more reliable reporters for younger children) (Barkley, 2006). While there is often
disagreement among multiple informants and subjective bias in parent report, parents are
thought to be crucial for a valid assessment of ADHD (Barkley, Fischer, Smallish, &
Fletcher, 2002; Cantwell, Lewinsohn, Rohde, & Seeley, 1997).
Symptom decreases over time might reflect true developmental changes, but also
may be due to other things such as artifacts of repeated measurement (Hart, et al., 1995)
and diagnostic inadequacies (e.g., applying symptoms that are not developmentally
sensitive (Willoughby, 2003). Additionally, the relationship between symptom change
and impairment in specific domains may be a function of the treatment or care that
individuals were provided, comorbidity, or other factors. While the impact of those things
is not known, and the findings are constrained by unadjusted percents and small numbers,
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this represents some of the only data available describing symptoms and functional
impairment for youth in a community setting.
Another limitation of this study is the proportion of baseline participants lost to
follow-up. If those individuals were less likely to have ADHD symptoms or more likely
to have ADHD symptoms or to take medication or not take medication, for example, the
findings are less likely to be representative of the initial sample. Also, due to the low
prevalence rate of ADHD medication use in this sample the estimates of these predictor
variables may not be precise. Finally, as the course of ADHD and subthreshold ADHD is
continually changing, one’s symptom and impairment status at baseline and follow-up
may not be static and future studies exploring changes in patterns of ADHD symptoms
and impairment are needed that use repeated observations.
CONCLUSIONS
The overall results of this study speak to the importance of identifying individuals
who may not experience chronically elevated symptom levels over time but who continue
to experience significant impairments associated with ADHD diminished symptom
counts. Applying the Jacobson & Traux method to these data demonstrates a useful
method for identifying individuals who are at risk for poor developmental outcomes. For
example, despite decreasing symptom counts among youth with ADHD at baseline, 20%
of those who fell into the subthreshold category at follow-up were significantly impaired
in at least one functional domain. This study also identified a minority of children with
ADHD and subthreshold ADHD who despite elevated or increasing symptoms over time
were not reported to have troublesome functional impairment. This investigation supports
the argument for using an alternative to narrowly dichotomizing ADHD. It is hoped that
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through a more careful consideration of symptom and impairment profiles resources can
be targeted to help children and adolescents with ADHD and subthreshold ADHD lead
less impaired lives.
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APPENDIX B – STUDY CONCEPTUAL MODEL

Study Conceptual Model
Time
Current thinking: persistent developmental lag not outgrown
Differences in Clinical Expression
e.g., genetic differences,
More
Dimensional Consideration of ADHD
brain structure and
Symptoms tend to decrease; impairment tends to increase
functioning, gender,
comorbidity

Biology

Dynamic
interplay

Environment

Shape ADHD
Symptom
Expression
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No change
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Dynamic
not
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Dynamic
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Non-ADHD

e.g., individual, family, social
experiences, family adversity,
psychosocial variables, medication use,
cultural norms, early identification
Diminishing or increasing risk (biological and/or environmental) to functioning and eventual outcome
Time
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APPENDIX C – DIAGNOSTIC CRITERIA FOR ADHD
Diagnostic Criteria for ADHD (taken from the Diagnostic and Statistical Manual of
Mental Disorders, 4th Ed. (DSM-IV). American Psychiatric Association, 1994)
A. Either 1 or 2
1) Six (or more) of the following symptoms of inattention have persisted for at least 6 months
to a degree that is maladaptive and inconsistent with developmental level:
Inattention
a) Often fails to give close attention to details or makes careless mistakes in schoolwork,
work, or other activities
b) Often has difficulty sustaining attention in tasks or play activities
c) Often does not seem to listen when spoken to directly
d) Often does not follow through on instructions and fails to finish schoolwork, chores, or
duties in the workplace (not due to oppositional behavior or failure to understand instructions)
e) Often has difficulty organizing tasks and activities
f) Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort
(such as schoolwork or homework)
g) Often loses things necessary for tasks or activities (eg, toys, school assignments, pencils,
books, or tools)
h) Is often easily distracted by extraneous stimuli
i) Is often forgetful in daily activities
2) Six (or more) of the following symptoms of hyperactivity-impulsivity have persisted for at
least 6 months to a degree that is maladaptive and inconsistent with developmental level:
Hyperactivity
a) Often fidgets with hands or feet or squirms in seat
b) Often leaves seat in classroom or in other situations in which remaining seated is expected
c) Often runs about or climbs excessively in situations in which it is inappropriate (in
adolescents or adults, may be limited to subjective feelings of restlessness)
d) Often has difficulty playing or engaging in leisure activities quietly
e) Is often "on the go" or often acts as if "driven by a motor"
f) Often talks excessively
Impulsivity
g) Often blurts out answers before questions have been completed
h) Often has difficulty awaiting turn
i) Often interrupts or intrudes on others (eg, butts into conversations or games)
B. Some hyperactive-impulsive or inattentive symptoms that caused impairment were present
before 7 years of age.
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C. Some impairment from the symptoms is present in 2 or more settings (eg, at school [or work]
or at home).
D. There must be clear evidence of clinically significant impairment in social, academic, or
occupational functioning.
E. The symptoms do not occur exclusively during the course of a pervasive developmental
disorder, schizophrenia, or other psychotic disorder and are not better accounted for by another
mental disorder (eg, mood disorder, anxiety disorder, dissociative disorder, or personality
disorder).
Code based on type:
314.01 Attention-Deficit/Hyperactivity Disorder, Combined Type: if both criteria A1 and A2
are met for the past 6 months
314.00 Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type: if
criterion A1 is met but criterion A2 is not met for the past 6 months
314.01 Attention-Deficit/Hyperactivity Disorder, Predominantly Hyperactive, Impulsive
Type: if criterion A2 is met but criterion A1 is not met for the past 6 months
314.9 Attention-Deficit/Hyperactivity Disorder Not Otherwise Specified
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APPENDIX D – STUDY DESIGN PHASES
SCPLAY FLOWCHART
School District
Screening
Population
8487

Yes
3881
(46%)

Interview Eligible

Yes
2206
(48%)

Recruited
630
(29%)

Phase I: Screening

No
152
(24%)

Parent Baseline
Interview

Phase II: Interviews

Parent Follow-up
Interview

No
189
(39%)

No
4606
(54%)

Parent and/or
Teacher Screener

No
2400
(52%)

Not
Recruited
1573
(71%)

Study Symptom Categories
Baseline
211 Non-ADHD
84 Subthreshold ADHD
186 Probable ADHD

Yes
481
(76%)

Follow-up
129 Non-ADHD
57 Subthreshold ADHD
106 Probable ADHD

Yes
292
(61%)

(Modified from: Figure 1: Project to Learn about Attention-Deficit/Hyperactivity Disorder in Youth Screening and Case Ascertainment Flowchart )
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